{"runtime_info":{"error_code":0,"error_message":"","exec_time":159.14169476786628,"retry_count":0},"data":{"content":"100\n\n100 Questions & Answers\n\nDepartmentofMedicine, NewYorkUniversityMedicalCenter\n\nWorldHeadquarters Jones and Bartlett Publishers 40 Tall Pine Drive Sudbury, MA 01776 info@jbpub.com www.jbpub.com\n\nJones and Bartlett Jones and Bartlett Publishers Publishers Canada 40 Tall Pine Drive 2406 Nikanna Road Sudbury, MA 01776 Mississauga, ON L5C 2W6 info@jbpub.com CANADA ww.iboub.com\n\nt 2005 by Jones and Bartlett Publishers, Inc\n\nJones and Bartlett Publishers Canada 2406 Nikanna Road Mississauga, ON L5C 2W6 CANADA\n\nJones and Bartlett Publishers International Barb House, Barb Mews London W6 7PA UK\n\nAll rights reserved. No part of the material protected by this copyright may be reproduced or utilized inany form,lectronic ormechanical, including photocopying,recording,orby any inon mation storage and retrieval system, without written permission from the copyright owner. The authors, editor, and publisher have made every effort to provide accurate information.However they are not responsible for errors, omissions, or for any outcomes related to the use of the con- tents of this book and take no responsibility for the use of the products described. Treatments and side effects described inthis book may not be applicable to all patients; likewise, some patients may require a dose or experience a side effect that is not described herein.The reader should con- fer with his or her own physician regarding specific treatments and side effects. Drugs and medica devices are discussed that may have limited availability controlled by the Food and Drug Adminis tration (FDA) for use only in a research study or clinical trial. The drug information presented ha been derived from reference sources,recently published data, and pharmaceutical tests.Research clinical practice, and government regulations often change the accepted standard in this field. When consideration is being given to use of any drug in the clinical setting, the health care provider or reader is responsible for determining FDA status of the drug, reading the package insert, reviewing prescribing information for the most up-to-date recommendations on dose, precautions, and contraindications, and determining the appropriate usage for the product. This is especially important in the case of drugs that are new or seldom used. The statements of the patients quoted in this book represent their own opinions and do not necessarily reflect the views of the authors or thepublisher.\n\nLibrary of Congress Cataloging-in-PublicationDat\n\nPlottel,Claudia S. 100 questions & answers about asthma / Claudia S. Plottel P.cm. Includes bibliographical references and index. ISBN 0-7637-4793-9 (pbk.) ， Asthma--Popular works. 2. Asthma--Miscellanea. I. T\n\nottel,CrauuraS 100 questions & answers about asthma/Claudia S.Plottel. P.cm. Includes bibliographical references and index. ISBN 0-7637-4793-9 (pbk.) 1.Asthma--Popular works. 2. Asthma--Miscellanea. I. Title: One hundred questions and answers about asthma. II. Title. RC591.P574 2005 616.2'38--dc22\n\nProduction Credits\n\nChief Executive Officer: ClaytonJones Chief Operating Officer: Don W. Jones, Jr. President, Higher Education and Professional Publishing:Ro V.P., Sales and Marketing: William J. Kane V.P.,Design and Production: Anne Spencer V.P., Manufacturing and Inventory Control: Therese Brauer Executive Publisher: Christopher Davis SpecialProjectsEditor:ElizabethPlatt Editorial Assistant:Kathy Richardson Senior Marketing Manager: Alisha Weisman MarketingAssociate:MatthewPayne Cover Design: Colleen Halloran Cover Image: Ablestock; Picturequest; PeterArnold. Printing and Binding: Malloy Incorporated Cover Printing: Malloy Incorporated Printed in the United States of America 08.07.06.0510.9.8.76.54.3.2 7621\n\nPreface Dedication\n\nPart1.Facts,Theories,andControversies\n\nQuestionsI-12updateusefulinformation about asthma,including: Whatis asthma? ·How many Americans have asthma? ·Is it true that asthma is on the upswing? ·Why is asthma so common? ·What causes asthma? What is the contemporary view of asthma, and how does it differ from the traditional?\n\nPart2.SymptomsandDiagnosis\n\nPart2.SymptomsandDiagnosis\n\nQuestions13-31 describethe symptoms ofasthma andmethods of diagnosis, suchas: ·What are the symptoms of asthma? ·Are there medical conditions that can mimic asthma or make it more severe? Could my symptoms be due to a condition other than asthma? How is the diagnosis of asthma established? ·What diagnostic tests are used to help diagnose asthma?\n\nPart3.ClassificationandVariantForm\n\nQuestions 32-40 highlight theNAEPP's asthma classification and review aty formsof asthma,including:\n\nQuestions 32-40 highlight the NAEPP's asthma classification and review atypical forms of asthma,including: ·What is the National Asthma Education and Prevention Program (NAEPP)? ·What is cough-variant asthma? ·Whatisexercise-induced asthma? What is the“asthmatic triad\"? What is occupational asthma?\n\nPart4.Asthma:TreatmentStrat\n\nPart4.Astbma:TreatmentStrategies\n\n1OOQUESTIONS&ANSWERSABOUTASTHMA\n\n| Questions 41-56 detail different methods of managing and treating asthma:  |\n| --- |\n| · What are written asthma management and action plans?  |\n| · Why should I use medicine if I feel fine?  |\n| · What are the goals of asthma treatment?  |\n| · My asthma is active; how do I know whether I should go to the nearest hospital  |\n| emergency room?  |\n| · How do I know if my physician is a specialist in asthma treatment?  |\n\nQuestions 41-56 detail different methods of managing and treating asthma: What are written asthma management and action plans? Why should I use medicine if I feel fine? 3 What are thegoals of asthma treatment? My asthma is active; how do I know whether I should go to the nearest hospital emergencyroom? ·How do I know if my physician is a specialist in asthma treatment?\n\n| Questions 5772 focus on medications used in asthma treatment:  |\n| --- |\n| · What medications are helpful for asthma?  |\n| · What is the difference between a medicine's generic name and brand name?  |\n| · Why are so many asthma medicines in inhaler form?  |\n| · What is the correct way to use to use my dry powder inhaler (DPI)?  |\n| · How can I tell when my inhaler is nearly empty?  |\n| · Are steroids dangerous medicines?  |\n\nQuestions57-72 focus on medications used in asthma treatment: 2 What medications are helpful for asthma? What is the difference between a medicine's generic name and brand nam ·Why are so many asthma medicines in inhaler form? What is the correct way to use to use my dry powder inhaler (DPI)? How can I tell when my inhaler is nearly empty? ·Are steroids dangerous medicines?\n\nPart6.Astbma:AHealtbyLifestyle\n\nQuestions 73-83 emphasize day to day living with asthma,including: What's new in asthma treatment? My asthma worsens each month near my period. Is that possible? Should I take extra vitamins or mineral supplements because I have asthma? ·Is obesityrelated to asthma? · Is caffeine good for people with asthma? ·What sports are especially beneficial for asthma? ·Is asthma mostly a psychological disease?\n\nPart7.SpecialTopic:AsthmaandPregnancy\n\n173\n\nQuestions 84-88 answer common questions of women in pregnancy, such as: Are asthma medications harmful to my unborn child? Will pregnancy worsen my asthma? ·Will I be able to breast-feed my baby if I'm taking medicine for my asthma?\n\nart8.SpecialTopic:Astbmaand\n\n183\n\nhe Appendix contains a selective listing of resources, publications,and references orfurtherinformationaboutasthma.\n\nfor further information about asthma. Glossary 201 Index 22\n\nGlossary Index\n\nThe good of a book lies in its being read.' TheNameoftheRose(1981)UmbertoEco(1932-\n\nThe very first question that comes to mind when thinking about 100 Questions & Answers About Astbma might well be:“Why read a book on the topic of asthma?”One answer would invoke the cur rent asthma epidemic. After all, asthma affects approximately 17 million Americans, including 5.3% of the adult population along with 6.3 million children. The numbers reflect the fact that we all know at least one person diagnosed with asthma. Perhaps you or one of your family members has asthma. Perhaps, like many of my own friends and relatives, you want to ask questions about the asthma care you've received from your doctor.You want toknow more, understand asthma better, and learn about contemporary developments. The second question you will likely immediately want to ask me personally is: “Why did you write 100 Questions & Answers About Asthma?\" I am a practicing lung specialist, board certified in internal medicine as well as in pulmonary medicine, with a particu- lar interest in asthma care, particularly in adults. In the more than twenty years since I graduated from medical school, the medical community's understanding of asthma has increased tremendously our views on effective treatment have changed a great deal, and highly effective medicines have been developed and brought tol market. I evaluate and treat patients with asthma on a daily basis in my professional life. Successful asthma treatment includes more than medication prescriptions, however. It requires an exchange off information, which goes hand-in-hand with effective communica- tion. The 100 questions I chose for this book are real questions that havebeen put to me over the years in my office\n\n100QuestionsAnswersAboutAsthmaprovidesscientific accurate,up-to-date information that reflects both the medical profession's current understanding of asthma and my own experi ence as an asthma specialist.Gemma Goode,whohas carried a diagnosis of asthma for most of her life,kindly and graciously agreed to offer a patient's perspective on asthma. The question- and-answer format lets you flip through the book to read ahead to the topics that most interest you. On the other hand, the questions are ordered in such a way that you can read them in sequence too. Writing1ooQuestionsAnswersAboutAsthmahascausedme to think about how best to communicate medical information and facts, how to explain “the doctor's side” of asthma, and how to pro vide optimal care for my patients with asthma. I wish to acknowledge Christopher Davis, Executive Publisher for Medicine at Jones and Bartlett Publishers, who has been stead- fast in his support for this book from the start. I am grateful to Elizabeth Platt,Special Projects Editor at Jones and Bartlett Pub- lishers, for her dedication, her enthusiasm, and her top-notch edi- torial expertise. To my husband, Larry Stam, MD, who with Elisabeth and Charles Stam consistently encouraged my efforts: I thankyoufromthebottomofmyheart. I have greatly enjoyed writing the book you now hold in your hands.Myhopeis that you toowill enjoy100QuestionsAnswers About Asthma and that you will learn as much from reading it as I didfromwritingit.\n\nClaudia S.Plottel,MD,FACP,FCCP August12,2004 NewYorkCity\n\nFor Charles and for Elisabeth. With all my love, now and forever.\n\nFacts,\n\nHow many Americans have asthma? Is it true that asthma is on the upswing? Why is asthma so common? What causes asthma?\n\n| \"Cost ume emtapetuse maladie due conserve! sa sante part  |\n| --- |\n| WT rnp grana regima.\"  |\n| \"It is a wearincome illness to preserve one's health by  |\n| too strict a regimen.\"  |\n| La Rochefoucauld (1613-1680),Maximus  |\n\n\"C'estuneennuyeusemaladiequedeconserversasantepar untropgrandregime. \"It is a wearisome illness to preserve one's health by too strict a regimen.\" —LaRochefoucauld(1613-1680),Maximes\n\n1.What is asthma?\n\n1.What is asthma?\n\nAsthma is a chronic lung (respiratory) condition. From a patient's perspective, it is characterized by symptoms of varying intensity and frequency. Asthma symptoms are related to the lungs and to breathing. Some people with asthma have very mild disease and have no symp- toms for much of the year. Individuals whose asthma is at the other end of the asthma spectrum may require several daily lung medications taken on a regular basis in order to normalize lung function and attain a symp tom-free state. In its most severe “life-threatening manifestation, asthma can be responsible for recurrent hospitalizations, severely compromised quality of life and even death.Physicians who specialize in asthma care firmly believe that even the most severely affected asthmasuffererscanbesuccessfullytreated.With proper medical care and cooperation between patient and physician, asthmatics should lead a full and satis- fyinglife\n\n2.HowmanyAmericansbaveasthma? Asthma is a very common lung disease. It has been described in all age groups, from childhood into the \"golden years.\" Asthma affects approximately 17 mil- lion Americans,including 6.3 million children\n\nyounger than 18 years of age. Asthma is the most common chronic disease of childhood. It is the pri- mary cause of school absences due to a chronic condi- tion.More than a million school days are missed annually because of asthma.The U.S. Centers for Dis- ease Control and Prevention estimates that in the year 2001, asthma accounted for 11.3 million visits to office-based physicians, 1.3 million visits to hospital clinics, and i.7 million visits to hospital emergency departments (Table 1). There were also 4,269 reported deaths from asthma for the same period.The last sta- tistic is especially shocking; it indicates that on aver- age, almost a dozen individuals die from asthma each day in the United States. These deaths occur at a time when science has made enormous strides in the under- standing of asthma.Neverbeforehashealth carebeen so sophisticated. Never before has the medical profes- sion had access to highly effective, safe medications and treatments for asthma. And yet, undiagnosed and inadequately treated asthma continues to represent a significant publichealthburden.\n\nTable1AsthmaintheUnitedStates\n\nApproximately 17 million Americans have asthma,including 6.3 million children younger than 18 years of age. In 2001 alone, asthma accounted for 11.3 million visits to office- based physicians,1.3 million visits to hospital clinics, and 1.7 million visits to hospital emergency departments. There were 4,269 reported deaths from asthma in 2001 in the U.S. Asthma-related health costs are estimated at $14 billion dollars annually. Asthma is responsible for approximately 14 million missed school days and 14.5 million missed work days annually.\n\n1OOQUESTIONS&ANSWERSABOUTASTHMA\n\n3.Isittruethatasthmaisontheupswing?\n\nYes, there are more “cases\" of asthma now than ever before in the United States. The prevalence of asthma is increasing in other industrialized countries world- wide as well. Prevalence is the total number of cases of a disease in a population at any given point in time. Of great concern to physicians are urban neighborhoods, such as parts of Harlem and of the South Bronx in New York City, where asthma in children has become epidemic and represents a health crisis.\n\nGemma's comment:\n\nIsasthmamorecommoninurbanthanruralareas?Envi- conmentalfactorsareveryimportantinthecity,butmany of the“triggers”that plague urban environments mayalso befoundinrural areas,such as volatileorganic compounds foundinvarnishes,aerosolsprays,bousebolddisinfectants, andsimilarproducts),peelingpaint,mold,decayingwood inolder buildings,not to mentionthebeavy smoke from those‘romantic’woodfiresthatvacationerslovetobuild when they go to the country.Myownchildhood was spent inasmallMidwesterntownwithnosignificantheavy industryorothercausesofenvironmentalpollution,yetit wasmarkedformebyanannualparadeofseasonalaller- gies,colds,andaperpetual wbeezing“croup.\"\n\n4.Wby is asthma so common?\n\nAsthma is very common, affecting approximately 1 of every 10 Americans at some point in their life, according to 2001 data from the CDC's National Health Interview Survey. It is not clear why asthma\n\nhas become such a prevalent chronic condition. One theory holds that physicians have become more adept at diagnosing asthma correctly so that the more pre- cise identification and more accurate counting of asthmatics has lead to a perceived increase in diag- nosed cases of asthma. Unfortunately, the opposite is true:Thediagnosisofasthmaistoooftenover looked, particularly in older age groups and in ado- lescents, especially teenage girls. The fact is that asthmahastrulybecome more common.Amore likelytheoryimplicatesvarious environmentalfac tors. Smoking, for example, became socially accept- ableforwomenafterWorldWarII.Infants of mothers who smoke are at risk for the development of wheezing and asthma in childhood. Increasing air oollutantsandparticulatesfound inurban orindus- trial areas may also play an important role. From the perspective of an asthma specialist, the enactment of anti-smoking laws banning smoking in all indoor public places, such as in New York City, is a crucial step toward improving air quality for all.\n\n5.Asthma is a disease of children, isn't it?\n\nAsthma is frequently diagnosed in children and is the most common chronic disease of childhood. Asthma, however, is not simply a disease of childhood.Asthma affects adults as well. Many asthmatics are diagnosed wellinto adulthood.Although some adults with asthma may previously have experienced asthma as a child, others develop the condition for the first time as an adult. Asthma can thus develop at any age.\n\n1OOQUESTIONS&ANSWERSABOUTASTHMA\n\n6.How do buman lungs work?\n\n6\\. How do buman lungs work?\n\nThe lungs are part of the respiratory system (Figure 1). A good way to understand the workings of the lungs is to first get an overview of their structure, or anatomy (Figure 1A). The human respiratory system begins at the nose and includes the nasal passages, which allow air to pass by the back of the throat and to enter the windpipe, or trachea. The trachea sits below the voice box (larynx), and can be felt in the front of your neck as it descends behind the breastbone(sternum）into the upper chest. The trachea divides into two branches: the right mainstem bronchus and the left mainstem bronchus. The right mainstem bronchus leads air to and from the right lung, and the left main- stem bronchus leads air to and from the left lung.\n\nThe area where the trachea divides into the right and left mainstem bronchi is called the carina.After the split, the right and left mainstem bronchi leading to each lung subdivide further into smaller and smaller tube-like passages, via the branching tracheo-bronchial tree.As the bronchi continue to subdivide into succes- sively narrower and narrower bronchi, they ultimately end in the tiniest subdivision, the bronchiole. Each bronchiole leads to the lung air sacs, the alveoli.\n\nThe area where the trachea dividesinto the right and leftmainstembronchiiscalledthecarina.Afterthe split, the right and left mainstem bronchi leading tol each lung subdivide further into smaller and smaller tube-like passages, via the branching tracheo-bronchial tree.As the bronchi continue to subdivideinto succes- sivelynarrower andnarrowerbronchi,theyultimately end in the tiniest subdivision,the bronchiole.Each bronchiole leads to the lung air sacs, the alveoli. The alveoli are specialized lung structures. They allow for fresh, oxygen-rich (O2) inhaled air to enter the body, and for oxygen-poor, carbon dioxide-rich (CO2) air to exit (Figure 1B). Oxygen is required for life; oxy gen deprivation is rapidly fatal. As oxygen is provided to the body's organs via the lungs, “used\" air—com- prised mostly of carbon dioxide (CO2)——is excreted by exhalation. Carbon dioxide is produced by the body's\n\nThe alveoli are specialized lung structures. They allow for fresh, oxygen-rich (O2) inhaled air to enter the body, and for oxygen-poor, carbon dioxide-rich (CO2) air to exit (Figure 1B). Oxygen is required for life; oxy gen deprivation is rapidly fatal. As oxygen is provided to the body's organs via the lungs, “used\" air—com- prised mostly of carbon dioxide (CO2)—is excreted by exhalation. Carbon dioxide is produced by the body's metabolism and is considered a“waste product.\"\n\nAbnormal accumulation of carbon dioxide in the body and the bloodstream is detrimental to health and is seen in certain forms of respiratory failure. The process that is responsible for the body's oxygen uptake and its carbon dioxide removal (or excretion) is called respira tion. Respiration is the primary, crucial function of the lungs and respiratory system. Physicians occasionally refer to respiration as “gas exchange.\" Gas exchange takes place in the deepest lung, at the level of the alve oli. Oxygen and carbon dioxide exchange takes place along a specialized zone where each air sac (alveolus) is in intimate contact with fine,minute blood vessels called capillaries. The capillary bed completely encir cles the alveoli along the alveolar-capillary membrane Elevations in blood carbon dioxide levels above normal leadtoadditionalaccumulationof acidsintheblood stream. As acids continue to build up in the body, res- piratoryfailure can ensue.\n\n\\[7. Do lungs continue to develop after\n\nYes. Humans lungs continue to grow and develop after birth. The specialized gas-exchanging lung units called alveoli, where oxygen is exchanged for carbon dioxide, develop postnatally. In fact, the majority of the lung alveoli—nearly 85%—are formed after birth, during the first three years of life. The blood supply within the capillary network matures in parallel with alveolar development from birth to 3 years of age Mucus cells also develop after birth.\n\nBecause the majority of alveoli develop postnatally, the first three years of life can be viewed as a potentially vulnerable period. Young children afflicted with severe\n\npneumonia or tuberculosisduring alveolar develop- ment, especially in the pre-antibiotic era, for example, were left with some degree of pulmonary impairment. Similarly, it is crucial that babies and young children be raised in cigarette and smoke-free homes to maxi- mizenormallungmaturation\n\nAfter the age of three, the lungs are basically formed, but not fully grown. As our bodies grow through adolescence to adulthood, so too do our lungs. Adolescence represents a second “vulnerable\" window.Recentscientific studiesindicate that teenagers who smoke are left with lung function that is less than predicted when compared to healthy nonsmoking teens. The finding of stunted lung function development in adolescent smokers is espe cially notable in girls.\n\n8.What causesasthma?\n\nAsthma has no single, easily identified cause. Multiple causes and the interaction of severalfactors maybe necessary to cause the disease. Studies have implicated a familial component. The tendency to develop asthma has an inherited basis. If one or both parents have asthma, for example, their child has a greater likeli- hood of developing asthma, as compared to another child whose parents have no personal history of asthma. Similarly, studies of large populations of twins, comparing asthma and allergy in pairs of identi- cal and fraternal twins, point to an inherited factor required for asthma development. The actual mode of inheritance is not known.Researchers around the world are working to identify a chromosomal basis for asthma. Investigation into different genes on certain\n\nchromosomes has yielded interesting results,but an “asthma gene\" has yet to be discovered. Advances in molecular biology will hopefully lead not only to the identification of primary asthma genes, but also to the genes responsible for disease severity (asthma severity modifying genes), as well as for response to standard treatments (asthma treatment-modifying genes). Clinicians have long noted that certain viral infections seem to be related to the development of asthma in predisposed individuals. Physicians for example describe“asthmagenic\" viruses that cause typical respi ratory infection and symptoms at first, only to leave the patient with an asthma-like condition. Asthma often goes hand-in-hand with allergies, especially in children and teens. Asthma is more common in per sons with atopy, allergic rhinitis, and eczema. Some types of asthma, called occupational asthma (discussed in Question 40), are related to specific industrial set- tings and exposures. The above observations, along with a large body of research findings, have lead to the current view that asthma is probably “caused\"by a complex interaction between a “susceptible” individual and certain environ- mental conditions (Figure 2). Gemma's comment: It'sespeciallyimportant toremember thatastbmais tricky changing weather conditions, bumidity bolding particles in the air,smoke,and volatile organic compounds all can pro duceasthma symptoms.In thecity wbere renovations,con- struction,street repair，cleaning beating systems，and blowingstackscan occur at any time,itsimportant tokeep a sharp eye (ear and nose, as well) on the ever-modifying) environment.\n\nThe above observations,along with a large body of research findings, have lead to the current view that asthma is probably“caused\" by a complex interaction between a“susceptible”individual and certain environ- mental conditions (Figure 2).\n\nIt's especiallyimportanttorememberthat asthma is tricky. changing weather conditions, bumidity bolding particles in the air, smoke,and volatileorganic compounds all can pro duceasthma symptoms.In thecity wbere renovations,con- struction,street repair,cleaning beating systems,and blowing stacks can occur at any time,its important to keep a sharp eye (ear and nose, as well) on the ever-modifying) environment.\n\nPossibleEnvironmentalFactorsinAsthmaDevelopment\n\nThedevelopmentofasthmareflectsaparticulargeneticorinnatepredisposition to thedisease.In addition,environmentalinfluenceshavebeenrecognized as significantintheemergenceofclinicalasthma.Thepreciseinterplaybetween environmentalandhereditaryfactorsleadingtoasthmaisstillinsufficiently understood.Itishaslongbeennotedthat thatsome environmentalexposures are associated with progressiontoasthma whileothertypes of exposuremight possiblyprevent or delay thedevelopment of asthma in susceptiblepersons.The complexrelationshipsarethesubjectofongoingresearch,atthemolecularlevel inlaboratoryanimals,andinhumanpopulations.\n\nIndoor environments play agreater rolethan outdoor onesin terms of asthn development.\n\nThe2000reporton:ClearingtheAir:AsthmaandIndoorAirExposuresfromthe Institute of Medicine concludes that thereis sufficient evidence to support a causa relationshipbetween asthma development and exposures tohouse dust mite (increased risk of asthma),environmentaltobacco(probablyincreased risk). Cockroach, cat, and dog carry a \"maybe\"increased risk.\n\n1OOQUESTIONS&ANSWERSABOUTASTHMA\n\n9\\. Do allergies cause asthma?\n\nThe answer depends on what you mean by“cause.\" On one hand, the condition we call “asthma\" is a disease that is different from allergy. On the other hand, aller gies and asthma frequently coexist in a given individ ual.An individual with significant allergies is more likely to also carry a diagnosis of asthma than someone without any allergies. Specific allergies can also be a type of external trigger for asthma exacerbations and increasing symptoms.For example,a child with asthma who is also allergic to cats will likely develop symptoms of his asthma if exposed to cats. For that child, cat exposure will worsen asthma, but it won't cause it.\n\nthat is different from allergy. On the other hand, aller- gies and asthma frequently coexist in a given individ ual.An individual withsignificant allergies is more likely to also carry a diagnosis of asthma than someone without any allergies. Specific allergies can also be a type of external trigger for asthma exacerbations and increasing symptoms. For example, a child with asthma who is also allergic to cats will likely develop symptoms of his asthma if exposed to cats. For that child, cat exposure will worsen asthma, but it won't cause it. The most severe form of an allergic reaction is called anaphylaxis. An anaphylactic reaction, especially if untreated, can involve the respiratory system and the lungs. It leads to bronchospasm and narrowed airways, with edema or swelling of the air passages. The ana- phylactic allergic response can cause wheezing, cough and difficulty breathing—symptoms indistinguishable from asthma. An anaphylactic reaction can occur in response to many agents, including bee venom and certain medications.It isconsidered a true medical emergency because it is potentially life threatening.\n\nThe most severe form of an allergic reaction is called anaphylaxis. An anaphylactic reaction, especially if untreated, can involve the respiratory system and the lungs. It leads to bronchospasm and narrowed airways with edema or swelling of the air passages. The ana- ohylactic allergic response can cause wheezing, cough and difficulty breathing—symptoms indistinguishable from asthma.An anaphylactic reaction can occur in response to many agents, including bee venom and certain medications.It is considered a true medical emergency because it is potentially life threatening.\n\n10.Is asthma preventable?\n\nIn an individual who has been diagnosed with asthma, the focus of contemporary treatment emphasizes pre vention of symptoms such as breathlessness, chest dis comfort, cough, mucus production, and wheezing. Certain asthma medications, sometimes referred to as “controller medicine,”are designed and prescribed to\n\nmaintain normal lung function, and to prevent an exac- erbation of asthma—what used tobe called an asthma attack\"(see Questions 12 and 14 for more on this sub- ject). Identification of an individual's asthma triggers and avoidance of exposure to the triggers are other waystopreventanasthmaexacerbation.\n\nPrevention of the development asthma in a given indi vidual is the subject of tremendous research. Patients, pulmonary specialists, allergists, and immunologists are all very interested in understanding the root causes of asthma. Right now, there is no known way to com- pletely prevent the development of asthma.Because asthma tends to run in families, physicians often make suggestions to try and modify the emergence of aller- gies and/or asthma in a child thought to be at increased risk for the development of the disease. Based on epidemiological studies, physicians may advise new parents with asthma to follow special guidelines in caring for their newborn. Many recom- mendations concern thebaby's diet and environment. For example, an exclusive diet of mother's milk for at least the first 6 months of life appears to delay, and possibly defer, the development of allergy and asthma. Similarly,earlyintroductionof solidfood isfrowned upon in an infant at increased risk for asthma. Certain highly allergenic foods should not be part of a toddler's diet. The foods responsible for most food allergy in children include cow's milk, eggs, nuts, and fish. More specifically, 90% of all allergic reactions to food are caused by eight foods: cow's milk, egg, peanut (which is a legume, not a true nut), tree nuts (such as walnuts, cashews, and hazelnuts), fish, shellfish, soy, and wheat. In addition to dietary guidelines, physicians stress the\n\nimportance of a 100% smoke-free home. Some may advise a bedroom free of dust-collecting items such as draperies, stuffed animals, and wall-to-wall carpeting.\n\n11\\. What is the “bygiene bypothesis?\n\nThe hygiene hypothesis is a theory that attempts to explain the increased prevalence of allergy and asthma in affluent, industrialized nations. It also strives to elu- cidate factors that are responsible for the development of asthma in individuals.\n\nThe British epidemiologist David Strachan advanced thehypothesisin1989after studying thehealth records of approximately 17,000 British children. The hypothesis proposes that the rising prevalence off asthma and allergic diseases parallels the decreasing prevalence of infections in childhood. Over the last 100 years, urbanization, advances in public health, improved sanitation, and the adoption of cleaner living environments, along with the introduction of antibi- otics, have all lead to reduction in infectious illnesses in children. During the same period of time, the occurrence of asthma and the allergic diseases has increased. The hygiene hypothesis links the two obser- vations. The hypothesis suggests that the reduced exposure to “dirty” environments and to infectious agents at a specific point in childhood leads to less stimulation of certain parts of the growing child's immune system. Changes consequently fail to take place in the maturing immune response and, in turn, predispose that child to an increased risk of developing allergies or asthma.\n\nEpidemiological studies of large groups of people botl with and without asthma have noted that two envi\n\nronmental factors seem to protect against the develop- mentofasthma:attendanceataday-carefacility before the age of 1 year and the presence of a dog in the family home before birth and onward.Both fac- tors support aspects of the hygiene hypothesis. Early exposure to “dirty,\" less sanitary environments appears to lead to a lower occurrence of asthma in that spe- cific, exposed population. Research continues in the area of the hygiene hypothesis. Is there an age at which a child's immune system needs to be “stimu- lated\" in a specific way, by certain environmental agents or viruses, in order for asthma not to develop? If such were the case, specific interventions or medica- tions couldbe developed to modify a child's risk of asthma. The hygiene hypothesis remains controversial, and at present it represents an intriguing theory that is farfromdefinitive.\n\n12\\. What is the contemporary view of asthma,and how does it differfrom traditionalviews?\n\nFor manyyears,asthma was viewed as a disease of airway narrowing, or bronchoconstriction. In the traditional view, the bronchial passages, especially those encircled by specialized muscle fibers, became narrowed or con- stricted, and an inevitable“attack\"would follow.The tra- ditional explanation emphasized that constriction of the bronchial tubes was the primary event in asthmatics. The focus of asthma treatment centered on attempts at reversing constricted breathing passages. Consequently treatment consisted mostly of relief of airway narrowing once symptoms developed and became established. Emphasis was placed on treatment of “attack\" symp- toms, rather than on preventive measures.\n\nble2Asthma:QuiescentversusExacerbated\n\nThe contemporary perspective on asthma recognizes the importance of bronchoconstriction, but assigns it a secondary role. The principal “player\" or “culprit\" in asthma is inflammation. In the contemporary model of asthma, asthmatics experience periods of active disease or exacerbation, along with quiescent periods of remis- sion (Table 2). During an exacerbation, there is increased inflammatory activity in the asthmatic lung The inflammation, if unchecked, leads to mucus gland stimulation with excess secretions, and to eventual bronchoconstriction, or airway narrowing. The in- creased mucus leads to cough.The bronchoconstric tion is responsible for symptoms of breathlessness, wheezing, and chest tightness.\n\nIndividuals with asthma have a propensity to develop an enhanced inflammatory response in their lungs They are said to have an innate state of lung “baseline hyperreactivity.\" A specialized lung test, called the methacholine challenge (bronchoprovocation）test discussed in Question 29),is helpful to clinicians when evaluating individuals suspected of having asthma and a state of lung hyperreactivity. The ten- dencytoincreasedbaselinehyperreactivityislikely\n\n| Inacting symptomatic asthma  | Active research and asthma  |\n| --- | --- |\n| Inflammation absent, quiescent  | Heightened inflammation  |\n| Air passages are clear of mucus  | Mucus production increases → leads to cough, clear mucus  |\n| Air tubes are patent, “fully” open  | Air tubes narrow, constrict → leads to wheezing, tightness, breathlessness  |\n\nhereditary.Increased baseline hyperreactivity explains why, for example, asthmatics are more “sensitive” to inhalation of different environmental stimuli such as cold air, strong odors, or cigarette smoke. The pres- ence of bronchial hyperreactivity is of great interest to asthma researchers. It is tempting to speculate about a medication that could modify a person's bronchial hyperreactivity and so reduce the severity of his or hen asthma\n\nThe current understanding of asthma as a disease pri- marily of inflammation,with secondary airway nar- rowing and constriction as a consequence of an increased inflammatory response, has both research and practical implications. It allows for preventive interventions andfor more directed medications.Con trolling and limiting airway inflammation controls asthma symptoms and allows for normal lung func- tion, an excellent prognosis, and a healthy lifestyle. Prompt treatment of an exacerbation, if and when it occurs, always includes anti-inflammatory treatment in addition to specific treatment of bronchoconstriction. Recognition of the importance of inflammation in asthma haslead toa better understanding of asthma, and to thedevelopmentofmoreeffectivetreatment.\n\nAsthmaexacerbationsoftenoccur predictablyand inevitably following certain exposures, such as the onset of cold winter temperatures,for example. Some individuals “get an attack” every fall at the change of season and must forego daily routines including work and school,or avoid leisure activities.Treatment of established symptoms of“an attack\"in the traditional view might include a burst of medications,hopefully in the office setting, but possibly in the hospital. The\n\nTable3\n\nThe modern view of asthma emphasizes the all-important role of inflammation. Consequently,contemporary asthma treatmentincludes: avoidingfactors thatincrease lunginflammation ·medications that have anti-inflammatory properties The traditional view erroneously assigned a primary role to airway nar- rowing(bronchoconstriction). Bronchoconstriction, or airway narrowing, is the consequence of a more powerful stimulus: airway inflammation.\n\ncontemporary view of asthma, however, emphasizes a preventative approach (Table 3). An asthmatic individ- ual with a pattern of worsening symptoms at the change of season would be prescribed anti-inflamma- tory medication as winter approached, for example. By successfully controlling inflammation,and by being alert to early signs and symptoms of disease exacerba- tion,“attacks” would be avoided, along with significant lifestyledisruptions.\n\nSymptoms\n\nWhat are the symptoms of asthma? Are there medical conditions that can mimic asthma or make it more severe?\n\nCould my symptoms be due to a condition\n\nHow is the diagnosis of asthma established? What diagnostic tests are used to help diagnose asthma?\n\nMore .\n\n1OOQUESTIONS&ANSWERSABOUTASTHMA\n\n13.What are the symptoms of asthmg\n\nThe symptoms of asthma will vary from person to per- son. Even for an individual, symptoms may vary over time. That said, and even though each individual is unique, certain symptoms are typical of asthma in gen- eral (Figure 3). Typical symptoms include one or more off the following: an awareness of breathing, an uncomfort- able feeling of breathing, chest pressure or discomfort, wheezing or noisy breathing, labored breathing, cough mucus production, and breathlessness with exertion. Nocturnal symptoms, such as waking from sleep with uncomfortable breathing or wheezing, are not uncom mon in asthma. Asthma symptoms are usually episodic; symptoms come and go, and need not be present con- stantly. Asthma exists in various forms, from mild to severe. A person with a milder form might experience different symptoms of different levels of intensity than someone with a more severe form of asthma\n\nAsthmaischaracterizedby\n\n1OOQUESTIONS&ANSWERSABOUTASTHMA\n\n14.Whatis an“exacerbation\"ofastbma?\n\nAsthma is characterized by periods of exacerbations and remissions.An exacerbation of asthma refers to an increase in lung inflammation and represents a period of increased asthma activity.It indicates a flare of the disease.An exacerbation of asthma manifests itself as the development of pulmonary symptomatology. Examples of exacerbation or “flare” symptoms include wheezing, coughing, nighttime symptoms, increased mucus production from the lungs, breathlessness or dyspnea, and chest pressure or discomfort (Table 4).\n\nTable4AsthmaExacerbations:Symptoms\n\nSymptomsare wbatanindividualexperiences.Physicians should always ask patientswithasthmatoreportsymptoms. Abnormal awareness of breathing:dyspnea “Ifeelmybreatbing;mybreathingisuncomfortable.\"\n\nBreathlessness, at first with exertion or activity; may also occur at rest as an exacerbationprogresses “Ican'tcatchmybreath;Imoutofbreathandneedair.\"\n\nNocturnal awakenings,interrupted sleep from difficulty breathing “Ikeepwaking upat2AManddon't feelright.\" Pressure sensation over chest, or feelings of tightness “\"Ifeel as ifthere's an elepbant sitting onmy chest.\"\n\nDuring anexacerbation,measurementofpeakflowwill usually decrease. Measurement of lung function also typically reveals reduced values. An exacerbation usually begins with mild symptoms. If unchecked, a mild exac- erbation will worsen and become more severe. Mild exacerbations, identified early and treated appropri- ately—perhaps with increased use of inhaled medica- tion—can be “nipped in the bud\" with minimal, if any disruption of health and lifestyle. More advanced exac- erbations may, however, require the use of additional medication, such as steroid tablets. Severe or rapidly progressive exacerbations can require hospital-based or emergency departmentintervention and treatment.\n\ntypically reveals reduced values. An exacerbation usually begins with mild symptoms. If unchecked, a mild exac- erbation will worsen and become more severe. Mild exacerbations, identified early and treated appropri- ately—perhaps with increased use of inhaled medica- tion—can be “nipped in the bud\" with minimal, if any disruption of health and lifestyle. More advanced exac- erbations may, however, require the use of additional medication, such as steroid tablets. Severe or rapidly progressive exacerbations can require hospital-based or emergency department intervention and treatment. Note that the term “asthma exacerbation\" has sup planted the outdated concept of“asthma attack.\"Exac erbation more accurately describes the gradual nature of the buildup in lung inflammation during a disease flare.An exacerbation of asthma,even of the milder type, should never be ignored or dismissed as insignifi- cant. Asthma treatment plans are helpful in providing a guide to initial self-management of symptom flares (Table5).\n\nNote that the term\"asthma exacerbation\"has sup- planted the outdated concept of“asthma attack.\"Exac erbation more accurately describes the gradual nature of the buildup in lung inflammation during a disease flare.An exacerbation of asthma,even of the milder type, should never be ignored or dismissed as insignifi cant. Asthma treatment plans are helpful in providing a guide to initial self-management of symptom flares (Table5).\n\n15.What is a wbeeze?\n\nA completephysical examination includes auscultation of the lungs with a stethoscope. The physician places the chest piece of the stethoscope on the patient's upper torso and listens as air enters and exits the lungs The patient is then asked to take several deep breaths breathing through his or her mouth. The physician pays close attention to the symmetry of the breath sounds and to any audible abnormalities.\n\nIOOQUESTIONS&ANSWERSABOUTASTHMA\n\nTable5AsthmaExacerbations:KeyPoints\n\nAn exacerbation of asthma reflects increased lung inflammation.An exacerbation is a flare of disease activity.\n\nQuick and appropriate intervention andresponse to a developing exacerbation will limit its extent, and restore normal lung function. Although asthma exacerbations develop and“build up”gradually,if untreated, they can rapidly amplify and may ultimately lead to hospital- ization,respiratory failure,and even death.\n\nNever ignore increasing or worsening asthma symptoms such as wheezing, cough, mucus production, nighttime awakenings, breath- lessness, uncomfortable breathing, or chest tightness. Not all sympto1 need to bepresent to define an exacerbation.\n\nExacerbation symptoms will vary from individual to individual.\n\nPrevention of exacerbations is a goal of contemporary asthma management.\n\nPrevention of exacerbations is a goal of contemporary asthma management. Remember that asthma and its symptoms are controllable.\n\nA wheeze refers to an abnormal breath sound made when air travels though a breathing passage (airway) that has become narrowed. The narrowing can be due to mucus secretions trapped in the airway or to the air- way muscles' constriction or tightening. In asthma, the airway narrowing is reversible. Medications prescribed for asthma help the narrowed airway return to its nor- mal size.A wheeze is best described as a high-pitched whistling sound. Wheezing can occur while breathing in (inspiratory wheezing, during the inspiratory phase of the breath), while breathing out (expiratory wheez ing, during the expiratory phase of the breath), or dur- ing the entire breath. Asthma is one of several conditions that can cause wheezing. If wheezing is severe, it can be heard without a stethoscope.\n\nWheezing in asthma reflects ongoing lung inflamma- tion and airway narrowing, or bronchoconstriction. The presence of wheezing in asthma indicates that the asthma is active,and that more intensive and effica- cious treatment is warranted. Wheezing should never be ignored. If airway narrowing and inflammation are left untreated, there is a real risk of the disease worsen- ing, which can become potentially life threatening.\n\n16.WillIknow when I wheeze?\n\nGemma'scomment:\n\nIn myteensIattendedaboarding scboolinnorthernNew YorkState.Ifound thatinwinterIcould alwaysdevelopa noisy“wheeze\" if I opened a window and took big gulps of cold air.The choking cough and noisy breathing that followed was enougb to getme excused from wbat was called winter \"sport\" (usually shoveling snow off a basketball court!), and that was wbatIwanted.Ididn't thinkIwassick,”just “smart.”Certainly,Inever discussed these symptoms with a doctor,because they served me well:they excused mefrom unwantedactivity.Ofcourse,suchwbeezesmightnothave beendiagnosedasasthma(asdiscussedinQuestion91).\n\nMost individuals with asthma can recognize when they are wheezing. They may become aware of the abnormal sound of wheezing as inhaled air travels though narrowed bronchial passages: “It sounded like a cat purring in my chest.\" Others may notice an uncomfortable mid-chest pressure. Wheezing should never be ignored or dismissed as unimportant. In people with a variant type of asthma called “cough variant asthma,” wheezing is absent, replaced by a dry,\n\nnonproductive cough. The emergence of wheezing, or persistent dry cough in the case of cough-variant asthma, is always significant and must be reported to the treating physician. The development of wheezing indicates inadequate asthma control and may herald the beginning of an exacerbation of the disease. The same is true of a cough in cough-variant asthma because the coughisequivalenttoawheeze\n\n17\\. Does wbeezing mean that Ibave\n\nNo, not necessarily. The to and fro movement of air through the lungs and tracheo-bronchial tree should always be silent. A wheeze is an abnormal sound pro duced by turbulent flow of air through the lungs. There are many different causes for wheezing (Table 6). However, the occurrence of a wheeze by itself with out any other symptoms is unusual. It is therefore important to note if the wheezing is recurrent or if it is associated with other lung symptoms such as breath- lessness,cough,ormucusproduction\n\nMedical students learn that“not all that wheezes is asthma.\" Although most people with asthma will at some point experience wheezing, not everyone who wheezes has a diagnosis of asthma. Some people who wheeze will have a lung condition other than asthma, while others will wheeze even though there is no iden tifiable lung condition and the lungs appear com- pletely normal. In the first category are those with a cigarette-related lung disease such as COPD, fon example. Other lung diseases, such as bronchiectasis or bronchiolitis, can alsolead to wheezing. Certain infec-\n\n1OOQUESTIONS&ANSWERSABOUTASTHMA\n\nTable6CausesofWheezing\n\n| Asthma  |\n| --- |\n| Foreign body aspiration  |\n| COPD  |\n| chronic obstructive bronchitis  |\n| emphysema  |\n| Bronchiectasis  |\n| Lung infections, infectious bronchitis, bronchiolitis, croup  |\n| Allergic reaction (severe, anaphylactoid)  |\n| Congestive heart failure  |\n| GERD (gastro-esophageal reflux disease)  |\n| Drug induced (beta-blockers)  |\n\ntions of the lungs can cause wheezing in completely normal lungs. Some people without lung disease who have a type of heart dysfunction called “congestive heart failure”can wheeze if they take in too much fluid. Still others might wheeze after a severe allergy, such as to a bee sting, for example. Gastric reflux, called “GERD\" (gastro-esophageal reflux disease), is a disease of the digestive system and is an example of a nonpulmonary condition that can mimic asthma. Sim ilarly, vocal cord dysfunction syndrome, or “VCD, affects the voice box (larynx)and is often confused with asthma. Finally, and especially in children, a wheeze can be caused by a foreign body trapped in the bronchial tree. Young children, in particular, explore the world by putting objects in their mouth. From there, it's a short trip “down\" into the breathing pas- sages. A foreign body should be retrieved, or “fished\n\nout” of the lung passages, usually via bronchoscopy. Medical journals andtextbooks have describedthe successful retrieval of many disparate items, from fish or chicken bones to coins, toy fragments, or even a coffeestirrer.\n\n18\\. Wby do I cough after jogging, running, or exercise?\n\nThe presence of a cough is always abnormal. There are many reasons why a person might develop a cough Each one of us has experienced a cough at some point in our lives, when ill with a respiratory infection or a head cold, for example. Most coughs due to colds are short lived. When a cough lasts longer than two or three weeks, or develops in a particular pattern, take note. The majority of individuals with chronic cough have one of three causes: asthma, gastric reflux, or sinus disease. Cough that regularly occurs with exer cise, in the setting of aerobic activity, strongly suggests the presence of asthma,unless proven otherwise\n\nExercise is considered a “trigger\" in all persons with asthma.Exercise does not cause asthma but acts as a stimulus to bronchoconstriction in asthmatics and causes increased airway inflammation. In young children in par- ticular, cough with exertion should never be ignored; it may be the“tip off\"to the diagnosis of asthma.\n\n19\\. Could my symptoms be due to a condition other than asthma?\n\n19\\. Could my symptoms be due to a\n\nYes, depending on what your symptoms are. Medical students and physicians in specialty training are taught the skill of “differential diagnosis.\" When reviewing and analyzing a patient's report of symptoms, the\n\nphysician generates a list of different possible condi- tions that could theoretically be responsible for the symptoms. That list of possible conditions is called the differential diagnosis. The physician then ranks the possibilities in order of likelihood. The most likely, based on the information available, is listed first. The next step usually involves attempting to confirm, or “rule in\" the doctor's initial diagnostic impression by performing specific tests as needed, in addition to the physical examination. For example, the differential diagnosis of a persistent, dry cough that lasts more than a month might include asthma, postnasal dis- charge and drip, or gastro-esophageal reflux disease (GERD),either alone or in combination.\n\nSome conditions mimic asthma (Table 7).For exam- ple, vocal cord dysfunction syndrome can exhibit symptoms similar to asthma. Specific types of heart disease, such as congestive heart failure, can be mis- taken for asthma. Some physicians even use the term \"cardiac asthma,”a misnomer, to describe the wheezing sounds associated with congestive heart failure. Simi- larly, lung diseases other than asthma can be responsible for symptoms suggestive of asthma. Emphysema and chronic obstructive bronchitis can “look like” asthma. but a significant history of smoking cigarettes is usually present. Pulmonary sarcoidosis can cause wheezing Rare lung diseases like obliterative bronchiolitis or eosiniphilic pneumonia are also occasionally in the dif- ferential diagnosis of asthma-like symptoms.\n\n20.What is“COPD\"?\n\n\"COPD\"is an acronym for the term chronic obstruc- tive pulmonary disease. Chronic obstructive pul- monary disease is a descriptive term rather than a\n\nTable7\n\nCertainotberlungdiseasesleadtosymptomstbatsbaresimilaritieswith asthma. COPD: chronic obstructive pulmonary disease that includes emphy sema and chronic obstructivebronchitis Pulmonaryembolus A lesion or tumor—-benign or malignant—that obstructs a major airway Rare lung diseases such as PIE: pulmonary infiltrates with eosinophiliaor eosiniphilicpneumonia\n\nCardiac dysfunctioncanalsomimiccertainasthma symptoms. CHF:congestive heart failure\n\ndisease, although it usually is used to refer to emphy. sema, or to chronic obstructive bronchitis.\n\nTechnically, COPD refers in a general way to several different lung conditions that demonstrate an abnor- mality on spirometry, a type of pulmonary function test. The abnormality that characterizes COPD is called obstructive dysfunction.\" Several different lung condi- tions typically exhibit the obstructive dysfunction pat tern of abnormality on pulmonary function testing. They include emphysema, chronic obstructive bronchi- tis, exacerbated asthma, and bronchiectasis. The two first diseases, in particular, share several features.Both\n\nemphysema and chronic obstructivebronchitis are asso- ciated with cigarette smoking. Both exhibit obstructive dysfunction on spirometry that does not completely reverse with medication, and thus demonstrate a“fixed' or “irreversible” type of obstructive dysfunction. Both cause respiratory symptoms such as breathlessness or cough. Interestingly, emphysema and chronic obstruc- tive bronchitis frequently coexist in the same person, usually a current or former cigarette smoker.\n\nPartlybecause emphysema and chronic obstructive bronchitis appear at first glance to be so similar, physi cians have taken to using the term COPD to refer specifically to either emphysema or chronic obstructive bronchitis, or even to a combination ofboth.The use of COPD as a kind of shorthand for a disease, whether emphysema or chronic obstructive bronchitis,has taken hold among medical professionals as well as the general public, despite disapproval from some linguistic purists.\n\nNo, not really. Asthma is a specific lung disease that is separate and different from emphysema and chronid obstructive bronchitis.COPDis often used to describe emphysema, chronic obstructive bronchitis, or a combi- nation of both. COPD, therefore, refers to diseases that are not asthma. COPD is not related to asthma, although COPD and asthma do share apparent similarities. In someindividuals,COPD can coexistwith asthma.\n\n22.Whatarethesimilaritiesand differencesbetweenasthmaandCOPD? COPD and asthma are lung ailments. Asthma and COPD are often confused because they can both give rise to similar symptomatology, and are sometimes\n\n22.Whatarethesimilaritiesand\n\ntreated with the same medicines.Both conditions can variably lead to symptoms of breathlessness, wheezy breathing, coughing, and mucus production. Some medicines prescribed for the treatment of asthma, such as the inhaled β2 agonist inhalers and theophylline, for example, are also used in COPD treatment. Asthma and the conditions caused by COPD may also demon strate a similar pattern of abnormality on pulmonary function testing called “obstructive dysfunction.'\n\nTo a pulmonologist, COPD and asthma are completely different.The single most common cause of COPD is cigarette smoking. COPD is a disease of mid to late adulthood. COPD is the fourth leading cause of death in the United States, and is a significant cause of lifestyle limitation. COPD's obstructive dysfunction, as noted on pulmonary function testing, is fixed or “irreversible. Asthma has a genetic basis. It affects all ages. The diag- nosis of asthma is compatible with a long and full life. By definition, the obstructive dysfunction on pulmonary function tests in asthma is reversible.\n\n23.Aretheremedicalconditionsthatcan\n\nSeveral medical conditionscan mimic asthma.Sur prisingly, not all of them are lung diseases (discussed in Question 19). Lung diseases that should be differenti- ated from asthma include the “COPD group\" and pul- monary embolus, as well as rarer diseases such as eosiniphilic pneumonia and PIE. A benign or malig nant growth arising in the major bronchial tubes can also lead to wheezing and shortness of breath and couldbe confusedwithasthma.Conditionsaffecting the upper respiratory system, more specifically, the lar- ynx or voice box, are well-known asthma“copycats.\"\n\nVocal cord dysfunction syndrome, along with dysfunc- tion and tumors of the voice box, are good examples.\n\nThe non-pulmonary asthma mimics include cardiac diseases, such as congestive heart failure (CHF), and digestive diseases, principally reflux and gastro- esophageal reflux disease (GERD). Finally, certain prescription medications can produce asthma-like symptoms in susceptible individuals. The antihyper tensive medicines known as ACE-inhibitors can give rise to a nagging dry cough that is easily mistaken for an asthmatic symptom. Beta-blocker medication, used in the treatment of glaucoma and cardiovascular dis- ease, can cause wheezing and breathlessness, often indistinguishablefromasthma\n\nMedical conditions such as sinusitis, allergic rhinitis, and reflux (GERD) can make asthmatic symptomatol- ogy more pronounced, particularly if they are not addressed and treated appropriately. So, in addition to avoidance of known asthma triggers, good asthma management should include identification, and prompt and effective treatment of any concurrent ill- nesses(Table 8).\n\n24\\. What is vocal cord dysfunction syndrome (VCD)?\n\n24.What is vocal cord dysfunction\n\nVocal cord dysfunction syndrome, or VCD, is a complex condition characterized by abnormal paradoxical move- ment of the vocal cords. Normally, the two vocal cords look like a “V\" When you take a breath in, the vocal cords assume an even wider “V\" shape and spread fur- ther apart to allow air into the trachea and lungs. In\n\nAny of the nine factors described below may contribute to making your asthma mord difficulttocontrol.\n\n| Factor  | Control measure  |\n| --- | --- |\n| Allergens  | Correctly identify specific allergens and address appropriately: avoidance, antihistamine therapy, immunotherapy injections. Epinephrine auto-injectors for emergency use might be prescribed.  |\n| Tobacco smoke  | Smoking cessation, smoke-free home and work environments.  |\n| Rhinitis  | Directed therapy: nasal sprays (cromolyn, nasal steroids), nasal washes, antihistamines, leukotriene antagonists, decongestants.  |\n| Sinusitis  | Correct diagnosis is important; drainage measures, washes, nasal steroids, antihistamines, and/or decongestants may be prescribed. Antibiotic therapy is reserved for acute bacterial infections.  |\n| Gastro-esophageal reflux, also known as GERD  | Dietary manipulations; small, frequent meals; prescription antacid medication. Elevation of the head of the bed may be advised.  |\n| Sensitivity to sulfite additives  | Sulfite-sensitive asthmatics should avoid all sulfite-containing foods. Common examples are red wine, beer, shrimp, dried fruits.  |\n| Selected medications  | Beta-blockers in any form: eye drops (used in glaucoma treatment), as will as pills (used in high blood pressure and heart disease treatment), can cause bronchospasm. “Aspirin-sensitive” asthmatics must avoid aspirin and the nonsteroidal, anti-inflammatory class of medicines.  |\n| Viral respiratory infections  | Yearly influenza vaccination should be recommended (unless contraindicated).  |\n| Occupational exposures  | Importance of a safe workplace environment: proper ventilation, avoidance, and when appropriate, personal protective respirators.  |\n\nactive VCD,however, the vocal cords close instead of opening during inspiration. Because the cords swing together instead of moving apart, the flow of air into the trachea and lungs becomes compromised. Wheezing occurs as air is forced through the abnormally narrowed vocal cord opening. Other symptoms of VCD include a change in voice quality, hoarseness, throat or chest tightness, and difficulty swallowing.\n\nVCD is often misdiagnosed as asthma,especially as difficult-to-control, or refractory, asthma. Clues to its diagnosis include non-response to asthma treatment, a preponderance of throat symptoms, as well as the absence of nocturnal symptomatology that is so char acteristic of asthma.VCD can occur in childhood, adolescence,or adulthood,but is more commonin people who are in their 20s to 40s. In younger patients, VCD may occur during competitive sports and sems to have an association with a driven or high-achieving personality style. Psychological factors may be impor tant in adults as well. Among adult patients, women predominate, as do female healthcare workers, for rea- sons that are not understood.\n\nIf VCD is suspected, referral to a specialized center familiar with diagnosis and treatment of VCD should be strongly considered. It is especially important to deter- mine whether VCD is present alone, or whether there is a dual diagnosis of asthma and VCD, as they can occa- sionally exist together in the same patient. Treatment of VCD includes discontinuance of any non-indicated medication, particularly steroids. Specialized speech therapy is the mainstay of treatment and is accompanied, when indicated, by relaxation exercises and psychological support.\n\nIOOQUESTIONS&ANSWERSABOUTASTHMA\n\nGERD is an acronym for gastro-esophageal reflux dis- ease, a medical condition related to the regurgitation of stomach acid. GERD is a very common condition and can be experienced as heartburn and indigestion. Acid refluxing from the stomach can irritate the vocal cords Hoarseness and a cough akin to throat clearing may ensue. Finally, any acid reaching the uppermost respira- tory passages can cause coughing and even wheezing, similar to asthma.GERDnot only mimics asthma symptoms, but can also worsen stable asthma. The good news is that GERD is highly treatable. Treatment con- sists of straightforward dietary and lifestyle modifica- tions, as well as medication to reduce the stomach's acid production. Sometimes measures as simple as avoiding carbonated beverages, fried foods, and caffeine, eating frequent, smaller meals, or not eating for three hours before bedtime will do wonders for reflux symptoms. Better reflux control will lead to improved asthma con- trol andreducedasthmasymptoms.\n\n26\\. How is the diagnosis of asthma\n\nGemma's comment:\n\nAsanolderadultinmy60s,Ihad,atdifferenttimes,two primary carepbysicians:onewhosespecialty wasgastroin testinalmedicine,theotherwbosespecialtywascardiology Inroutineinterviews,theybothaskedifIcougbedona daily basis,and of course I said yes.Yet neither one sug- gested thatIshouldseeapulmonologist,andIwasnotsur prised,sinceIwas usedto cougbing andthougbtofit as\n\n“normal.\"MyasthmawasdiagnosedonlywbenIturned upfor aroutinevisitinthecardiologist's officewithabad cold and a wbeeze.In the light of my experience,it's easy formetobelievethatastbmaisunderdiagnosed.\n\nThe diagnosis of asthma is often straightforward, but can also be frustrating and elusive. Asthma can mani- fest differently in different individuals because of its waxing and waning nature, as well as its variability. A physician evaluating a patient with a typical, or “text- book,” presentation will likely be able to correctly diagnose asthma at the first visit. A patient with vari- ant or atypical symptoms may require repeat visits or specialized diagnostic testing to confirm the suspected diagnosis of asthma.Usually, more severe forms off asthma are easier to pinpoint and diagnose accurately Consider some examples in each category. A previ- ously healthy, nonsmoking young adult who reports an episodic history of intermittent wheezing, cough, chest discomfort, and breathlessness with exposure to cold winter air is describing a history typical of asthma. The college student who sees the doctor because of a “nag- ging cough,” and who is concerned about chronic or recurrent “bronchitis and colds,” might actually be asthmatic. Similarly, the teenager who gets “really winded\" playing racquetball, and then “gets used to\" coughing for a few hours after each match, could cer- tainlyhaveasthmaaswell.\n\nAsthma can be confidently diagnosed when specific symptoms, physical examination findings, and special- ized test abnormalities are present. The first step in the evaluation of suspected asthma is a complete medical history, during which the doctor and the patient meet face to face for an in-depth conversation and exchange ofinformation.The patient will describe in detail what\n\nsymptoms he or she is experiencing, and the physician will ask a series of directed questions regarding lung health, followed by more general health inquiries. In this fashion, the physician will obtain information not only about the patient's specific pulmonary symptoms, but also about the presence or absence of allergies, and other medical or surgical conditions. Other important background information derives from review of the patient's medication history, along with their travel, occupational, and social history. Some questions may at first sound intrusive,but should nonetheless be answered truthfully. When I ask a patient if there is wall-to-wall carpeting in the bedroom, or who does the vacuuming, for example, I'm far from interested in dis- cussing domestic decorating or cleaning arrangements. Rather,I'mgatheringfactstohelpmedecidewhethei a allergic response to the home environment is a possi- bility. Similarly, when I ask, “Is anyone else at home coughing, too?\" or “Is anyone at home a smoker?\", I'm searchingforcluestohelpmehoneinonthecorrect diagnosis. All conversations between my patients and I are entirely confidential; truthfulness between us is an important part of the successful doctor-patient rela- tionship. Just as I would never think of telling a patient an untruth, so, too, do I count on my patients to pro- vide me with an accurate description or history.\n\nAfter history-taking comes the physical exam. Most lung specialists will perform a directed physical, with special emphasis on the respiratory system. One can expect measurement of vital signs, including blood pres- sure, respiratory rate, pulse, and if necessary, tempera- ture. The lungs are examined by inspection, percussion, and auscultation. Inspection refers to a visual \"look.\" Do both lungs move in and out with each breath, for exam- ple? Percussion involves gently tapping on the chest. If\n\nTable9ToolsforDiagnosing Asthma\n\n| · History  |\n| --- |\n| · Physical Examination  |\n| · Pulmonary Function Testing  |\n| · Spirometry  |\n| · Peak Expiratory Flow  |\n| · Challenge Testing  |\n| · Arterial Blood Gas  |\n| · Blood Tests  |\n| · Radiographic Tests  |\n| · Chest X-ray  |\n| · Chest CT Scan  |\n\nHistory Physical Examination ·Pulmonary Function Testing ·Spirometry ·Peak Expiratory Flow ·Challenge Testing ·Arterial Blood Gas ·Blood Tests ·Radiographic Tests ·Chest X-ray ·Chest CT Scan\n\nthe lungs are full of air, the tapping will sound “reso- nant.\" If the lungs are not filled with air, then the tap- ping will give rise to a “dull\" sound. Auscultation requires a stethoscope. As described in Question 15, the examiner will ask the patient to inhale and exhale deeply and regularly during auscultation. The presence or absence of wheezing is especially significant.\n\nAfter thehistory and thephysical exam are completed, the doctor will be able to generate a list of diagnostic possibilities, called “the differential diagnosis.\" The doctor's “clinical impression\" rates the possible diag noses in order of likelihood. Sometimes it may be obvious tothe doctor that asthma ispresent.If not and if asthma is high on the list of possible explana tions for a patient's symptoms, then additional diag nostic testing is often obtained (Table 9).\n\n27.Whatdiagnostic tests are used to belp diagnoseasthma? The most helpful diagnostic tests for asthma are pul- monary function tests, often referred to as PFTs (dis-\n\n27.Whatdiagnostictests areused tobelp\n\ncussed inQuestion28).Other usefultestsinclude blood tests and X-ray studies. Additional, more special- ized studies may be indicated. An example of a special- ized study is skin-prick testing for suspected allergy. Blood tests are useful in getting an overall picture of a person's health, as well as in excluding other diagnoses. Assessment of immune function and allergies, for example, can be performed in part via blood testing. X-ray studies include conventional chest X-rays, as well as three-dimensional chest CT (computed tomogra- phy) scans. Chest X-rays and CT scans provide infor- mation about the anatomy or structure of the lungs and larger breathing passages. In quiescent, controlled asthma, the chest X-ray should be entirely normal. The same is true of the chest CT scan. During an exacerba- tion, however, the lungs appearance on an X-ray may suggest what radiologists call “hyperinflation,” and the CT might reveal “air-trapping.\" Both findings reflect the uneven lung filling and emptying when breathing occurs through inflamed, constricted air tubes.\n\nMRI (magnetic resonance imaging) scanning and PET (positron emission tomography) scanning, while useful in other types of lung diseases, are not required in asthma. The same is true of nuclear medicine scans, such as ventilation-perfusion scans, and gallium scans.\n\n28\\. What are pulmonary function tests (PFTs), spirometry, and peak expiratory flow (PEF)measurements?\n\n28.What are pulmonary function tests\n\nPulmonary function tests (PFTs)—as the name implies—are tests designed to measure lung function (Table 10). PFTs were originally used as research tools, available only in specialized academic hospital centers.\n\n1OOQUESTIONS&ANSWERSABOUTASTHMA\n\nTable10\n\nPFTs were originally designed for physiological lung research. No longer simply a specialized research tool, PFTs help clinicians establish the diagnosis of asthma, and help answer practical questions about dis- ease management and treatment. Items in boldface print are PFTs used in the NAEPP's asthma classification and treatment guidelines.\n\nThey are now widely available and are frequently indi- cated because of their usefulness in the diagnosis and treatmentofasthma.\n\nThe term PFTs is used to describe several different specific tests. Spirometry is the most useful of the PFTs when it comes to asthma diagnosis and treat- ment. Spirometry, in turn, includes two important\n\nsub-tests. The first is called the “peak expiratory flow, abbreviated PEF.The second is the FEV,,the forced expiratory volume in one second. Measurements of PEF and FEV, are thus parts, or sub-tests, of the spirometry portion of the PFTs. The availability of inexpensive, highly portable, and easy-to-use peak- flow monitors makes it possible for every asthmatic to measure his or her peak flow at home on a daily basis. FEV, measurements, on the other hand, require the use of a spirometer, which is far more costly, requires special maintenance, and is impractical for home use. Self-monitoring of PEF allows an asthmatic insight into his or her condition and permits an assessment of asthma control. Both PEF and FEV, play a pivotal role in the National Asthma Education and Preven tion Program's (NAEPP) asthma diagnosis, classifica tion, and treatment guidelines.\n\nTo perform spirometry and PEF, the patient is first asked totake a maximal,deepbreathof room air Then, that biggest single breath is forcefully and rap- ldly exhaled into a mouthpiece connected to the spirometer, or peak flow meter. The maneuver is repeated several times during testing to ensure accu- rate, reproducible values. The spirometer measures the exhaled lung volume, as well as the flow of air through themouthpieceforthetimethatexhalationtakes place. The spirometry measurements are recorded by the spirometer, and are printed out and graphed for review and future reference. Each individual patient measurement is compared to a predicted value. The predicted values for pulmonary function tests are based on three variables:(1) age,(2) height, and (3) gender Predictedvaluesare differentfora 21-year-old,six foot-tall man than for a five-foot-tall, 46-year-old\n\nwoman. Therefore, the PEF value, or FEV1, that is considered normal for a short, older female with asthma would be abnormally low if obtained by a tall, adolescent male with asthma.\n\nBecause asthma is characterized as a disease of lung emptying, exhalation time is abnormally prolonged in asthma. Anyone with active asthma who attempts to blow out all the candles on a birthday cake with one sin- gle mighty blow of air knows about impaired “lung emp tying\" firsthand! Depending on the degree of asthma and other factors, such as how much airway narrowing, or bronchospasm, is present, full exhalation during spirometry might last as long as 12 to 14 seconds rather than the normal 5 to 6 seconds.The FEV, and PEF val ues reflect the efficiency and status of lung emptying and thus provide information about how an asthmatic's lung function is affected by his or her condition.\n\nThe FEV,is defined as the volume of air that is exhaled in the first second of forceful exhalation as measured by spirometry. If asthma is poorly controlled, it will take longer than predicted for the lungs to fully empty. Since total exhalation time is prolonged in asthma,thenitfollows that the amount or volume of air exhaled in the first second of exhalation is reduced as compared to a predicted normal. The FEV, will be decreased in symptomatic or poorly controlled asthma. With treatment, the lungs should empty more effi- ciently, and the FEV, value should return to normal.\n\nstarttoempty.Peakflowsreflecttheflowofair through the larger, so-called “conducting” airways in asthma. Peak flow generally “tracks\" asthma activity. Monitoring peak flow at home initially identifies an asthmatic's predicted PEF, along with his or her “per sonal best”measurements, obtained when the asthma is well controlled. Home-based PEF monitoring can then help identify even a mild exacerbation and guide medication adjustment up or down, depending on how the PEF value fluctuates from the “personal best. Self-administered PEFmeasurements over time are a component of asthma action plans.\n\n29\\. Wbat is a metbacboline challenge (bronchoprovocation)test?\n\n29.What is a methacboline challenge\n\nA methacholine challenge test is a diagnostic test used in the evaluation of suspected asthma. The metha- choline challenge is also used for research purposes to study airway hyperreactivity. Under special circum- stances it plays a role in the clinical arena. It is one type of a class of specialized tests called bronchoprovo- cation tests. Cold-air exercise tests are another exam- ple of abronchoprovocation test.\n\nA bronchoprovocation test might be ordered in the evaluation of suspected asthma.It is not considered a routine” test. Usually, the patient describes subtle symptoms suggestive of asthma. Spirometry and other pulmonary function testing are entirely normal. History, physical examination, blood tests, and X-rays fail to reveal an alternative diagnosis or medical explanation for the reported symptoms. The bronchoprovocation test is then indicated to further evaluate for the possibil- ity of asthma. It is an extremely powerful test for elimi- nating or “ruling out” asthma. In other words, if the test\n\nis “negative,”then asthma is not present. However, if the test is “positive” and the symptoms correspond, then the patient likely has asthma. People with asthma demon- strate an increased sensitivity to the inhalation of methacholine and therefore obtain a“positive” test result. The converse statement is not true: Although everyone with asthma has a“positive” result on metha- choline testing, not everyone demonstrating a “positive” result on methacholine testing will have asthma.\n\nThe actual methacholine challenge test is usually per- formed in a hospital pulmonary function lab. The test involves obtaining a baseline spirometry measurement, and then repeating spirometry after inhalation of higher and higher concentrations of methacholine The baseline spirometry values should be normal, which is why the challenge test is indicated.If the spirometry measurements remain close to baseline val- uesafter inhalationof increasingdosesof metha choline, the test is said to be “negative,” and asthma is effectively ruled out.If,on the otherhand,the spirom etry values decline significantly after the methacholine inhalation, or if wheezing or other symptoms develop the test is reported as “positive.\"The testing immedi- ately stops at that point, and an inhaled, short-acting bronchodilator is administered to relieve symptoms and reverse the abnormal lung function.\n\n30\\. What is arterial blood gas (ABG) sampling?\n\n30\\. What is arterial blood gas (ABG)\n\nWhen a physician wants information on how effi- ciently a patient's lungs are functioning, an arterial blood gas (ABG) can provide the answer. The ABG is a blood test. Performance of a routine blood test\n\nrequires blood taken from a vein, often from the area near the elbow crease. For an ABG test, however, blood is drawn from an artery instead of a vein, and it is analyzed immediately for oxygen (O2) content, car- bon dioxide (CO2), and pH, a measure of acidity. The radial artery in the wrist is a frequent site for ABG sampling. The ABG gives information about the arte- rial blood's oxygen and carbon dioxide content, as well as the blood's acidity. Because the lungs are responsible for the extraction of oxygen from the outside air as well as for the removal of carbon dioxide, analysis of the artery sample for those gases indicates how well thelungsarefunctioning.\n\nThe mainfunction of the respiratory system is tocarry out respiration: the exchange of O2 for CO2. Respira tion provides the body's vital organs with oxygen and allows for removal of accumulated “waste products, primarily, acid. After the blood supply passes though the lungs and picks up oxygen, it becomes oxygen-rich and carbon dioxide-poor. The oxygen-rich blood is then pumped by the heart to the entire body—via the arteries—-in order to supply organs with needed oxygen. AlthoughanABGisnot aroutinetest inoutpatient asthma management, it is frequently used in intensive care. If a person is suffering a severe asthmatic exacer- bation, the ABG will reveal decreased oxygen and car- bon dioxide.If the asthma worsens further, carbon dioxide may rise, and the pH will drop, indicating a dangerous buildup of acid. Such a scenario may indi- cate life-threatening asthma. If such is the case, respi- ratory failure will ensue from continued carbon dioxide accumulationand 1oxygen deprivation; treatment includes “life support\" with a ventilator. Patients on\n\nventilator assistance may require frequent ABG moni- toring to assist physicians in selecting optimal ventila- tor settings and to ensure adequate oxygen delivery to vitalorgans.\n\n31\\. What is bronchoscopy?\n\nBronchoscopy is a lung procedure that allows the physician to look directly into the bronchi and to obtain samples or biopsies of any abnormalities found in the bronchial tree. Bronchoscopy is said to be“diag nostic\" when it is carried out to assist physicians in investigating a lung abnormality. A bronchoscopy is 'therapeutic\" when performed to remove excess lung secretions or to retrieve aspirated (inhaled) foreign bodies. There are two types of bronchoscopes (the instruments used to perform bronchoscopy): flexible bronchoscopes and rigid bronchoscopes.\n\nFlexible bronchoscopy is also called flexible fiberoptic bronchoscopy, or FOB. Pulmonologists perform FOB as do thoracic (chest) surgeons. FOB is usually per formed with the patient sedated, but breathing on his or her own. The bronchoscopist passes the broncho- scope instrument (or scope, for short) through the nose or the mouth, through the vocal cords,and into the trachea. From there, the bronchoscopist can enter and visually inspect the main bronchi and all narrower divisions. The scope enters the lung passages the same way air does. The scope has a light at its tip, as well as a channel, through which the bronchoscopist can inject local numbing medication, pass biopsy tweezers, and suck up any secretions. FOB is often used diag- nostically in the investigation of masses or abnormali- ties seen on chest X-ray studies.\n\nA rigid bronchoscopy is always performed in the oper- ating room by a thoracic (chest) surgeon with the patient unconscious under anesthesia. The rigid bron- choscope is larger and less maneuverable than the flex- ible scope. It is considered superior to the flexible scope in two specific settings: when dealing with bleeding within the lung, and when retrieving larger aspirated (inhaled) foreign bodies. It also allows for the placement of bronchial stents in specialized circum- stances. Most rigid bronchoscopies are indicated for therapeuticpurposes.\n\nBronchoscopy is not routinely performed in the care of someone with asthma. Rare situations involving very severe asthma, when marked accumulation of mucus extensively blocks the bronchial passages, can require bronchoscopy to remove the thick, obstruct- ingmucusplugs.\n\nHaving well-controlled asthma is not a contraindica- tion to undergoing bronchoscopy if it is required for evaluation of another (non-asthma) lung condition. It is important that a patient's asthma be quiescent and inactive when the bronchoscopy is performed. In par- ticular, if a person scheduled to undergo bronchoscopy is wheezing, the procedure should be cancelled and the wheezing brought under control before proceeding withthetest.\n\nAsthma:\n\nWhat is the National Asthma Education\n\nWhat is the National Asthma Education and Prevention Program (NAEPP)? What is cough-variant asthma? What is exercise-induced asthma? What is the asthmatic triad?\n\nOOQUESTIONS&ANSWERSABOUTASTHMA\n\n32.WhatistheNationalAstbma\n\nThe National Asthma Education and Prevention Pro- gram, or NAEPP, was founded in March 1989 to address the growing problem of asthma in the United States. Although much was known about asthma itself, treat- ment and outcomes were clearly suboptimal, especiall when viewed from a national perspective. The NAEPP? primary goal is to improve asthma care in the United States. Its main focus is education: to teach health profes sionals, asthma patients, and the general public about asthma. The program strives to improve the quality of life for those with asthma and hopes to decrease asthma related morbidity and mortality. The NAEPP is adminis tered and coordinated by the U.S. Department of Health and Human Services’ National Institute of Health's National Heart Lung and Blood Institute (NHLBI).\n\nThe NHLBI convened a panel of medical experts as part of the NAEPP in order to improve the clinical manage ment of asthma in the United States, and to stimulate additional research on asthma. Their landmark findings, ExpertPanelReport:GuidelinesfortheDiagnosisandMan agement of Astbma, appeared in 1991 under the auspices of NAEPP. Since then, updated guidelines for diagnosis and treatment of asthma have been published, reflecting the tremendous amount of new information about asthma The Expert PanelReport 2was published in April 1997 In June 2002, the NAEPP provided an additional refine ment to the 1997 document: Expert Panel Report: Guide lines for the Diagnosis and Management of Asthma-Update on Selected Topics 2002. The expert panel reports are avail-\n\nableonline throughtheInternet(www.nblbi.nib.gov) about/naepp/index.btm), as well as in print (NHLBI Infor- mation Center,PO.Box 30105,Bethesda,MD 20824 0105).\n\nA key component of the NAEPP's asthma treatment guidelines is the classification of asthma into four cate- gories based on asthmatic symptoms, pulmonary func tion test values, and disease severity. An individual with asthma will fall into one of the four groups at the time of their initial assessment. Interestingly, that person's classification may change over time as he or she “moves\" between asthma of varying severity, depending, for example, on how well the disease is controlled. Patients at any level of severity can also experience exacerba- tions, which also can be mild, moderate, or severe in intensity. The importance of correctly assessing and classifying a person's asthma is part of the NAEPP's efforttoensurebetter carefor asthmatics.TheNAEPP recommends specific treatments and interventions for eachlevel of asthma severity (Figure 4).\n\n33.What constitutes “mild\n\nMild intermittent asthma is one of the four classifica- tions described in the NAEPP's expert panel report. As the name implies, mild intermittent asthma is the mildest, or least symptomatic, manifestation of asthma (Table 11). An asthmatic exhibiting certain clinical features is classified as having mild intermittent asthma. Such an individual would experience symp toms two or fewer days a week, and nocturnal symp- toms two or fewer times a month. Like any person\n\nTheNAEPP'sexpertpanelclassifiesfourcategoriesofasthma severity. Specifictherapiesarerecommendedforeachcategoryof asthma.\n\nINTERMITTENT Mildintermittentasthma\n\nwith asthma, someone with mild, intermittent disease can experience exacerbations of any severity, but these are usually brief, on the order of hours todays Between exacerbations,measurement of peak flow is normal, and the individual is completely asympto- matic. Lung-function testing in mild intermittent asthma will demonstrate FEV, and peak flow values greater than or equal to 80% of predicted, and peak flow variability of less than 20% from prior “personal best\"values\n\nAll patients with asthma (of any severity) should be prescribed inhaled,“quick-relief\" bronchodilator ther- apy to be used when and if symptoms develop, on an as-needed basis. A short-acting, inhaled β, agonist is\n\nTable11Mild IntermittentAsthma\n\nSymptoms Daytime symptoms ≤ 2 times a week Nighttime symptoms ≤ 2 times a month Exacerbationsmay affect activity\n\nLungfunctiontests\n\nPeak flow (PEF)measurement ≥ 80% of predicted Forced expiratory volume (FEV)≥80% of predicted Peakflow(PEF)variability<20%\n\nAll patients with asthma should be prescribed inhaled “quick-relief\" bronchodilator therapy to be used on an as-needed basis. A short- acting inhaled β2 agonist is the recommended“quick-relief' agent. ·No daily medication needed.\n\nAnyone with mild intermittent asthma can experience exacerbations of their asthma.The exacerbations may be mild, moderate, or even severe, but they are usually brief, on the order of hours to days. Treatment of the exacerbation is, of course, mandatory and will require additional medication to ensure a return to baseline symptoms. A course of“res- cue” steroids may be needed. Between exacerbations, measurement of peak flow is normal, and the individual classified as having mild inter- mittent asthma is completely asymptomatic.There can be long periods of normal lung function without any symptoms between exacerbations.\n\nthe recommended quick-relief agent for older children and adults. Very young children and infants might instead be placed on a short-acting β2 agonist med- ication taken by mouth (orally) in liquid or syrup form as an alternative, especially if inhalation of med- ication isunfeasible.\n\nMild intermittent asthma requires “Step 1\" treatment. Daily maintenance or “controller” medication is not needed for “Step 1\" treatment. A short-acting, inhaled β2 agonist is usually prescribed for adults and children 5 years of age or older as a quick-relief agent to be\n\nused as needed. If you or your child with mild inter- mittent asthma require the short-acting β2 agonist medication (inhaled or oral form） more frequently than twice a week, your asthma might not be satisfac torily controlled. Additional medication should then be considered in order to achieve better control.\n\nAnyone with mild intermittent asthma can experience exacerbations of their asthma. The exacerbations may be mild, moderate, or even severe, but they are usually brief, on the order of hours to days. A typical exacer bation might be triggered by a viral respiratory infec tion, especially in children.S Somepeople :are completely “normal\" until “allergy Vseason\" arrives. Treatment of the exacerbation is mandatory, and will require additional medication to ensure return to base- line symptoms. A course of “rescue” steroids may be needed.Between exacerbations,measurement of peak flow is normal, and the individual classified as having mild, intermittent asthma is completely asymptomatic. There can be long periods of normal lung function without any symptomsbetweenexacerbations.\n\nGemma's comment:\n\nMydaugbterwas notdiagnosedwithastbmauntilshe was in ber 2Os, but we believe that the diagnosis might bavebeen mademuchearlier.As achild sbebadfrequent and serious colds,as well as many allergies (to animals, mold,dust,plants,etc.),wbichoftencaused bertofeelthat berneck wasswollen andherthroat andchestweretigbt Like most children she saw,at one time and another,a series ofpediatricians,wbo did regular check-ups，were \"on-call\"(by phone) for colds and flu,and gave the shots\n\nIOOQUESTIONS&ANSWERSABOUTASTHMA\n\nrequiredfor scbool.Noneofthemeversuggested testingfor allergiesorastbma.\n\n34.Wbat constitutes“mild persistent\n\nMild persistent asthma is one of the four classifica- tions described in the NAEPP's expert panel report. A person whose asthma is classified as mild persistent would be expected to experience symptoms more often than two days in a week, but no more than once in an individual day (Table 12). He or she would also experi- enceatmosttwonightsamonthwithnocturnal\n\nTable12 MildPersistentAsthma\n\nSymptoms Daytime symptoms > 2 times a week, but < 1 time a day Nighttime symptoms >2 times a month\n\nLung function tests\n\nPeak flow (PEF) measurement ≥ 80% of predicted Forced expiratory volume (FEV)≥ 80% of predicted Peak flow (PEF)variablility 20 to 30%\n\nTreatment (\"Step 2\")\n\nAll patients with asthma should be prescribed inhaled “quick-relief bronchodilator therapy to be used on an as-needed basis. A short- acting inhaled β2 agonist is the recommended “quick-relief\" agent. Daily medication is required. In most cases, inhaled anti-inflamma- tory medication is preferred. Pills such as leukotriene modifiers or sustained-release theophylline tabletscanbe alternatives.\n\nAnyone with mild persistent asthma can experience exacerbations of their asthma.The exacerbations may be mild, moderate, or even severe,， and they may affect activity. Treatment of the exacerbation is, of course,mandatory, and will require additional medication to ensure return to baseline symptoms. A course of“rescue”steroids may be needed.\n\nsymptoms. Lung function testing in mild persistent asthma will demonstrate FEV, and peak flow values greater than or equal to 80% of predicted, and peak flow variability between 20 and 30% from prior per- sonalbestvalues.\n\nAll patients with asthma (of any severity) should be prescribed inhaled, “quick-relief\" bronchodilator ther- apy to be used when and if symptoms develop, on an as- needed basis. A short-acting, inhaled β2 agonist is the recommended quick-relief agent for older children and adults. Very young children and infants might instead be placed on a short-acting β2 agonist medication taken by mouth (orally) in liquid or syrup form as an alterna- tive, especially if inhalation of medication is unfeasible.\n\n\"Step 2\" medical therapy is advocated in the treatment of mild persistent asthma.“Step 2\" requires the use of daily “controller” medication prescribed in addition to the quick-relief, short-acting β2 agonist medication used as needed. Inhaled, low-dose corticosteroids are the preferred daily “controller” medicine in mild per- sistent asthma.A number of alternate “controller maintenance medicines can be prescribed for daily use in“Step2\"therapy and consideredon an individual basis. They include, in alphabetical order, cromolyn leukotriene modifiers,nedocromil,and sustained- release theophylline. Consultation with an asthma spe cialist should be considered for infants and children younger than 5 years of age, and can also be considered for older children and adults who require alternative treatment. It is important to remember that inhaled low-dose corticosteroids are first-line,Step 2 treat- ment because they specifically target the inflammatory response that characterizes mild persistent asthma.\n\nInhaled corticosteroids have been studied extensively and there is strong data to consider them clinically superior to the other alternative agents.\n\nAnindividual withmild persistent asthma can experi- ence exacerbations of any severity. An exacerbation in the setting of mild persistent asthma is likely to limit activity. It is important to gain control of the increased symptoms as soon as possible, and to step up bron chodilator and anti-inflammatory treatments expedi tiously. An individualized,written asthma-treatment plan can help patients know how to get started treating the exacerbation at home. A short course, or “burst,” of gradually tapering doses of oral steroid medication may be required in the treatment of the exacerbation When used in this fashion, the oral steroid treatment is sometimes referred to as a“steroid rescue.\n\n35.Whatconstitutes“moderate persistent asthma\"?\n\n35.Whatconstitutes“moderate\n\nModerate persistent asthma is one of the four classifi- cations described in the NAEPP's expert panel report. Symptoms occur daily in asthma classified as moderate persistent (Table 13). Nighttime symptoms also develop with increasing frequency, one night or more per week. Measurements of lung function reveal an FEV1 and peak flows between 60 and 80% of pre- dicted. The peak flow is quite variable, with a greater than 30% variability from personal best values.\n\nAll patients with asthma (of any severity) should be prescribed inhaled, “quick-relief\" bronchodilator ther- apy to be used when and if symptoms develop, on an as- needed basis. A short-acting, inhaled β, agonist is the\n\n1OOQUESTIONS&ANSWERSABOUTASTHMI\n\nTable13ModeratePersistentAsthma\n\nSymptoms Daily symptoms Nighttime symptoms > 1 night a week Exacerbations affect activity Exacerbations ≥ 2 times a week; may last days\n\nLungfunctiontests\n\nPeak flow (PEF)measurement<80% and >60% of predicted Forced expiratory volume (FEV)< 80% and > 60% predicted Peak flow(PEF)variablility >30%\n\nTreatment(Step3\")\n\nTreatment(\"Step3\")\n\nAnyone with moderate persistent asthma can experience exacerbations of their asthma.The exacerbations tend to last for several days.Treat- ment of the exacerbation is, of course, mandatory, and will require additional medication, such as“rescue”steroids to ensure return to baselinesymptoms.\n\nrecommended quick relief agent for older children and adults. Very young children and infants might instead be placed on a short-acting β2 agonist medication taken by mouth (orally) in liquid or syrup form as an alterna- tive, especially if inhalation of medication is unfeasible.\n\nReferral to an asthma specialist is recommended for all infants and children younger than 5 years of age who require “Step 3” treatment for moderate persistent asthma. Adults and older children can also be consid-\n\nered for specialty care, particularly if their asthma con- trol is inadequate. The preferred treatment for moder- ate persistent asthma in children older than 5 years of age and for adults is a combination of a long-acting, inhaled β2 agonist and low-to-medium doses of inhaledcorticosteroids.The combination has been shown toleadtoimprovements inlung function and in symptoms, while allowing for reduction in required doses of quick-relief, short-acting β2 agonists. Alter- native therapy consists of a combination of either a leukotriene modifier, or sustained-release theophylline and low-to-medium doses of inhaled corticosteroids.\n\nExacerbations arebest identified earlyandtreated aggressively as in mild persistent asthma. Oral steroid bursts are commonlyrequired.\n\n36.What constitutes severe persistent\n\nThe category of severe persistent asthma is the most serious form of asthma in the NAEPP's expert panel report. Symptoms in severe persistent asthma occur continually; nocturnal symptoms are frequent (Table 14). Lung function testing yields compromised FEV1 and peak flow values of less than or equal to 60% of predicted.The peak flow varies by more than 30% from personal best baseline values.\n\nAll patients with asthma (of any severity) should be prescribed inhaled“quick-relief\" bronchodilator ther- apy to be used when and if symptoms develop, on an as-needed basis. A short-acting, inhaled β2 agonist is the recommended quick-relief agent for older children and adults. Very young children and infants might\n\nTable14SeverePersistentAsthma\n\nSymptoms Continual symptoms Frequent nighttime symptoms Limited physical activity ·Frequent exacerbations\n\nLungfunctiontests\n\nPeakflow(PEF) measurement≤60% of predicted Forced expiratory volume (FEV)≤ 60% predicted Peak flow (PEF) variablility > 30%\n\nTreatment(Step4\")\n\nAll patients with asthma should be prescribed inhaled“quick-relief bronchodilator therapy to be used on an as-needed basis. A short- acting inhaled β2 agonist is the recommended “quick-relief” agent ·Up to three types of daily medication are required. Inhaled high- dose corticosteroid preparations are mandatory. They are best com- bined with inhaled long-acting β2 agonists.Corticosteroid tablets on syrup in the smallest dose required may also part of the daily mainte nance regimen. Additional medications are discussed in the text. .\"Rescue”steroid medication may be prescribed, along with stepped- up therapy during exacerbations. ·Adults as well as children with severe persistent asthma should be under the care of a physician who is an asthma specialist.\n\ninstead be placed on a short-acting β2 agonist medica- tion taken by mouth (orally) in liquid or syrup form as an alternative, especially if inhalation of medication is unfeasible. It is important to remember that a need for increasing use of such quick-relief medicine reflects increasing asthma activity.\n\nAll patients with severe persistent asthma should be under the care of a physician specializing in asthma care. Step 4 treatment includes the several-times-daily use of high-dose, inhaled corticosteroids combined with a long-acting, inhaled β2 agonist. In addition, oral corticosteroid tablets may be required daily, or\n\ngoal will be to prescribe the smallest oral corticosteroid dose necessary for adequate control. Additional medi- cines including cromolyn, leukotriene modifiers, nedocromil, and sustained-release theophylline can alsobeprescribed.\n\nCough-variant asthma is a type of asthma with cough as the principal, and sometimes only, symptom. A per son with cough-variant asthma experiences dry, gener ally nonproductive cough without wheezing or breathlessness (Table 15). The cough can be consid- ered as a “wheeze equivalent.\" It may be provoked by triggers such as cold air or viral upper respiratory tract infections. Like “typical\" asthma, there may be a sig nificant nocturnal component. Cough-variant asthma has been described in all age groups, from toddlers to\n\nTable15\n\n| Important points about cough-variant asthma include:. Cough-variant asthma is a subclass, or variant of asthma.. Although individuals with asthma can experience cough as onesymptom along with wheezing and breathlessness, individuals withthe cough-variant form have only cough as a symptom, usually with-out wheezing or breathlessness.  |\n| --- |\n| . The chest x-ray is normal.  |\n| . Pulmonary function tests are normal.  |\n| . Metaboline challenge testing is abnormal, or \"positive.\"  |\n| . Corticosteroids, either inhaled or in pill form, are effective treatments and should be part of the treatment regimen.  |\n| . The response to oral corticosteroids can be dramatic, with marked  |\n| improvement in as little as 24 hours.  |\n| . A person with dry cough for three weeks or more should be evaluated for possible cough-variant asthma, especially if the chest x-rayand pulmonary function tests are normal.  |\n| . Other causes of chronic dry cough of three weeks duration or morewith normal chest x-ray and spirometry include: (1) gastro-esophageal reflux (GERD), (2) post-nasal drip or discharge, and (3)post-viral cough following a viral respiratory illness.  |\n\nseniors. The chest X-ray is normal in cough-variant asthma, as is spirometry and pulmonary-function test- ing. The diagnosis may require bronchoprovocation testing, such as a methacholine challenge test. Treat- ment requires anti-inflammatory steroid medication Inhaled steroids can be effective, and a two-week triall is often helpful. If there is no response to the inhaled steroids, then a course of oral (pill form) steroids is indicated, which can often yield prompt and dramatic improvement. Bronchodilators are often part of the treatment regimen, along with corticosteroids. Studies indicate that up to 30% of individuals diagnosed with cough-variant asthma will, in time, go on to develop typicalasthma.\n\n38.What isexercise-induced asthma\n\nExercise is a common asthma trigger. Individuals with inadequately controlled asthma often experience vari- able cough, wheezing, and breathlessness with exertion and exercise.Exercise-induced asthma (EIA) is a clini cally different phenomenon. EIA does not reflect inadequately controlled asthma. Some physicians con- sider it a subtype of asthma while others view it as a possible precursor to asthma, and prefer the descriptive term 1“exercise-induced bronchospasm”to clearly emphasize that EIA is not a separate disease.\n\nIndividuals with EIA experience respiratory symptoms in the setting of aerobic exercise. The symptoms may include dry cough, wheezing, and shortness of breath, along with chest discomfort. The symptoms usually develop as exercise begins and often lessen or even resolvealtogetherasexerciseiscontinuedand\n\nrepeated. Symptoms can also first develop after exer- cise ends. Treatment includes proper attention to warm-up and cool-down maneuvers, as well as pre- scription medication. Medicines effective in the treat- ment of EIA include oral leukotriene modifiers as well as inhaled, short-acting β2 agonists, and/or inhaled cromolyn. If inhalers are prescribed, they should be taken about 20 minutes prior to the warm-up routine. In EIA, airway narrowing occurs secondary to vigor- ous exercise. The mechanism responsible for EIA implicates inhalation of cold dry air, specifically, fluxes in humidity and temperature within the airways dur ing rapid breathing.\n\nGemma's comment:\n\nAsInotedbefore,mydaugbterwasnotdiagnosedwith asthmauntilsbewasinber2Os,butshenowfeelsthatshe badEIA asa teenager wbenshebeganrunningwith school teams.Outdoors,andespeciallyincoldweather,shewoula bavetroublebreathingwbileexercising,butwben she stoppedshewouldrecoverquicklyandfeelthattheproblem badgoneaway.Sbewas,andis,veryatbletic,andparticu larlydevotedtorunning.Atthetime,shedidn't complain ofbreathingproblems andnocoachevernoticed them.I sbouldaddthatsheisstillanavidrunner,butnowshe carriesabroncbodilatorwithberandiscarefulaboutrun ningin very cold weatber or wben theair seems especially polluted.\n\n39.What is the“astbmatic triad\"?\n\n39.Whatis theasthmatictriad\"\n\nThe first report of what is now called “the asthmatic triad\" appeared in a French medical journal in 1922. The authors of the report, Widal, Abrami, and Ler- moyez, described an association between sensitivity to\n\naspirin—a fairly new medication at that time——and the occurrence of nasal polyps and asthma. In the late 1960s, Dr. Max Samter published a series of articles characterizing the triad and further elucidated the nature of the aspirin intolerance. Dr. Samter greatly advanced knowledge in the area, and perhaps in recog- nition of the fact, the asthmatic triad is also known as \"Samter'sSyndrome.\"\n\nAspirin, or acetylsalicylic acid (ASA), is a widely pre- scribed and consumed drug with beneficial anti-inflam matory, anti-fever, and pain-relieving properties (Table 16). It is very useful, as well, as a mild “blood thinner\" in the treatment of heart diseases and in certain types of stroke prevention. The consumption of aspirin in the United States has been estimated at approximately 80 billion tablets per year. In many ways, aspirin is an ideal medication: inexpensive, safe, and highly effective (Table 17). In some people with asthma, however aspirin is a dangerous medication. The term “aspirin- induced asthma,” or AIA, refers to the development of wheezing and bronchoconstriction after the ingestion of aspirin, or aspirin-like products called NSAIDs—nons- teroidal anti-inflammatory drugs. AIA usually occurs in the setting of severe, chronic asthma and is more com- mon among females. Approximately 10% to 20% of people with asthma also have AIA. It is estimated that, of those asthmatics with AIA,50% have steroid- dependent asthma classified as chronic persistent, 30% have moderate persistent disease, and 20% have mild intermittentorpersistent asthma\n\nSymptoms of AIA include, first and foremost, an acute exacerbation of asthma within three hours of taking aspirin or one of the NSAIDs. Respiratory symptoms include wheezing, cough, and breathlessness, second-\n\n2\n\nAspirin or acetylsalicylic acid\n\n“Pure”aspirin is available over the counter without a prescription,in generic and non-generic (or brand) formulations. Examples include: acetylsalicylic acid (generic),Ascriptin?,Bayer,Bufferin?, Ecotrin?,Empirin?,Halfprin?,and St Joseph?.Look at the list of ingredients carefullyforthewords aspirin oracetylsalicylic acid, aloneorincombination.\n\nAspirin-containingformulations\n\nMany remedies contain aspirin as an ingredient,combined with othermedicines.These remedies include both over-the-counter and prescription formulations.In the first category are products such as: Alka Seltzer Plus?, Anacin?, Aspergum?, Doan's Pills?, Exedrin? Goody's Headache Powders?, Pamprin?, Peptol Bismol products, and others. Many products you see on the shelves in addition to those listed here may contain aspirin. They may be labeled for treat ment of arthritis pain, cold symptoms,headache, indigestion, men strual pain, pain from minor sprains or injury, and sinus symptoms Make sure to check the list of ingredients carefully and look for the words aspirin or acetylsalicylic acid, alone or in combination. Prescription medicines that contain aspirin are also very common, and are often used for pain control and relief. Some such medicines are Darvon?,Fiorinal,Percodan?, Talwin?,and Zorprin?.Make certain that all your treating doctors know that you have AIA, and that you must avoid taking aspirin, as wellas NSAIDs. Check to make sure that the pharmacist who fills your prescription is aware of your aspirin sensitivity. Read any inserts provided with the pre- scribedmedicine.\n\nNSAIDS\n\nNSAIDs include a large number of products, including both over- the-counter and prescription drugs. NSAIDs are useful in pain and arthritis treatment. Some of the most commonly used NSAIDs are ibuprofen (Advil?, Motrin) and naprosyn (Aleve?), which are available without a prescription.Newer Cox-2 medications such as celecoxib(Celebrex?) and valdecoxib(Bextra?)should likewise be avoided.\n\ninclude wheezing, cough, and breathlessness, second- ary to bronchoconstriction and inflammation. The acute chest symptoms are accompanied by nasal, eye, and skin symptoms including severe runny nose; red, puffy, itchy eyes; and flushing and reddening of the skin of the face or neck. The asthmatic exacerbation\n\n\"Safe”MedicinesinAspirin-lnducedAsthm\n\nYour physician and your pharmacist are professionals who can pro- vide you withinformation about the safety of both prescription and over-the-counter medications in AIA. You have a responsibility to inform them that you have a diagnosis of AIA and should ask them any questions you have about any medicine. Many of the products you must avoid are used in the treatment of pain (headache,menstrual, sprains,and injuries) and inflammatory conditions (arthritis, osteoarthritis). Below is a list of the generic name of medicines that are usually considered safe by medical experts. ■Acetaminophen ■Sodium salicylate Salicylamide Choline magnesium trisalicylate ■Benzydamine ■Chloroquine ■Azapropazone ■Dextropropoxiphene\n\ntreatment orevenadmissiontohospital.AIA isa cause of near-fatal asthma.Studies have suggested that up to 25% of all asthmatics admitted to hospital in res piratory failure requiring intensive care and ventilator support may have had the event precipitated by aspirin orNSAIDingestion.\n\nTreatment of AIA consists of life-long aspirin and NSAID avoidance. The oral leukotriene modifier medications (zafirlukast, zileuton, and montelukast) are useful in blocking and preventing the response to aspirin and NSAIDs to a variable extent in AIA. If aspirin therapy is deemed essential for medical reasons, then the asthmatic with AIA should be referred to an allergist with expertise in aspirin desensitization. Aspirin desensitization is a special, individualized treatment that eventually permits the asthmatic with\n\nAIA to tolerate regular, daily doses of aspirin. Desensi- tization could, for example, be considered for an asth- matic known to have AIA and who must take small daily doses of aspirin to prevent a second heart attack.\n\n40\\. What is occupational asthma?\n\n40.What is occupational astbma?\n\nGemma's commer\n\nIworkedformanyyearsinalargepublicbuilding,wbich was often described as a‘sick”building, in part because of itsfaultyventilatingsystem.Ioftennoticedbreathing broblems,especiallywbenwater intheradiatorsleaked, leavingtheindustrial carpetingonmyofficefloordamp and probably moldy.Although thebuilding was studied severaltimesbyenvironmentalistspecialistsandalways found tobe“sick,”publicfunds tofix theseproblems were nevermadeavailable\n\nOccupational asthma describes asthma that is caused by exposure to a precise, defined substance in the workplace environment. Although figures vary from country to country and are difficult to pinpoint, it is estimated that 5 to 15% of newly diagnosed asthma in working adults is due to occupational (or workplace) exposure. Many physicians fail to consider the possi- bility of occupational asthma in adults with newly identified asthma and can remain unaware of the dis- ease specifics. Symptoms of occupational asthma may be indistinguishable from “classic” asthma. An astute physician will enquire about current and past jobs held by an adult in whom asthma is newly diagnosed. Another clue to the diagnosis canbe provided by close observation of any temporal associations between work, leisure time, and respiratory symptoms. Serial peak flow measurements during an entire month, for\n\nexample, while at work as well as on weekends or days off, can be helpful in identifying patterns that might suggest occupational asthma. It is crucial to correctly identify occupational asthma because the key to suc- cessful treatment is prompt removal of the patient from the workplace exposure that is causing the asthma. If occupational asthma is properly identified in a timely manner, and if the exposure to the offend- ing agent ceases within a certain period of time, then the prognosis is favorable. If exposure continues, how- ever, there is a point of“no return” past which a person with occupational asthma may have permanent respi ratory symptoms and disability, even if the exposure ceases at a later date\n\nOccupational asthma is different from work-aggra- vated asthma.Work-aggravated asthma refers to preexisting asthma that worsens at work. For exam- ple, a person with a history of easily controlled asthma in adolescence might develop an increase in asthma symptoms as an adult when working out- doors during cold winter months. Another example of work-aggravated asthma involves asthma that worsens at work because of irritant exposures, such asmightbethecaseforabartenderwithasthma working in a restaurant full of cigarette smoke or an asthmatic indoor garage attendant inhaling automo- bile\\_exhaustfumes\n\nTrue occupational, or work-related, asthma is a poten- tially serious medical condition with significant socio- economic repercussions. The immunologist and allergist Dr. David I. Bernstein's 1993 characterization of occupational asthma has been widely accepted as\n\nthe standard definition of the disease. The definition states:“Occupational asthma is a disease characterized by variable air flow limitation and/or airway hyper- responsiveness due to causes and conditions attributa- ble to a particular occupational environment and not to stimuli encountered outside the workplace.\"\n\nThere are twogeneraltypes of true occupational asthma (OA). Experts have classified the two types as asthma with latency” and “asthma without latency. The first type of OA is asthma that develops over time, caused by repeated inhalation of sensitizing work exposures to a specific substance, usually a large pro- tein. Examples of sensitizing agents include formalde hyde, mineral dusts, animal proteins, flours, and grains. More that 250 different workplace substances have been reported to cause occupational asthma Many different manufacturing industries are involved from baking, to veterinary work, to paint and circuit board production. Interestingly, not all workers in a certain industry and with clear-cut exposure actually go on to develop asthma. Studies suggest that atopy and cigarette smoking may predispose some persons to the development of occupational asthma.The second more unusual type of OA involves the emergence of “new” asthma after a single, intense, and often dra matic exposure to potent respiratory irritants, such as bleach, chlorine gas, or strong acids, for example. Chemicalspills and workplace accidents are often implicated.The term“RADS\"was coined by Dr. Stu art M. Brooks and his co-workers in 1985. The term describes“reactive airways dysfunction syndrome,”a type of OA “without latency” that begins abruptly, usually within 24hours of anintense,inhaled-irritant\n\n1OOQUESTIONS&ANSWERSABOUTASTHMA exposure that persists for longer than three months and behaves like “typical\" asthma. Occupational asthma is more than a single entity, as the above clearly indicates. If OA is suspected, medical evaluation and consultation by an occupational health physicianshouldbeconsidered.\n\nAsthma:\n\nWhat are written asthma management\n\nWhat are the goals of asthma treatment?\n\nMy asthma is active; how do I know whether I should go to the nearest hospital emergency room? How do I know whether my physician is a specialist in asthma treatment?\n\n41.Whatareasthmamanagementand actionplans? The National Asthma Education and Prevention Pro gram (NAEPP) stresses patient education, and an “active partnership\" between the patient and the treat- ing healthcare provider to ensure optimal asthma treat- ment.Asthma self-management is a component of effective asthma care.TheNAEPPadvocates thateach patient be provided both a written individualized “daily self-management plan (Table 18),” as well as an \"asthma action plan (Figure 5).\"The NAEPP suggests that the plans be drawn up at the time of the patient's first visit, subject to review and revisions at follow-up visits. The daily asthma management plan emphasizes overall goals, maintenance medications, patient obser vations and self-monitoring during periods of quies cent asthma, and good asthma control. The asthma action plan provides written guidelines for treatment of increasing symptomatology and exacerbated asthma. The key feature of any written asthma plan is that it is individualized. Just as two people with asthma will have different manifestations oftheirdisease,so,too,will they have different treatment and action plans. A person whose asthma usually exacerbates when suffering from a cold, for example, will likely have instructions in thein plan to quickly double the dose of inhaled steroid med- ication at the earliest cold symptom. Another person, whose asthma has only rarely been triggered by cold symptoms, will not need to increase his or her controller medication as quickly, or to the same extent as,the first person. Another point to remember is that if you have been provided with an action plan, it should be reviewed and revised (as needed) at every visit. Sample asthma\n\n41.What are asthma management and\n\nThe National Asthma Education and Prevention Pro gram (NAEPP) stresses patient education, and an \"active partnership\" between the patient and the treat- ing healthcare provider to ensure optimal asthma treat- ment.Asthmaself-management isacomponent of effective asthma care.TheNAEPPadvocates thateach patient be provided both a written individualized“daily self-management plan (Table 18),” as well as an \"asthma action plan (Figure 5).\"The NAEPP suggests that the plans be drawn up at the time of the patient's first visit, subject to review and revisions at follow-up visits. The daily asthma management plan emphasizes overall goals,maintenance medications, patient obser vations and self-monitoring during periods of quies cent asthma, and good asthma control. The asthma action plan provides written guidelines for treatment of increasing symptomatology and exacerbated asthma.\n\nThe key feature of any written asthma plan is that it is individualized. Just as two people with asthma will have different manifestations of their disease, so, too, will they have different treatment and action plans. A person whose asthma usually exacerbates when suffering from a cold, for example, will likely have instructions in their plan to quickly double the dose of inhaled steroid med- ication at the earliest cold symptom. Another person, whose asthma has only rarely been triggered by cold symptoms, will not need to increase his or her controller medication as quickly, or to the same extent as, the first person. Another point to remember is that if you have been provided with an action plan, it should be reviewed and revised (as needed) at every visit. Sample asthma\n\nMaintain your record in a separate log or diary Recordsymptoms Measure peak flow (PEF). Record use of “rescue” or quick-relief inhaler medicatid Record use of maintenance medicine.\n\n| 100% of personal best PEF =  | 80% of personal best PEF =  |\n| --- | --- |\n| 50% of personal best PEF =  | Less than 50% of personal best PEF =  |\n\n| Peak Flow  | Symptoms  | Treatment  | Other  |\n| --- | --- | --- | --- |\n| \"Green Zone\"PEF 80 to 100%  | · Comfortablebreathing  | Take:  | Maintain dailyactivities.  |\n| GO!  | · No symptoms· No nocturnalawakenings  |  |  |\n| \"Yellow Zone\"PEF 60 to 80%  | · Uncomfortable· Chest tightness· Cough  | Add:  | Increase medicine,treat cold ifpresent, limitexertion. Call MDIif not improved.  |\n| CAJTION!  | · Wheeze· Nocturnalsymptoms  |  | Increase medicine,treat cold ifpresent, limitexertion. Call MDIif not improved.  |\n| \"Red Zone\"PEF < 60%  | · Very uncomfortable· Limitation onactivities  | Add:  | Start steroids! Getprofessionalmedical opinion.  |\n| DANGER!  | · Cough, wheeze  | CONTACT MDOrGO TO ER  | Start steroids! Getprofessionalmedical opinion.  |\n\nFigure5 Asampleasthmaactionplan.\n\nplans can be found on the Internet. Simply use youn favorite browser, and type “asthma action plan\" in the searchwindow.\n\nDespite the strong recommendations of the NAEPP, as well as enthusiastic support from professional med- ical societies and managed care insurance companies, written asthma plans are not universally popular in the asthmacommunity. Whenpolled，mostasthma patients prefer having a written plan of action. Many doctors, however, especially physicians practicing inl private practice rather than in clinic or hospital set- tings, don't like written asthma plans. The most com- mon reason for an asthmatic not following a written action planis quite simply thathis orher physicianhas never provided one. Studies of written action plans, both here and abroad,have yielded inconsistent results. Some report that most patients, especially chil- dren, clearly benefit from written asthma plans. The implementation of the action plan ideally reduces hos- pitalization and improves asthma control. Other stud- ies suggest that it is not the written plan that improves outcomes,but rather the focused attention of the physician andthe enhancedinteractionbetween patient and healthcare provider. In other words, as long as the proper advice on increasing and adjusting medication in asthma is provided, the outcome is improved regardless of whether the instructions were given in writing as part of a plan or verbally during an office visit or over the telephone.\n\n42.Wby should Iuse medicine ifIfeelfin\n\nA major advance in the medical profession's under- standing of asthma is the recognition of the crucial role of lung and airway inflammation. If an individual with\n\nasthma has ongoing lung inflammation, his or her asthma will not be properly controlled, and that indi- vidual will experience one or more different asthma symptoms. Too many people with inadequately treated asthma“adapt” to abnormal lung function,and con sciously or not, learn to live with their symptoms. I clearly recall, for example, a middle-aged patient of mine who during her initial visit with me reported that she would always take a taxi to and from workin Man hattan all winter long despite the expense. Rather than walk, wait for a bus, or take the subway, she always pre- ferred to“go by cab\" during the winter because of the development of cold-induced dry cough and uncom fortable breathing. When the temperature would dip below 40°F, she could walk only very brief distances before she would experience cough and breathlessness. She was, when I first met her, proud of how she had “learned to live\"with asthma, which she referred to as her “condition.\" She believed then that she was a model patient by “toughing it out.\" She was mistaken, however, and did not realize that she should have been taking a combination of asthma medicine instead.\n\nIn asthma management, the primary treatment goal is the absence of daily daytime and nighttime symptoms. Your breathing should be comfortable all the time. During a normal day, you should have no awareness of your breathing, which should be quiet, effortless, and automatic.If your asthma falls into a classification other than the NAEPP's mild intermittent, then you are likely to be prescribed daily “controller” medication along with “quick-relief\" or “rescue” inhaled medicine as I did for my taxi-traveler patient. The “controller\" medicine addresses theinflammatory component of\n\nasthma. The medicine is designed to be taken daily, around the clock, to keep the inflammation controlled and quiescent. It is a preventive medicine. You should use it as prescribed, especially if you have no symp- toms. The fact that you have no symptoms means that the medicine is working perfectly! Continue taking it! If you stop your medicine because you “fel fine,” you may not “feel fine” for long. Instead of stopping medi- cine on your own, contact your asthma doctor for advice. The fact that you feel healthy certainly indi- cates that your treatment has been effective. It may also be a hint that now that your asthma symptoms have responded to treatment, you may ready to “step down”thatparticulartreatment.\n\nWhat about my patient who suffered daily symp- toms from Thanksgiving until Easter? After her first visit several years ago, and the prescription of two different inhalers, she was no longer symptomatic in the cold weather. Together we learned that her asthma requires only infrequent doses of inhaled, short acting β2 agonist bronchodilator therapy in the spring and summer for control. In the late fall and through the winter, she needs to take additional medicine daily. She begins using the inhalers as soon as the weather cools and before she develops the cold air induced cough and breathlessness. Now that she has control over her asthma, she has more choices of how to get to work! She also decided to get a small dog (which she'd always wanted) and proudly walks the pup before and after work, in all kinds of nasty weather!\n\n43\\. What are asthma “triggers\"?\n\n43.What are asthma\"triggers\"?\n\nGemma's comment:\n\nMydaugbterandIseemtobeespeciallysensitivetocertain foods,like soy and nuts.My daugbterfeels that if sbe bas d cold,theskin of some fods (e.g,peacbes and eggplant) make ber throat“close up.\"I,too,bave bad such symptoms, butIthinkthatfoodsensitivities,wbicharequitedifferent fromtastepreferences,changeovertime\n\nAsthma triggers are exposures that precipitate or worsen a person's asthma (Table 19). Some triggers are nearly universal. Most people with asthma will notice that a respiratory infection, bronchitis, or a chest cold willworsen their asthma.Inhalation of very cold air\n\nTable19Asthma Triggers\n\nAsthma triggers are exposures that precipitate or worsen a person's asthma.A person with asthma may have more than one trigger. Some triggers are nearly universal among asthmatics; others are more individual. Allergens Common examples include pets (such as cats or dogs), foods (such as peanut, tree nuts, shellfish), or so-called aeroallergens (such as ragweed, grasses, or pollens) Cold air Cigarette smoke Exercise Infections: viral orbacterial ·Bronchitis/chest colds ·Pneumonia ·Sinusitis Irritants Medications Stress Sulfites By correctly identifying your asthma triggers and avoiding exposure to those triggers, your asthma will be better controlled.\n\nand strenuous aerobic exercise are also triggers. Other triggers are more individual or idiosyncratic. Strong odors or perfumes, as well as cigarette smoke, can all be asthma triggers. Asthmatics who have specific aller- gies will notice that allergens are triggers, too. This is often the case in a cat-allergic person, for example who begins to experience chest discomfort, tightness, wheezing, and shortness of breath after visiting home with cats in residence.Some foods,sulfite food additives, as well as certain medications can trigger asthmatic symptoms in susceptible persons. The importance of identifying an individual's asthma trig- gers cannot be overstated. Modern asthma treatment includes identification of each patient's asthma triggers in order to avoid exposure to them as much as possible. By completely avoiding, or at least minimizing, expo sure to triggers, asthma symptoms are greatly reduced. Often, medication can be decreased as well.\n\n44\\. Wbat are the goals of astbmd\n\n44\\. What are the goals of astbma treatment?\n\nThe principal goal of asthma therapy is control of all symptoms (Table 20). Physicians and their patients shouldtherefore strive to attain an asymptomatic state.\n\nTable 20AsthmaTreatment\n\nPatient education:asthma physiology,proper use ofmedicines,sel monitoring, asthma action plans. Pharmacological treatment: when and how to use medicines Environmental controls and modifications:identify allergens and minimize or eliminate exposure, especially in the home and in the patient'sbedroom. Trigger identification and avoidance Alliance between patient and caregiver Treatment includes an emphasis and focus on preventive therapy, not merely on symptomatic therapy.\n\nAny indicated medication should be prescribed and taken as directed. An effective asthma regimen will succeed in achieving a minimal requirement for short- acting β2 agonist “rescue” medication. An effective asthma regimen will also ensure minimal, if any, side effects from the prescribed medicines. Lung function should normalize with proper asthma care. Symptoms should be absent or minimal during the daytime, as well as at night (Table 21). Sleep should be restful and uninterrupted.There should be no absences from work or school due to asthma.Exacerbations should alsobe few (or none), and far between.When an exacerbation does develop, it should be recognized immediately and treated aggressively. When people can “forget” that they have asthma, except for the fact that they have to take medicine, and when they can fully participate in work, play, and sports, and enjoy life without limita- tion, then the principal goal of asthma treatment has beensuccessfullymet.\n\nTable21MajorGoalsofAsthmaTreatmen\n\nDaytime symptoms should be absent or minimal. Nocturnal symptoms should be absent or minimal; sleep should be restful and uninterrupted. Elimination of absences from work or school because of asthma; parents of children with asthma should similarly not have any missed days of work because of the child's asthma. Full participation in sports and team competitions; regular aerobic exercise is an important component of good asthma management, as well as a key feature of a healthy lifestyle. Exacerbations should be nonexistent or“few and far between.\" They should be addressed and treated promptly and effectively. Requirement for“rescue treatment,”usually in the form of a short- acting inhaled β2 agonist (inhaled or oral, in the case of young chil- dren), should be minimal. Medicines for asthma treatment should be associated with minimal, if any, side effects.\n\n1OOQUESTIONS&ANSWERSABOUTASTHMA\n\n45.Will asthma lead to loss of oxygen?\n\nWell-controlled, stable, treated asthma does not affect the body's oxygen levels. If lung function is normal- ized, gas exchange also continues normally. For exam- ple, an asthmatic experiencing chest tightness on wheezing that responds to two puffs of a rescue inhalen every few days is not in any danger from low blood oxygenlevels.\n\nAsthmainitsmoreextremeformscanleadto reduced oxygen levels. Both severe exacerbations of asthma, as well as life-threatening asthma, have the potential to significantly interfere with the lungs ability to extract oxygen from the air. In particular, when bronchospasm,swelling,and mucus accumula tion narrow the bronchial passages, oxygen levels may dip. The emergency treatment of an asthma exacerbation that brings a patient to the emergency room, for example, always begins with supplemental oxygen, given by either an oxygen mask or nasal prongs. In an asthmatic emergency, it is always bet- ter to err on the side of safety and automatically prescribe supplemental oxygen, rather than risk reducedoxygen.\n\n46\\. What is an asthma specialist?\n\nAn asthma specialist is a physician whohas a special interest in treating patients with asthma, and who has completed post-doctoral training either in adult or pediatric lung diseases (pulmonary medicine), or in allergy and immunology. A physician is a medical doc- tor who has graduated from college and from medical school. After medical school, a future asthma specialist will continue post-doctoral training, called internship\n\nand residency, for three to four years in a broad field such as adult internal medicine, family practice, or pediatrics (Table 22). Much of this time is spent in a hospital setting or in a clinic. After internship and res- idency training, the future asthma specialist will spend an additional three to five years in even more special- ized training. Such additional training is called a fel- lowship. Fellowships in the fields of adult pulmonary medicine lead to adult asthma specialization, whereas those in the field of pediatric pulmonology train asthma specialists for children. Fellowships in allergy and immunology train physicians to care for asthma patientsofall ages.\n\nThere are two types of medical schools in the United States. The majority of medical schools—numbering close to 125—are allopathic medical schools and grant the M.D. degree after four years of post-college study. There are also approximately 20 osteopathic medical schools in the United States, with far fewer students enrolled. Osteopathic schools grant the D.O. degree The D.O. stands for “Doctor of Osteopathy.\" Allo pathic medicine has existed for centuries.Andrew Tay lor founded the discipline of osteopathic medicine less than 150 years ago, in 1874. The philosophy of osteo pathic medicine differs from the allopathic. Osteopa thy seeks to treat the“whole patient”and emphasizes the importance of the musculoskeletal system, as well as the importance of “osteopathic manipulative treat- ment.\" In the past, requirements for admission to an osteopathic medical school were considered to be less stringent than for admission to an allopathic medical school, but that has changed. The curricula of both schools are quite similar, and state licensing authori-\n\nTable22Physicians'Qualifications and Specialties M.D. Your\n\n| M.D.  | Your physician is an allopathic medicalschool graduate.  |\n| --- | --- |\n| D.O.  | Your physician is an osteopathic medicalschool graduate.  |\n| \"Board Certified\"The American Board of Medical Specialties includes:ABAI-American Board of Allergy &  | The American Board of Medical Specialists(www.abms.org) sanctions 24 medical specialties. Each different medical Board evaluates M.D. and D.O. candidates whovoluntarily present for evaluation of their  |\n| Immunology (www.abai.org)ABIM-American Board of InternalMedicine (www.abim.org)ABPed-American Board of Pediatrics(www.abp.org)\"You can check to see that your asthmaphysician is board certified by theABIM on the Web. Go to:www.abim.org/dp/apps/physr.htm andfollow the on screen directions.  | credentials and qualifications. The qualified candidate physician then takes a specializedexamination. The successful candidate isthen “certified\" by the specific Board. MostBoards require re-certification at specifictime intervals.  |\n| FACP  | Your physician is a Fellow of the AmericanCollege of Physicians, a mark of distinctionfor an internist, or physician specialized inthe medical care of adults. The ACP(www.aeponline.org) is a professional society.  |\n| FAAP  | Your physician is a Fellow of the AmericanAcademy of Pediatrics, a mark of distinctionfor a pediatrician, or physician specialized inthe medical care of children and adolescents.The AAP (www.aap.org) is a professionalsociety.  |\n| FAAFP  | Your physician is a Fellow of the AmericanAcademy of Family Physicians, a mark ofdistinction for a family practitioner, orphysician specialized in the general care ofpersons from infancy onward, through adulthood. The AAFP (www.aap.org) is a professional society.  |\n| FCCP  | Your physician is a Fellow of the AmericanCollege of Chest Physicians, a professionalsociety dedicated to the treatment lung disease (www.chesten.org). Usually requirepostgraduate training through the fellowship, several years experience, and subspecialty board certification.  |\n\n1OOQUESTIONS&ANSWERSABOUTASTHM\n\n| Tablet  | (commer)  |\n| --- | --- |\n| FAAAI  | Your physician is a Fellow of the AmericanAcademy of Allergy, Asthma, andImmunology (www.aaai.org) a professionalsociety. Usually requires postgraduatetraining through the fellowship, severalyears experience and sub-specialty board  |\n| P.C.  | cerification.The designation \"P.C.\" after your physician'sname is not a medical honor or qualification.Itis a legal designation. The initials standfor \"Professional Corporation\" and indicatethat the physician has formed a legal corporation and has filed articles of incorporationwith the state.  |\n\nties, as well as most hospitals, recognize the M.D. and the D.O. degrees as equivalent.\n\nAfter medical school, internship, residency, and fel- lowship training, qualified specialist physicians in the United States are permitted to take national, special- ized examinations called“board examinations.\"Suc cessful candidates are then said to be “board certified” in their field, for example, in pulmonary medicine, or allergy and immunology. Board certifi cation indicates that the physician has met stringent training and testing qualifications. Many asthma spe cialists also enjoy teaching medical students, interns, residents, and fellows, and are members of a medical schoolfaculty.\n\nGeneral pediatricians, who take care of the majority off children with asthma, are experienced in asthma treat- ment, but are not technically “true\" asthma specialists\n\nbecause they have not completed the specialized training described above. The same is true for family practitioners and general adult internists who treat adult asthmatics.\n\n47.Howdo I know whether my pbysician\n\nThe best way to ascertain whether your treating physician specializes in asthma treatment is to ask the doctor directly.Make sure that your asthma physicianisprimarilyaclinicianoradoctorwho “takes care of patients for a living.\" Some lung physi- cians are more accurately described as physician-sci- entists. Although trained in respiratory medicine or allergy, they spend the great majority of their profes- sional life in the laboratory, advancing our under standing and knowledge of the scientific aspects off asthma.Such physician-scientists might, for exam- ple, develop a new medication for asthma treatment or research the way asthma genes are transmitted. They are asthma specialists. They advance the knowledge of asthma,but are not involved with the direct delivery of health care. The concept of special- ization thus includes not only sophisticated medical training beyond that of a general doctor, but also a real and abiding interest in asthma and in caring fon peoplewithasthma.\n\n48\\. Do I need to consult a pbysician wbo specializesin asthma?\n\n48\\. Do I need to consult a pbysician who\n\nReferral to an asthma specialist is advised under two general circumstances: the “tricky” diagnosis, and the need for“special\"evaluation or treatment.In the first\n\ncircumstance, referral leads to resolution of a diagnos- tic puzzle. Asthma might be a suspected yet unproven diagnosis, either because of atypical symptoms or because of a competing illness. In the second circum- stance, referral leads to improved asthma control. Dif- ficult-to-control asthma can reflect a myriad of factors, fromadverse socioeconomic circumstancestoarare form of corticosteroid-resistant asthma\n\nIn the United States, the majority of individuals with asthma receive their care from physicians who are generalist doctors, such as family practitioners internists,and pediatricians.The decision to seek care from an asthma specialist can be a matter of patient preference, but is more frequently a consequence of severity of disease. Consultation from an asthma spe cialist is indicated and appropriate when a person's asthma is not well controlled. An example is someone who has daily symptoms, frequent absences from work or school, or who requires hospitalization for asthma despite good adherence to a treatment plan Similarly, asthmatics classified as having severe per- sistentasthmashouldreceivetheircarefroman asthmaspecialist.\n\nThe most recent update of the NAEPP's Expert Panel Report (2002) addresses the question of when referral toanasthma specialist ismandatoryand when it should be considered.Any adult with severe persistent asthma, or any patient who requires “Step 4” asthma treatment, should be under the care of a physician with an expertise in clinical asthma management. Similarly, referral to an asthma specialist should be considered for adults with moderate persistent asthma requiring \"Step3\"treatment.\n\n49.HowcanIfindout wbether I\n\nMany people think they may be allergic to certain foods or aeroallergens, such as pollens or dog dander for example. A good observer might notice that after exposure to the suspected agent, an allergic symptom, such as itchy, watery eyes, nasal stuffiness, or throat tingling develops. At the other extreme, a person might be allergic and not make the connection. Either way, consultation with an allergy specialist or allergist can be extremely helpful and is highly recommended in order todetermine whether or not an allergy is present. Allergists are experts in identifying specific allergies Their tools include a detailed history along with a physi calexamination.Sometimesbloodtests areobtained. Skin“patch” testing with extracts of the suspected aller gen are usually performed for greater precision in reach ing a conclusion. It is just as important to know whether you are allergic to a substance as it is to find out that you are not. If an allergy to a specific allergen is confirmed, then allergen avoidance is usually recommended.Fon example, a person allergic to penicillin should never take penicillin-containing antibiotics. If complete allergen avoidance is not practical, then medication may be required. Such would be the case for someone who is allergic to ragweed and resides in the northeastern UnitedStatesinlate summer.\n\nAllergists are also qualified to administer immuno- therapy, a special type of allergy treatment also known as “allergy shots.\" Immunotherapy is reserved for very specific types of allergy accompanied by very specific symptoms. It requires a skilled allergist and a motivated\n\npatient who is willing to undergo treatment for at least three years, initially getting injections once a week. Immunotherapy is highly effective if prescribed prop- erly, but it is not for mild symptoms, or for symptoms that are easily controlled with antihistamine medication andallergenavoidancemeasures.\n\n50.What is immunoglobulin E (IgE)?\n\nSo.wsat tstmmunogtoouiin E(igE) Immunoglobulins are protein molecules that circulate in the bloodstream. They are part of the body's immune response to a stimulus perceived as foreign, such as bacteria, parasites, or allergens. There are five classes of immunoglobulins, named G, A, M, E and D, and abbreviated: IgG, IgA, IgM, IgD, and IgE Each class has its own characteristics.IgE is an immunoglobulin that rises in certain situations including in the setting of an allergic response. Persons with allergy and asthma will often demonstrate ele- vated IgE blood levels as compared to a “normal\" sub- ject with neither allergy nor asthma. IgE plays an important, central role in several “allergic\" conditions: asthma, allergic rhinitis, atopic dermatitis (also known as eczema), certain food allergies (e.g., peanuts, fish), urticaria (hives), and anaphylaxis. Recent understand- ing of the pivotal role of IgE has lead directly to the development of a new and novel medication that blocks the effects of IgE, as discussed in Question 73. By blocking IgE, the allergic response is lessened on eliminated, offering promising treatment for asthma and severe food allergies.\n\n1OOQUESTIONS&ANSWERSABOUTASTHMA\n\n51.Myasthmaisactive;bowdoIknow\n\nGemma'scomment:\n\nEmergencies can be scary.During a vacation at a popular seasideresort inthenortbeast,Iwas caugbt onthebeach as a squall came up,blowing sand in my face and mouth Because my children were playingbappily,I delayed leav ing the beacb, and by the time I did, I was gasping for breath,almostunabletoclimbupthedunes.BytbetimeI gottoan emergencyroom laterthat evening,my breathing was very labored. The treatment was scary,too.I was givena shot ofadrenaline,wbichmadebreathing easy,and sent home.The adrenaline kept me“wired”(i.e.,extremely tenseandunabletosleep)formorethanaday.Ishouldadd that this emergency occurred twenty years ago, and that I wastreatedinasmallregionalbospital,betterpreparedto deal withboating accidents than breathing problems.I'm surethetreatmentwouldbebettertoday\n\nThe inability to gain control of an asthma exacerbation is the major reason for proceeding to the nearest hos- pital for emergency treatment (Table 23). The simple fact that your asthma is more active might not in itself warrant an emergency room visit. If your asthma responds to increased “stepped-up” treatment as advo- cated in the NAEPP's guidelines, or as outlined in your asthma care plan, then you might simply need to check in with your asthma provider. If your asthma symptoms do not respond to the increased treatment, or if your symptoms worsen despite such treatment, then a visit to the emergency room is indicated. The decision to proceed to the emergency room is based on\n\nTable23SeriousSigns andSymptoms\n\nOOQUESTIONS&ANSWERSABOUTASTHMA\n\n| Make sure you and your asthma healthcare provider have a plan for asthma emergencies. Keep important phone numbers handy.  |\n| --- |\n| The worrisome asthma symptoms listed below warrant seeking emergency medical careimmediately. Asthma healthcare providers may instruct their patients to begin steroidtreatment at the first suspicion of an asthma emergency.  |\n\n| Children and Adults  | Babies and Young Children  |\n| --- | --- |\n| Marked breathlessness  | Noisy, raspy breathing  |\n| · Difficulty speaking in full sentences  |  |\n| · Difficulty walking  | Cough  |\n| · Tight chest  |  |\n| · Feels winded  | Fast breathing  |\n| Labored breathing  | Fussy behavior  |\n| · Shoulders rise with breathing  |  |\n| · Neck and ribs move inward with breathing  | Sits upright, won't lie down  |\n| · Rapid, uncomfortable breaths  | Difficult to feed; can't eat or drink  |\n| · Cough, day and/or night  | because of breathing  |\n| · Wheezing  | Nostrils flare with breathing  |\n| Altered mentation  |  |\n| · Difficulty thinking clearly  | Neck moves inward when breathing  |\n| · Confusion, loss of alertness  |  |\n|  | Ribs move inward while breathing  |\n| Lowered oxygen  |  |\n| · Gray or blue lips  | Discolored blue-gray skin near mouth  |\n| · Gray or blue fingertips  | Medicines aren't effective  |\n| Low PEF values  |  |\n| · PEF < 60% personal best  |  |\n| Medicines “Not Working\"  |  |\n| · PEF fails to rise after using “quick-relief\" medicine  |  |\n| · Symptoms continue  |  |\n\nChildren and Adults\n\nmedical considerations, as well as common sense.Keep in mind that each individual's asthma is unique in its own way. Some individuals may experience rapidly worsening exacerbations, for example, and the rate off how rapidly your asthma tends to progress should cer- tainly be taken into account as well.\n\nI always remind my patients that emergency rooms are open and staffed 24 hours a day for a reason—-because they are needed! Asthma unresponsive to stepped-up home treatment is exactly the type of condition that emergency rooms are geared to treat. The key is not to hesitate to proceed to the emergency room if your asthma specialist advises you to, or if the protocol you're following as part of your asthma action plan calls for it. Don't delay! Trying to “tough it out”\" will only make it harder to control your exacerbation. It is better to inter- vene early and quickly. Consider, as part of your “routine asthma care, discussing ahead of time with your asthma doctor how best tohandleincreased asthma symptoms, when to start steroid therapy, when to telephone for advice, and when to go to the emergency room.\n\n52.What kind of\"emergency\"treatment canI expect wbenIget to the emergency room?\n\n52.What kind of“emergency\"treatment\n\nThe actual treatment you receive in the emergency department of the hospital depends on the individual characteristics of your asthma, other health conditions you may have, as well as the severity of your symptoms when you arrive in the emergency room. In general, you can expect three components to your emergency care. The first will consist of immediate treatment with supplemen tal oxygen, bronchodilators, and anti-inflammatory medi- cines to gain control of the asthma exacerbation.The\n\nsecond component to your care will consist of careful assessment of the degree of asthma severity, along with close monitoring of your condition and overall response to treatment. The third component will determine whether any other superimposed conditions are present and how they might impact your asthma.\n\nYou can expect to be given supplemental oxygen to breathe, either via nasal prongs or a mask. You will likely be given repeated doses of short-acting β2 inhaled bronchodilator therapy in succession by a neb- ulizer, or MDI (metered-dose inhaler) with a spacer or holding chamber. A temporary intravenous catheter (IV)may be inserted into a vein in your arm to allow for rapid administration of fluids to counter any dehy dration.Steroids in pillform or via theIV(if already placed) will be prescribed to reduce airway inflamma- tion.Other inhaled treatments and intravenous medi cine may be prescribed on a case-by-case basis. As your treatment gets underway, you will be examined with close attention to vital signs and the lung exam. Your pulse and oxygen level will likely be monitored by a special sensor called a pulse-oximeter. The pulse oximeter clips onto your fingertip and is painless. You may be asked to wear a cardiac monitor, which is made up of thin wires that are attached to the skin of the chest and connect to a monitor screen. The emergency room doctor and nurse assigned to your care will keep a close watch on you as you receive the prescribed treatments. Some hospitals also have respiratory thera- pists on duty in the emergency room, and they will certainly play a role in your care as well. You will be asked to perform serial peak-flow measurements to help gauge your response to treatment.\n\nYou can expect to spend at least 4 to 6 hours under- going emergency treatment of asthma. You may undergo a chest X-ray and blood tests if an infection is suspected. You may be asked if you know what triggered your asthma. Under the ideal circumstances, your exac- erbation will become controlled in the emergency room, and your asthma will be stabilized. Your symptoms will lessen, and your peak flow will rise into a safe zone and remain there during your emergency room stay. You will be given specific instructions for stepped-up asthma care, and will need to contact and see your regular asthma doctor for a visit within a few days of the emer gency room visit. If, on the other hand, your exacerba- tion cannot be controlled within 6 to 12 hours of aggressive management, you will likely be admitted to the hospitalfor continued care.Ifthephysicians treating you in the emergency setting advise hospitalization, then agree. You must take their best medical advice, no matter how inconvenient it may seem! The “worst case” sce- nario consists of an individual who misjudges the sever ity of an exacerbation and waits too long for treatment, or who doesnt follow recommendations and ends up with out-of-control asthma that can lead to respiratory failure, and sometimes even death\n\n53.Can someone really die ofasthma?\n\nYes, asthma can be fatal. Over 4,000 people die each year in theUnited States from uncontrolled asthma. Asthma is a highly treatable disease. Death from asthma is especially tragic because each one of those deaths is theoretically 100% preventable.\n\n54.What are the characteristics of\\*fatal or“near-fatal\"asthma?\n\n54.What are the characteristics of \\*fatal\n\nFatal and near-fatal asthma have been the subject ofl much interest and study by physicians. By obtaining as much information as possible on persons who die or almost die of asthma, we can hopefully learn how to prevent similar deaths in the future.\n\nThe majority of persons with near-fatal or fatal asthma tend to underestimate the severity of their symptoms and present for care only after several days of clearly worsening symptoms. The symptoms are usually responses to triggers that can include a viral infection intense exposure to allergens, noncompliance with pre scribed asthma treatment, air pollution, changes in weather, or severe emotional stress. By waiting for a period of days before intervening to control the exac- erbation, the opportunity for effective treatment is lost; in other words, it is too late by the time help is on the way. In most cases of fatal or near-fatal asthma, the actual disease can be controlled, but “human patient factors”adversely modify the outcome.\n\nThe more unusual scenario of very rapidly progressive asthma that exacerbates dramatically over the course of several hours occurs in the minority of patients with near-fatal or fatal asthma (Table 24).Some individuals have a particularly aggressive and severe type of asthma that, despite ideal and perfect compliance with medical treatment and recommendations, does lead to severe complications. Those persons should be under the care of an asthma specialist and may be candidates for cutting-edge therapies.\n\nTable24FatalAsthma:RiskFactors\n\nRespiratory failure occurs when the lungs and respira- tory system become unable to provide the body with sufficient oxygen and fail to “blow off\" accumulated carbon dioxide. If the major disturbance is primarily an inability of the respiratory system to meet the body's oxygen requirement, then “hypoxemic\" respira- tory failure is present. If carbon dioxide and acid levels rise within the body because the lungs are unable to keep up their excretory function, then “hypercarbic\"\n\nrespiratory failure occurs. Both a mixed hypoxemic and hypercarbic patternmay coexist.\n\nRespiratory failure can be very gradual, and may develop and progress slowly over time, from months to years, as in the case of“chronic\" respiratory failure, for example. Cigarette-related emphysema is one example of gradual respiratory failure. Asthma is not typically a cause of chronic respiratory failure. Acute respiratory failure, as the name implies, occurs rapidly over a period of hours to days.\n\nFatal or near-fatal asthma areboth causes of acute respira- tory failure. In either situation, acute versus chronic, there comes a point where the respiratory failure becomes so marked that the body will become deprived of adequate oxygen, and be subjected to dangerously rising levels of carbon dioxide and acids. Sampling of arterial blood gases (ABGs) in fatal and near-fatal asthma, for example, show low values of oxygen (the PaO2 value is < 60 mmHg) and rising levels of carbon dioxide (the PaCO2 value rises above 41 mmHg). As the lungs no longer function effec tively and “fail,\"' other organs will begin to fail in response The brain, in particular, is very sensitive to low oxygen levels,as well as toelevations in carbon dioxide values each of which are harmful separately. As the oxygen and carbon dioxide levels become more abnormal, conscious- ness becomes impaired. Coma and death will ensue.An individual with progressive respiratory failure is usually critically ill and in danger of death without aggressive medical intervention and life support.\n\n56.Whatisendotracbealintubation?\n\nEndotrachealintubationis performed in the setting of respiratory failure due to any cause, including respira- tory failure from asthma. It is considered a potentially\n\nlife-saving medical intervention. Patients who require endotracheal intubation are critically ill, because thein lungs are unable to take in oxygen and exhale carbon dioxide. The procedure itself can be performed in an emergency room,an intensive care unit,or out ofhos pital, “in the field,” provided the appropriate equip mentandqualifiedmedicalpersonnelareavailable Ambulance crews withACLS(advanced cardiaclive support) certification are trained in endotracheal intu bation. The procedure itself consists of the temporary placement of a soft, flexible, plastic “breathing tube through the nose or mouth, past the voice box (lar- ynx), and into the trachea or main breathing tube. Endotracheal intubation serves three major functions. It keeps a person's airway open in situations when it would otherwise close off causing asphyxiation, such as in the case of decreasing levels of consciousness. It also allows for the removal, by suctioning, of any mucus that has accumulated in the airways. Perhaps most importantly, however, endotracheal intubation allows a doctor to provide the intubated patient with breaths and extra oxygen to inhale, thus taking over the work of breathing from failing lungs. In order to take over a person's breathing, the end of the endotracheal tube is connected to a ventilator. A ventilator is a machine that is designed to provide individualized support to a patient in respiratory failure, due to any cause. The support provided by the ventilator consists of breaths along with supplemental oxygen.\n\nAsthma\n\nWhat medications are helpful for asthma?\n\nWhy are so many asthma medicines in inhaler form?\n\nHow can I tell when my inhaler is nearly empty? Are steroids dangerous medicines?\n\nAre steroids dangerous medicines?\n\ne steroids dangerous medid\n\n57.Whatmedications arehelpfulfor\n\nMany different classes of medicines are useful in the treatment of asthma.The NAEPP's asthma classifica- tion helps define the severity of a person's asthma and assists in guiding therapy. Notice that for each asthma classification, the NAEPP makes specific suggestions about the best type of medicine to use for treating that specificlevelof asthma.\n\nAsthma medicines are generally prescribed in a “step wise\" approach. The physician will begin with one class of medicine and add or reduce medication based on the patient's symptoms control, lung function, and overall state of well-being. A person with mild inter- mittent asthma, for example, might be instructed to use a short-acting β2 inhaler as needed for symptom relief. With the onset of winter and colder tempera- tures, that individual's symptoms may start to become more prominent and increase. The inhaled, short-act- ing β2 medicine that formerly kept asthma symptoms under control is now required several times daily. No longer mild intermittent, our patient's asthma has ‘moved up”a classification to become mild persistent asthma. Just as the classification has “moved up,”\" the treatment is “stepped up.\" For our previously mild intermittent asthmatic who developed increasing wheezing that was not easily controlled with intermit- tent inhalations of the prescribed short-acting βz inhaler,an additional,second medication with anti- inflammatory properties, such as an inhaled steroid, would be a good choice. After a certain period of time and when good asthma control is achieved, it would then be appropriate to consider a “step down,” espe-\n\ncially if the stimulus to “stepped up” asthma has resolved(such as the endof cold winter weather). Asthma treatment has to take into account the often fluid and changeable character of asthma itself.\n\nOne way of classifying asthma medicines is by their method of action. In such a schema, major categories include quick-relief medicines, controller or mainte- nance medicines, and medicines used for the treatment of a flare or exacerbation (Table 25).\n\nQuick-relief medicines are usually inhaled. The inhaled route ispreferredbecause itdeliversthe medicine directly into the breathing passages. Side effects, if any, are minimal. Why take a pill form of a medicine that leadstomeasurabledruglevelsintheentirebodywhen you can deposit effective medicine exactly where it's needed for quick symptom relief? Short-acting β2 agents like albuterol, pirbuterol, bitolterol, or terbu- taline in inhaled form are all good examples of ideal quick-relief medicines. Quick-relief or“rescue”inhalers areusuallyprescribedfor usewhenneeded.The onset of action is rapid, and the beneficial effects last between 4 to 6 hours. You should keep your quick-relief inhaler handy during the day. Keep it in a briefcase, pocket, purse, or gym bag. Like your house key, your rescue inhaler should accompany you wherever you go. Controller or maintenance medicines are used in addi tion to quick-relief medicine for treatment of the per sistent forms of asthma: mild persistent, moderate persistent, and severe persistent. Controller medicines\n\nController or maintenance medicines are used in addi- tion to quick-relief medicine for treatment of the per- sistent forms of asthma: mild persistent, moderate persistent, and severe persistent. Controller medicines include both inhaled and oral or pill form prepara- tions. The NAEPP recommends\\_ inhaled steroids as\n\nMedicationsUsedinAsthmaTreatment:Classif\n\n| long-fam (ontro) identifiers  | quick sealsf identifiers  |\n| --- | --- |\n| Inhaled corticosteroids• beclomethasone• budesonide• flunisolide• fluticasone• triamcinolone  | Inhaled short-acting β2 agonists· albuterol· bitolterol· pirbuterol· terbutaline  |\n| Inhaled cromolyn and nedocromil· cromolyn sodium· nedocromil sodium  | Inhaled anticholinergics· ipratropium bromide·tiotropium  |\n| Oral leukotriene modifiers· zafirlukast· zileuton· montelukast  | Oral corticosteroids in “bursts\" for rescue· methylprednisolone· prednisone· prednisolone  |\n| Long-acting β2 agonists· salmeterol (inhaled)· formoterol (inhaled)· albuterol (oral; pill form)  |  |\n| Oral theophylline· sustained-release theophylline  |  |\n| Emerging therapies· IgE blockers  |  |\n\n“first-line”inhaled anti-inflammatory treatment and advocates their use beginning with mild persistent asthma. The leukotriene-modifier class of controller- asthma medicine is a newer type of controller medica- tion and is FDA approved for young children in addition to adolescents and adults. The leukotriene modifiers appear to be useful in asthmatics with aller-\n\ngic symptoms, especially allergic rhinitis. Leukotriene modifiers are also effective in exercise-induced asthma.\n\nLong-term, controller-asthma medication must be taken as prescribed, day in and day out, even if symp- toms are quiescent. Most controller medications can be left at home and are taken once or twice daily, depending on the medicine and the prescription.\n\nSeveral years ago, I was completing my pulmonary fel- owship at Bellevue Hospital in New York City. An elderly lady with complicated asthma was assigned to my clinic for her care. At first, she had difficulty understanding how and when to use her inhalers.We reviewed the different medicines, which ones were as- needed “quick relief\" for “rescue,” and which ones were day-in and day-out “controllers” for “mainte- nance.” After a few moments, a broad, triumphant grin spread across my patient's face. “I got it!\" she exclaimed. A minute later, she elaborated,“The white inhaler is like my husband—he's always there, morn- ing and night; but, the yellow one is like my boyfriend—he comes around only when I need him! From that day on, there was no more confusion about those inhalers!\n\n58.Whatisthedifferencebetweena\n\nAll medicines have several different names.When a drug is first discovered, it is given a chemical name, which describes the molecular composition of the drug. Chemical names are complicated and cumber- some, with parentheses and subscripts, numbers and initials. The pharmaceutical company working to\n\ndevelop the drug for market usually will give the drug an“in-house”or code name, such as RU 486, for exam- ple. The name usually includes letters abbreviating the company's name (MSD for Merck, or GSK for Glaxo Smith Kline, for example), followed by a number.\n\nAfter approval by the FDA, the ready-for-market med- ication is given both a generic and a trade name. Each generic and trade name must be unique and distinctive enough to avoid confusion with other products. In the U.S., the United States Adopted Names (USAN) Council assigns a drug its generic name. For example the generic name for a widely prescribed, short-acting β agent, inhaled, quick-relief medicine is albuterol sulfate. A medicine's generic name is also its “official name.\"The drug's manufacturer then selects the medicine's trade (or brand) name. The FDA must approve the trade name selected by the manufacturer. To use our previous ex- ample, the albuterol sulfate inhaler manufactured by the Schering company is named Proventil?, while the inhaler produced by GlaxoSmithKline is Ventolin? Trade names are often selected to be catchy and easily remembered. The trade name may also reflect a charac teristic of the medicine. Many respiratory medicines incorporate “air\" or “vent” (as in, ventilation) as part of the trade name. Examples include Singulair?, Advair@ Aerobid?, Maxair?, Xolair?，as well as Flovent? Serevent?,Atrovent?，Combivent?，Ventolin?，and Proventil?\n\nWhen a new medicine is discovered,the inventor applies for a patent for the discovery. The patent details the discovery, and in doing so makes it public and open to all (including competitors) while protecting the inventor's right to make, use, or sell the medicine for a\n\ndefined period of time, after which the patent is said to expire. When a medicine is new on the market, and its manufacturer is the only producer of that medicine, only one form of the drug is available to the consumer. As time goes by, the patent protection expires, and other companies may choose to produce the generic form of the medicine. In most cases, the generic form of a med- ication sold in the United States is pharmacologically equivalent to the brand formulation. Most generic med- icine sold in the United States is generally less costly than the brand-name medicine, and is of good quality In the state of New York, for example, where I practice pulmonary medicine, the pharmacist will dispense a generic formulation of the medication I prescribe for my patient unless I specifically write “DAW\" (for “dispense as written\") on the prescription. Similarly, your physi- cian will, in most circumstances, approve that a pre- scription medicine be filled with a generic formulation rather than with a specific brand. It is easy to become confused by the fact that a medi- cine will have different names. I usually ask my patients to bring all their medicines with them to my office so that I can make sure they understand what medicines they shouldtakeandhow totake them.I frequently come across a patient who thinks that he or she is tak- ing “a lot of medicine,” only to discover that the “two different inhalers\"are“different\"only to the extent that two different manufacturers are producing the same medicine. If a patient is using inhaled Proventil@ along with inhaled Ventolin?, they are really only using one type of drug: the trade form of albuterol sulfate Remember that the generic name of a medicine refers tothe drug itself,whereas the trade name refers to a specific company's product and brand. Aspirin is a\n\nIt is easy to become confused by the fact that a medi- cine will have different names. I usually ask my patients to bring all their medicines with them to my office so that I can make sure they understand what medicines they should take and how to take them. I frequently come across a patient who thinks that he or she is tak- ing “a lot of medicine,” only to discover that the “two different inhalers\"are“different”only to the extent that two different manufacturers are producing the same medicine. If a patient is using inhaled Proventil@ along with inhaled Ventolin?, they are really only using one type of drug: the trade form of albuterol sulfate. Remember that the generic name of a medicine refers tothe drug itself,whereas the trade name refers to a specific company's product and brand. Aspirin is a\n\ngeneric product; Bufferin?is not. To find out the names of your medicines, ask your doctor or pharma- cist. Read labels and package inserts. In the case of an inhaled medication, the inhaler label will always carry the drug's trade name along with its generic name, albeit usually in smaller print. Even over-the-counter medicines are carefully labeled to specify generic and trade names. A final label-reading “trick\" to remember is that a trademark name is always followed by the ? symbol, whereas the generic name is not.\n\n59.Wbyao1 wake uparouna 2 AMtouse my inbaler before going back to sleep? If you are waking in the early morning hours with uncomfortable breathing or respiratory symptoms, you are experiencing what asthma specialists refer to as “nocturnal awakenings,” or “nocturnal symptoms.\" Nocturnal awakenings due to asthma are not normal and are undesirable from many points of view. Apart from interfering with sleep and rest, they indicate that your asthma is not adequately controlled and that youn asthma is becoming more active. Nocturnal awaken- ings should always be reported to your treating physi- cian. In the NAEPP classification, a person with mild, intermittent asthma experiences no more than two nocturnal awakenings in a month. If an asthmatic developsnocturnal 1symptomsmorethantwice monthly, the asthma is considered to be “persistent. Weekly nocturnal awakenings are seen in moderate persistent disease and in severe disease as well\n\nWhen you awaken with asthma symptoms, it is a good idea to use your quick-relief, short-acting, inhaled bronchodilator. It hopefully will workyour asthma\n\nsymptoms lessen and respond, allowing you to go back to sleep. When you then wake up in the morning, you need to give some thought to your asthma. If your asthma was previously under good control, try to fig ure out why you have developed nocturnal symptoms. Did you omit (or simply forget) your usual asthma medicine? What was your last peak flow (PEF) meas- urement? Have you been exposed to any known trig gers? Did you eat a large, heavy meal right before bedtime, with consequent acid reflux? Are you becom- ing ill with a viral cold or sinus symptoms? Are your spring allergies flaring?\n\nIfyouhaveexperiencedmorethantwonighttime asthma episodes in the last 30 days, you probably require additional asthma medicine to regain control of your disease and to prevent an exacerbation Stepped-up anti-inflammatory and bronchodilator medicine should be considered,and any co-incident factors, such as reflux, infection, or allergy, should also be addressed. Remember, a major goal of asthma treat- ment includes restful, uninterrupted sleep.\n\n60\\. Wby are so many asthma medicines in inbalerform?\n\nThe inhaled route of medication delivery represents an ideal method of asthma treatment. The “problem” with asthma resides in the lung, and in and around the air- ways. It makes perfect sense to administer medicine directly where it is needed, right into the air passages. Inhaled medication goes precisely where it is required, with minimal, if any, absorption by other organs. By limiting medicine in the bloodstream, as well as in other organs, potential drug interactions are avoided,\n\nand side effects and toxicity are minimized. Inhalers are practical. They travel with you and fit in a pocket or handbag. They work at room temperature. They can be taken without regard to meals or time of day. With proper instruction, children as young as 5 or 6 years of age can successfully use inhaled medications.\n\n61.Whatisthe1987MontrealProto\n\nThe Montreal Protocol is a landmark, international treaty designed to enhance air quality and to protect the uppermost (or stratospheric) ozone layer. In 1987 24 countries, as well as the European Economic Com- munity, negotiated and signed The Montreal Protocol on Substances that Deplete the Ozone Layer.The initial pro tocol aimed to decrease the use of ozone-depleting man-made chemicals by 50% by the year 1999.Addi tional supplements to the Montreal Protocol, known as the London, Copenhagen, and Beijing Amend- ments, were adopted in 1990, 1992, and 1999, respec- tively, and further addressed the use and production of various ozone-depleting chemicals, as well as ia timetablefor theirphaseout.\n\nOzone is a molecule made up of three oxygen atoms and is a essential constituent of our atmosphere. About 90% of the ozone resides in a layer between 6 and 25 miles above the Earth's surface in a zone called the stratosphere.The presence of the correct amount of Ozone in the Earth's stratosphere is crucial and serves to absorb dangerous radiation emanating from the sun. The stratosphere's ozone, in a sense, envelops our planet in a protective envelope. For example, increased exposure to the sun's ultraviolet rays, as would occur\n\nfrom depletion of theEarth's protective ozone layer, is associated with an increased risk of developing skin cancer and ocular cataracts in humans. Ozone deple- tion may also adversely affect animal and plant life.\n\nStudies of the ozonelayer over thelast 30 years have revealedasignificantdeclineintheEarth'sprotective Ozone layer over Antarctica. The first report of \"holes in the stratospheric ozone layer byBritish scientists in May1985hasbeensubsequentlyconfirmedanc detailed.A widelyusedclass of synthetic chemicals called chlorofluorocarbons (CFCs) has been impli- cated as major source of atmospheric ozone depletion CFCs contain chlorine, fluorine, and carbon atoms. CFCs were invented in the 1920s, and are, in many ways, ideal compounds. CFCs are nontoxic, noncorro- sive, and nonflammable. They are inert and nonreac- tive with most substances.In the second half of the 20th century, CFCs found extensive use as propellants in aerosols and spray cans, as coolants in refrigerators and air conditioners, as solvents in cleaners—particu larly for electronic circuit boards—and as a blowing agent in the production of foam in devices such as fire extinguishers. Freon?, for example, is a familiar brand ofaclassofCFCsthatwasusedinrefrigeration CFCs are very stable, and it is now recognized that they can persist in the atmosphere for up to 100 years And so, even though the production and release of CFCs have been greatly curtailed, the damage to the ozone layer from past use will continue well into the currentcentury.\n\nThe Montreal Protocol was codified by Congress into law in TitleVI of the Clean Air Act and stipulated\n\nthat theproductionof CFCsin theUnited States would be banned as of January 1, 1996. Existing med- ical products that contained CFCs were exempt from the ban until acceptable alternatives could be devel- oped. An essential medical use of CFCs especially rel- evant to asthmatics is the use of CFCs as a propellant in metered-dose inhalers (MDIs). MDIs are used extensively in the treatment of asthma, emphysema, and chronic obstructive bronchitis.\n\n62\\. Wby are my inbaler medicines no\n\n62\\. Wby are my inbaler medicines no longer being manufactured?\n\n18 Effective treatment of asthma, as discussed in Ques- tion 57, requires the inhalation of bronchodilator and anti-inflammatory medicines (Table 26). Metered- dose inhalers(MDIs）werefirst introduced inthe 1950s. Despite their complexity from an engineering perspective, MDIs are conceptually simple and use1 friendly. They are small, convenient, and highly reli able devices that deliver precise doses of inhaled med- ication directly into the lungs’ respiratory passages. Doctors and patients alike assume that MDIs are “all drug.\" In fact, a large portion of each puff delivered by the traditional MDI is actually inert propellant. The propellant is inhaled, along with the active medication Rather than being absorbed by the lungs, however, the propellant is rapidly exhaled unchanged, and then fully eliminated from the body. The propellant released by the MDI is thus released into the atmosphere.Unti recently, all available MDIs employed chlorofluorocar bons (CFCs) as propellants. Although CFCs are safe for individuals using MDIs because they are inert and do not accumulate in the body, they are harmful to the\n\nShort-Actingβ2Agonist“Rescue\"Treatment Albuterol (albuterol sulfate) MDI Proventil? HFA Albuterol (albuterol sulfate) Ventolin?HFAAlbuterol(albuterolsulfate） Maxair?Autohaler@(pirbuterol acetate)\n\nenvironment as they persist in the atmosphere for a longperiodof time.\n\nIn accord with the Montreal Protocol, the U.S. gov- ernment has banned the use or manufacture of all CFCs (discussed in Question 61). CFCs are no longer used in the manufacture of aerosol spray cans, air con- ditioners, or refrigeration units, for example. As of this writing, MDIs are the only commercial product for which CFCs are still being produced.Because MDIs\n\nareessentialfor asthmatreatment,theEPA and the FDA have allowed an extension to the timeline ban- ning CFC manufacture, and have proposed and over- seen the gradual phase out of all MDIs containing CFCs (MDI-CFC). No CFC-containing MDI is removed from the market until a safe and effective equivalent medicine is available. The goal is to develop CFC-free alternativeMDIs and cease the manufacture ofCFCsaltogether.\n\nPharmaceuticalmanufacturers are either(1)reformu- lating their MDIs to be CFC free, or (2) developing inhaled drug-delivery systems that do not require any propellant at all. Reformulated MDIs substitute a dif- ferent, non-CFC type of propellant called hydrofluo roalkane (HFA). The FDA has thus far approved two different CFC-free brands of albuterol sulfate bron chodilator MDIs， and 1onebrandofMDI beclomethasoneinhaledcorticosteroidthatisalso CFC-free. The products are Proventil HFA?, Ven- tolin HFA?, and Qvar?. Other CFC-free products are available in Europe, but are not currently FDA approved for use in the United States. In addition tol producing g HFA-propelled MDIs, pharmaceutical manufacturers have devised inhalers that donot rely on any propellants. Several different asthma medicines are now available as “dry powder inhalers\" (DPI) in the United States, and more are sure to follow.\n\n63\\. What is a “Diskus?\"? Is it the same as a dry powder inbaler (DPI)?\n\nA Diskus is one of several types of dry powder inhaler devicesused inasthmatreatment.Otherdevicesthat allow for the inhalation of asthma medicines include,\n\nin addition to the Diskus?: the Turbuhaler?, the Rota- haler?，theDiskhaler?，andtheAerolizer?\n\nDry powder inhalers (DPIs) are devices that allow the self-administrationof preciselymeasureddoses of inhaled medicine.DPIs were developed as a conse quence of the phasing out of chlorofluorocarbon (CFC) containing metered dose inhalers (MDIs). To use a medicine via a DPI, you inhale a very fine pow- der, made up of the actual asthma drug, through the DPI's mouthpiece. By inhaling deeply and creating a flow of air,you draw the medicine deepinto your lungs. There is no propellant to “push\" the medicine along.A few patientsI take care ofhappily report that they“really suck down that medicine, Doc,”after mak- ing the switch from MDIs to DPIs. DPIs and MDIs both dispense very precise doses of medication, but DPIs are fundamentally different from MDIs.The DPI device automatically releases medicine as you generate an inward flow of air with your lips around the mouthpiece. The DPI is thus “breath activated. The MDI, on the other hand, requires a greater degree of coordination, timing, and skill for you to trigger the release of the medicine just as you begin to inhale. Some DPIs have a month's supply of asthma medicine already preloaded into the device. You “bring up\" each dose as it is needed, usually by clicking a lever or twist- ing the base of the DPI unit immediately before use. Other DPIs require that you open the DPI before each inhalation and place a capsule that contains a sin- gle dose of medicine in powdered form into a groove before snapping the DPI back into place. Medicines provided via Diskus? or Turbuhaler? are preloaded vith a month's cunnly of mcdicine Hee of Rotahaler?\n\nSome DPIs have a month's supply of asthma medicine already preloaded into the device. You “bring up\" each dose as it is needed, usually by clicking a lever or twist- ing the base of the DPI unit immediately before use. Other DPIs require that you open the DPI before each inhalation and place a capsule that contains a sin gle dose of medicine in powdered form into a groove before snapping the DPI back into place. Medicines provided via Diskus? or Turbuhaler@ are preloaded with a month's supply of medicine. Use of Rotahaler?\n\nor Aerolizer requires you to load a medicine filled capsule before each use. The Diskhaler? lets you load up to eight doses at once. By keeping track of how many doses or capsules you have used and inhaled, the DPI technology makes it simple to know when to refill your prescription before you run out of medicine. The design of the Diskus? stands out and features a small counter that displays how many doses remain in thedevice.\n\nSeveral different medicines come in DPI form, includ- ing long-acting β2 agonists (such as salmeterol and formoterol),inhaled corticosteroids(such as budes onide and fluticasone), and combination DPIs con- taining g different potency inhaled corticosteroids, directly combined with long-acting β2 agonists (such as mixtures of salmeterol and fluticasone).Trade names include:Serevent?Diskus?,Foradil?Aerolizer? Pulmicort?Turbuhaler?,Flovent?Diskus?,Flovent? RotadiskDiskhaler?,andAdvair?Diskus?\n\n64.What is the correct way to use my dry powder inhaler (DPI)?\n\nDry powder inhalers (DPIs) deliver asthma medicine as fine particles of powder. As discussed in Question 63, there are many types of DPIs available on the mar- ket. Each type of DPI is manufactured by a different pharmaceutical company, and each type of DPI conse quently has its unique set of instructions for optimal use. When your physician prescribes a DPI for treat- ment of your asthma,have him or her demonstrate the correct way for you to use the DPI and provide you with any required instructional materials. When you fill the prescription, make sure that the dispensing pharmacist includes the directions provided by the\n\nmanufacturer. Remember, too, that many pharmacists can advise you on proper DPI usage techniques.\n\nEven though each DPI comes with its own set of instructions, all DPIs share similar conceptual and design features. They are prized for their ease of use reliability, efficiency, and convenience. All DPIs are breath activated. When you inhale through a DPI, a precisely pre-measured dose of medicine is automati- cally released. The way you breathe the medicine in allows it to travel into your airways where it is needed. The general principle is that you inhale the medicine via the DPI mouthpiece starting with “empty” lungs, and then hold your breath before exhaling and breath ing normally. The basic technique consists of: (1) an initial exhalation to empty your lungs, (2) fairly rapid inhalation from the mouthpiece, followed by (3) breathholding.\n\nTo use a DPI correctly, you first “prepare” the pre- measured dose of medicine, either by rotating and clicking the device, advancing a small lever, or by physically inserting powder-containing capsules into a specially designed groove in the device, depending on which type of DPI you have been prescribed. When the medicine is in place, you take a big breath of room air, and fully, yet gently, exhale it into the room. When you feel that your lungs are completely “empty, quickly place your lips around the DPI's mouthpiece, and take a full,deep breath,inhaling the medicine until you can't breathe in any further. Once you reach the point when your lungs are “full\" of medicine, hold your breath.You should try to hold your breath for 10 seconds before exhaling. Count to 10 in your head. After you reach a count of 10, remove the DPI mouth- piece from your lips, and let your breath out. Remem-\n\nber toexhaleinto theroom.Donotexhaleinto a DP device.\n\nThe reason you need to hold your breath after taking the inhaled dose of medicine is to allow the medicine to deposit in the air passages. When you hold your breath, there is no movement of air in the lungs. Since there is no movement of air, either in or out, your asthma medicine remains in the lungs long enough to beofbenefittoyou.\n\nBecome familiar with the specific DPI device you have been prescribed. Read the manufacturer's “Instructions for Patient Use” insert provided with the product. Ask your treating physician any questions you may have. I often ask my patients to bring their DPI with them to their appointment so that they can demonstrate how they use it.I am then able to assess the effectiveness of their technique and, if appropriate, make specific sug- gestions. Note that each DPI not only looks unique, but also has specific characteristics. For example, the disposable Diskus? device is packaged in a foil pouch, and its manufacturer states that a Diskus? should be used or discarded within one month of opening the foil pouch to prevent the medicine from drying out. The Diskus? also has a unique dosage counter that shows how many doses of medicine remain in the device. The numbers in the Diskus? dose indicaton turn red when only 5 doses are left to alert you to refill your prescription. When the “O\" is displayed, your Diskus? is empty. You should always keep the inhaler in a horizontal position during use.If you are left handed, you may find it more comfortable and natural to turn the Diskus? device over and use it upside down, so that the lever is easier to click into position with your left thumb while holding the device in your\n\nleft hand.TheDiskus?should be closed to cover the mouthpiece after each use and does not require any other maintenance or cleaning. Never exhale into a Diskus? to avoid introducing moisture into the device and damaging it.\n\nThe Turbuhaler?is similar totheDiskus?in that it comes preloaded with medicine. Rather than having to push a lever away from you to prepare the dose the way you do with the Diskus?, the Turbuhaler? requires you to rotate the base of the device all the way to the right until it “clicks.\" The Turbuhaler doesn't actually display the amount of doses remaining in the device, but it alerts you when 20 doses are left. A red mark appears at the top of the window when you are down to 20 doses. When the marking is at the bottom of the window, the Turbuhaler? is empty. Always re-cap the Turbuhaler? after using it to keep it clean and dry; you can wipe the mouthpiece with a dry cloth,but do not wash the device The Diskhaler?,Aerolizer?, and Handihaler? devices require that you load the DPI before using it. The Diskhaler? holds up to 8 doses of medicine at a time and requires simple but regular maintenance and cleaning. The Aerolizer? and Handihaler? accept only one dose at a time. The Rotahaler? similarly requires insertion of a dose before use, as well as regular cleaning. Although one of the first DPIs developed for patient use, the Rota- haler? has been supplanted in practice bv newer DPIs.\n\n65.Whatisthecorrectwaytousemy metered-doseinbaler(MDI)?\n\nMetered-dose inhalers (MDIs) are convenient, highly portable, and very reliable devices designed to deliver active medicine by inhalation. MDIs are conceptually\n\nsimilar to dry powder inhalers (DPls)(discussed in Question62).BothMDlsandDPlsallowforthedeliv ery of accurate, predetermined doses of medicine directly to the respiratory passages. MDIs and DPIs also have some basic, fundamental differences. All MDIs use a propellant to“push\" the medicine out of its dosing canis- ter. All MDIs on the market in the United States are manually activated rather than breath activated (with one exception: the Maxair? Autohaler@). Manually activated means that the medicine is released from the MDI can- ister when you press down on the MDI. Breath activated means that the medicine is automatically released when you inhale deeply. Because MDIs are patient activated (except for the Maxair? Autohaler?, which is the only breath-activated MDI), their proper use is technically more demanding and requires more “coaching” as com- paredwithDPIs.\n\nThe correct way touseyourMDIis best demonstrated by your physician. There are two techniques for “best' use: the open-mouth and the closed-mouth technique All MDIs come with directions. The directions, or what your pharmacist calls the manufacturer's “package insert,” describe the closed-mouth technique.Pul- monary specialists (such as myself) generally prefer to teach their patients the open-mouth method of using the MDI. Many pulmonary specialists believe that using the MDI with an open mouth enhances the delivery of medicine andfavors the inhalation of the more desirable, smaller particles released by the MDI. MDIs should be kept at room temperature and should not be subjected to sustained temperatures below 59°F or above 77°F. MDIs should be stored in a vertical posi-\n\ntion with the mouthpiece down when not in use. If you notice that the plastic mouthpiece becomes coated with a whitish powder, pull the metal MDI canister out from the plastic mouthpiece and rinse the mouthpiece under warm tap water until it looks clean. Make sure the mouthpiece is completely dry before reinserting the metal canister. It is fine to let the plastic part air-dry.\n\nAllMDlsshouldideallybeallowedtoreachroom temperature before use. If you carry your “rescue” MDI with you, and you are outdoors on an especially cold day, place it in an inner pocket close to your body rather than in a handbag or backpack. Never leave an MDI in the glove compartment or trunk of your car on a hot summer day; its contents are under pressure andcanexplodeinveryhotenvironments(120°For above). Several years ago, one of my patients didn't seem to be faring as well as I had expected. She was an elderly widow and lived alone in the same big house where she had raised her children.She and I spent an entire office visit carefully going over “what had changed\" to explain her loss of asthma control. Imag- ine my consternation when she confided that she had hit on a “great way\" to remember where she had put her MDIs: She stored them in her refrigerator's veg- etable drawer! Her medicines were stored in her fridge, at about 40°to45°F.She would take themfrom the vegetable bin, and go through the process of using the MDI, not realizing that they needed to be stored in a warmer environment,and certainly warmed to room temperature before use! After we decided that she should keepher medicines on the top of the chest of drawers in the bedroom, her asthma once again became controlled,much to our mutual satisfaction\n\nThe general concept in using an MDl is that you trig- ger the release of medicine from the MDI while simultaneously inhaling the medication into “empty lungs. The basic technique consists of: (1) an initial exhalation to empty your lungs, (2) release of a “puff' of medication to coincide with a full,steady, deep inhalation, followed by (3) breath holding.\n\ninhalation,followedby(3)breathholding. To use your MDI, first remove the cap from the mouthpiece. You should ideally stand upright to use your inhaler. If you prefer to be seated, make sure that you sit upright. Hold the inhaler upright, with the mouthpiece at the bottom. Many people find it most comfortable tohold theMDIwith their thumbatthe lowermost portion and their third finger on the top- most metal portion of the MDI canister. Next, shake the MDI canister to mix the medicine. After shaking the MDI, position the mouthpiece 2 to 3 finger widths (1 to 2 in.) in front of your open mouth. Tilt your head back slightly, and gently breathe out. When you have emptied your lungs, press on the MDI, and as simulta neously as you can, take a slow, deep breath. Keep breathing inwards, for at least 5 seconds. Once you have inhaled fully, hold your breath to allow the medi cine to fully penetrate in your lungs and deposit there. Try to hold your breath for 10 seconds. Exhale and resume normal breathing. If your doctor has prescribed a second puff of medication, you may be instructed to wait a minute or more between doses.The MDI-deliv ered medicine should be going straight into your lungss consequently, it not should irritate your throat or cause you to cough, nor should it land on your tongue and cause a “weird\" taste. It is important that you learn to use your prescribed MDI correctly (Table 27). Make sureyou askyour physician any questions you may have\n\nForgetting to shake the MDI canister before use Sittinghunchedoverwheninhalingyourmedicine Blocking the MDI mouthpiece with your tongue or your teeth Releasing the puff of medicine either before (\"too soon\") or after (\"too late\") you have started to inhale deeply (\"poor coordination\" pattern) Taking too shallow a breath in Forgeting to hold your breath for at least 10 seconds after inhalin themedicine Neglecting to rinse your mouth after using the inhaled corticoster MDI Immersing the canister in water Forgetting to replace the MDI canister before the expiration date marked on the label\n\nabout the way you are using your MDI. I have found it very useful to watch my patient's MDI technique dur- ing an office visit. A well-placed “pointer\" can make a world of difference. Remember that mastering good MDI technique involves a learning curve, and with proper instruction and supervision, even young chil- dren can use MDI-delivered asthma medication.\n\n66\\. Wby does my doctor say I sbould rinse my mouth after using my metered dose inbaler (MDI)?\n\n66\\. Wby does my doctor say I sbould\n\nYour doctor has likely requested that you rinse your mouth after using your inhaler in order to gently wash away any medicine particles that were not inhaled into the lungs and may have remained behind in the throat. In particular, it is important to always rinse youn mouth after using any inhaled corticosteroid prepara- tion, whether administered by MDI, DPI, or jet nebu- lizer.The inhaledcorticosteroidmedicationsin particular can, if they“land\" in your throat, cause\n\nthroat irritation and also occasionally lead to a yeast infection in the mouth or throat called “thrush.\" Rins- ing your mouth and gargling is thought to reduce your chances of getting thrush, and decreases the chance you'll experience throat irritation or hoarseness. Remember to spit after rinsing; don't swallow the liq- uid you gargledwith!\n\n67.How canItell wbenmy inbaler is nearly empty?\n\nIt is easy to know whether a dry powder inhaler (DPI) is empty or not because DPIs are specifically designed withcountersthatkeeptrack of howmanydoses remain in the inhaler and “remind\" you when to refill your prescription. Preloaded DPIs such as the Diskus@ are dispensed by your pharmacist in a moisture-protec- tive foil wrapper. The preloaded DPI must be discarded within 30 days of opening the foil wrapper, regardless of whether or not the counter registers “O\" doses. Metered-dose inhalers (MDIs) do not have built-in dose counters. Various strategies have been advocated over the years to help you know when your MDI is empty or nearly empty. One suggestion involved removing the metal MDI canister from its plastid mouthpiece and dropping it into a tall glass of water. If the metal canister sank to the bottom, it was close to full. If it settled halfway to the surface, you still had plenty of medicine. If it started to bob close to the sur- face, it was time to head for the pharmacy for a refill MDI manufacturers are strongly opposed to immersing the metal MDI canister in water, so most doctors don't currently recommend “floating” the canister under any circumstances. You cannot tell whether an MDI is\n\nempty or not by shaking it. It may have propellant in it even after the active medicinehasbeen used up.\n\nThe only way to be certain that an MDI still has med- icine in it istoactuallycounteachandeverydose used.Small external counters that fit in the palm of your hand,likethe counters used to count attendance at museums or concerts, can be“clicked\" each time you use the MDI. The truth is that there is no method of MDI dose counting that is both reliable and conven- ient at the same time. So, instead of trying to guess when your MDI is completely empty, I would suggest that you estimate ahead of time when you will need to replace the MDI. Your estimate should take into account(1)how many doses or“actuations\"the MDI contains, and (2) how frequently you use the MDI. For example, let's say that you are prescribed an MDI that contains 240 puffs of medicine. If you take two puffs of the medication three times a day, then you are using it for a total of six puffs daily.Given that the new MDI comes with 240 puffs, it should provide enough medicine for 40 days. You can also ask your pulmonary doctor or pharmacist to help you estimate in advance when you will need to obtain an MDI refill. Basically, you divide the total number of doses in the full MDI by the number total of daily doses you plan to use to determine how long the MDI will last. Consider writ- ing the date in your calendar or PDA ahead of time so youremember to contactyour pharmacist a day or two ahead of the anticipated “empty\" MDI date. Finally note that CFC-free MDIs may have special require ments. The CFC-free Ventolin HFA?, which is often prescribed as a“rescue\" asthma medication, should be discardedandreplacedafteryouhavereleased200\n\npuffs from the MDI, or if 90 days have passed since you opened the sealed, moisture-protective foil wrap- per,whichever comes first.\n\n68\\. What is a spacer device, and wby\n\nA spacer is a device that is often prescribed with a metered-dose inhaler (MDI). A holding chamber is a type of spacer, and the terms are sometimes used inter- changeably. The benefits of spacer use are at least threefold. The spacer enhances the delivery of the MDI's medication into the lung passages. It reduces potential side effects such as cough, hoarseness, thrush, and throat irritation related to asthma medicine “land- ing” in the throat. More medicine goes where it is needed, and “less\" where it is not. Spacers also greatly simplify the hardest step for most MDI users: having tocoordinate and precisely time inhalation with acti- vation and pumping of the canister. Spacers were given their name because they allow you to “space\" MDI activation and deep inhalation in time. You first press on the MDI canister to release the medicine into the spacer device, and a second or so later, you can inhale that same puff of medication from the spacer. What is a one-step procedure with MDIs becomes a two-step ? process with the MDI-spacer combination.\n\nSpacers make it easier for you or your childwith asthma to use an MDI effectively. Spacers are recom- mended for children, or for anyone who experiences difficulty coordinating deep inhalation and activation of the MDI. They are also indicated when metered- dose inhaled corticosteroids are prescribed. In fact, one inhaled corticosteroid, Azmacort? (the brand of tri- amcinolone manufactured byAventisPharmaceuti-\n\ncals), is sold with an incorporated spacer device so that any asthmatic using Azmacort? inhales the medica- tionviaitsspacer.\n\nSpacers require a doctor's prescription in the United States,and there are several different brands available on the market today. Your lung specialist may recommend a specific brand or type of spacer that is best for you. All spacers come with instructions for cleaning and use. You should, of course, familiarize yourself with the details of the particular spacer that has been prescribed for you.\n\nOne compact “collapsible” spacer, the InspirEase?, has always reminded me of an accordion. It consists of a special mouthpiece with a disposable plastic reservoir bag at its end. The MDI attaches to the mouthpiece separately. When you are ready to take your asthma medicine, place your lips around the InspirEase@ mouthpiece, and press on the (previously shaken) MDI canister which then releases the MDI's puff into the reservoir bag.You then deeply inhale through the mouthpiece. The reservoir bag collapses inward as you inhale the air and medicine (“sucking in\"), after which you hold your breath. If you inhale too rapidly the InspirEase? device emits a whistling sound to alert you to slow down. It coaches you to develop a good inhalation technique. Many patients like the InspirEase? device because it requires very little in the way of maintenance. The reservoir bags must be replaced if they become cracked or torn. Washing the bagsisnotgenerallyadvised.\n\nIn contrast to InspirEase?, the majority of lightweight spacers on the market today are rigid devices. The spacers resemble a transparent plastic cylinder. You use a spacer by inserting the mouthpiece of the MDI at\n\nthe far end of the tube, and placing your lips around the spacer's mouthpiece at the opposite end. First, depress the MDI canister to release the medicine into the spacer, and then a moment later inhale deeply and steadily before holding your breath for 10 seconds or more. Some rigid spacers, such as the Aerochamber? family of products,whistle ifyou breathe intoofast Learn to inhale so that the spacer remains silent. Remember to wash any new plastic spacer with mild dishwashing soap and warm water before you first use it. Make certain to rinse it and allow it to air-dry. Dc not rub it dry. Plastic spacers are such that they have an electrostatic field that draws some of the MDI's particles toward the inside of the spacer's walls. Clean- ing the spacer may reduce the electrostatic charge and cause it to dissipate. Most doctors agree that if you have a plastic spacer that you use regularly, you should take it apart according to the manufacturer's direc- tions, and wash it gently in dishwashing soap and warm water every 2 to 4 weeks. As of this writing, thereisonecommerciallyavailablenon-electrostatic spacer on the North American market. The Pari Res- piratory Equipment Company's Vortex? is a novel spacer made of aluminum. Because it is not made of plastic, and therefore non-electrostatic, it improves the consistency of the MDI medication delivery; no medi- cine particles are attracted to the spacer walls, and more particles remain available for inhalation.Another convenient advantage to the aluminum spacer is that itl can be washed in a dishwasher!\n\n69\\. What is a nebulizer?\n\n69\\. What is a nebulizer?\n\nA nebulizer is a machine that runs off electrical current or batteries. Some people use the term “breathing machine\" interchangeably with the term“nebulizer.\" A\n\nnebulizer creates a fine mist of medicine particles that are easily inhaled into the lungs' breathing passages. Nebulizers can be fitted with either a mouthpiece or a facemask. Babies and very young children are candi- dates for the latter. Many different medications used in asthma treatment are manufactured in a liquid form suitable for nebulization. The two major types of nebu- lizers are jet nebulizers and ultrasonic nebulizers. Most pulmonologists prefer jet nebulizers for their patients. If you or your child has been prescribed Pulmicort? Respules?, which is an inhaled steroid preparation, it must be administered by a jet nebulizer. The Respules@ should not be given by ultrasonic nebulization.\n\nThe machine that “transforms\" the liquid medication into a fine mist is the nebulizer, and the part of the appa ratus that permits the mist to be inhaled is the air com- pressor. All nebulizer units consist of a nebulizer proper, as well as a small cup tohold the liquid form of medica- tion. Special tubing connects the nebulizer proper to an air compressor that shoots air though the medication cup and transforms the liquid medicine into a fine mist suit- ableforinhalation.Severalstudieshaverevealedthatthe differentnebulizersavailableonthemarkethavediffer ent medication-delivery profiles. Although all nebulizers work in a similar way, you should familiarize yourself fully with the nebulizer that your physician prescribes for you or your child. Read any directions for use and main- tenance carefully. Many nebulizer manufacturers main tain Web sites for their products and can be a good source of information for patients.\n\nTo use your nebulizer you will need to: (1) assemble the nebulizer and air compressor, (2) take the nebulized med- ication (\"treatment\"), which should last about 15 to 20 minutes, (3) clean and prepare the nebulizer for the next\n\nuse, and (4) every other day, clean more thoroughly. Here are some general guidelines on how to use your nebulizer, using a mouthpiece. Babies and young children will need to use a special mask rather than a mouthpiece.\n\nUnderstand that your individual machine may require slightlydifferent handling.First always collect allthe equipment and medicine you will require, including the nebulizer, tubing, medicine, and the compressor. Wash your hands. Use a clean nebulizer and fill the medication ‘cup”with one dose of your medicine as directed by your physician. Connect the air tubing between the nebulizer and the compressor, along with a finger valve if your setup requires one. Attach a mouthpiece (or mask) to the nebulizer. Turn the compressor on and check that the nebulizer is producing a medication mist. Now you're ready to place your lips around the mouthpiece. You should stabilize the mouthpiece between your teeth. Remember to hold the nebulizer upright to avoid spills and to increase its effectiveness.Breathe gently and calmly.Try tobreathein deeply for 3to 5 seconds before holding your breath for up to 10 seconds, and then exhale normally. If your nebulizer has a finger valve, you should cover the hole in the finger valve while you inhale and uncover the valve when you exhale. Repeat, drawing deep breaths, followed by breath holds until the nebulizer begins to make sputtering sounds. The sputtering sound signals that your treatment is finished.\n\nWhen all the medication solution has been nebulized, take the nebulizer setup apart. Wash all the parts- except for the tubing and the finger valve—in liquid dish soap and water. Rinse in tap water, and shake off any excess water droplets. Reconnect the different parts and run the compressor to dry the nebulizer.\n\nWait until the nebulizer is completely dry before stor- ing it. If you use a nebulizer daily, you should also per- form a more in-depth cleaning every 48 hours or so. To do so, wash your hands first. Then, put aside the tub- ing and valve. Prepare a fresh solution of distilled white vinegar and hot water. The proportions are: 1 part white vinegar to 3 parts hot water (one quarter white vinegar to three quarters hot water). Soak all parts of the nebulizer (except the tubing and mask) in the vine- gar and hot water solution for 60 minutes. After an hour, remove the nebulizer parts and rinse them under running water.Throw away the soaking solution.Aften rinsing in fresh water, shake off any excess water droplets. Reconnect the different parts of the setup, and run the compressor to dry the nebulizer. Wait until the nebulizer is completely drybefore storing it.Make it a point to find out whether the compressor unit you are using requires specific maintenance or cleaning.\n\nmoreeffectivethanthatinaninhaler? The surprising answer is: “No, not necessarily, and not usually\"Severalstudies have demonstrated that inhaledasthmamedicationinMDIformisjust as effective as that administered via a nebulizer, provided that a spacer is used with the MDI and the patient has mastered appropriate MDI technique. MDIs are inex- pensive, basically maintenance free, highly portable, and very convenient. Nebulizers are more cumber- some, require a power source, and need frequent clean- ing. The same medicine that can be administered in two or three minutes by an MDI will take at least a quarter of an hour by nebulization. There are a few specific instances when a nebulizer rather than an\n\nMDI-spacer setup might be considered. Babies and very young children who are too young to learn MDI technique should receive their medicine by nebuliza- tion, usually via a face mask. Most children can be taught correct MDItechnique whenthey are of kindergarten age, particularly if there is a motivated adult in the home to supervise and encourage the child. Many such children can also be prescribed a nebulizer to keep in reserve at home for “emergency” use under the guidance of a doctor in the case of a severe exacer- bation. A patient of any age who cannot master correct MDI-spacer technique will require medication admin- istration by nebulizer.Persons who are unable to use MDIs, perhaps because of physical or neurological impairments,can usually receive their prescribed medi cine via a nebulizer. Finally, some individuals with very compromised lung function cannot inhale from an MDI deeply enough to benefit and should switch to a nebulizer. The last scenario is unusual in a person with asthma alone and is more likely with a cigarette-associ- ated lung condition, such as advanced emphysema.\n\n71\\. Are steroids dangerous medicines? No, not if you take steroids exactly as prescribed by your physician. Each and every prescription medica tion for sale in the United States has passed the FDA's rigorous approval process. Steroids are no exception; like any other class of medicine, steroids are safe and effective when prescribed appropriately, and when used exactly as directed. Steroids are not inherently any more or less “dangerous\" than other medicines. Like any other medicine, they do carry potential side effects, especially if used in pill form chronically (long term) and in large doses. Steroid preparations have\n\nimportant and diverse medical uses.The development of inhaled corticosteroid medicines in MDI and DPI forms has revolutionized the treatment of asthma and transformedthelivesofcountlessasthmaticsforthe better. Steroids come in forms other than pills and inhalers. An allergic child with eczema may be treated with a steroid cream, for example. Similarly, ophthal- mologists may prescribe steroid eye drops for specific conditions. Steroids are a powerful medicine in the pulmonologist's and allergist's armamentarium, and they can be life saving in certain medical situations, such as a severe exacerbation of asthma\n\nWhy, then, might people think of steroids as “danger- ous?\" Some confuse anabolic steroid medications with corticosteroids.Anabolic steroidshave been abused by some weight builders and athletes to help them “bulk up\" and build muscle mass. Corticosteroids are com- pletely different medicines from anabolic steroids and are used extensively in allergy and asthma manage- ment. Another reason you might think of steroids as dangerous is because they have to be taken exactly as directed. If your doctor instructs you to take tapering or decreasing doses daily, for example,then you should follow thephysician'sdirections totheletter.There are at least two important reasons for you not to stop tak- ing the pill form of corticosteroids abruptly. The first reason is that if prescribed for asthma treatment, there is a good chance that the asthma will flare anew if the steroid dosage is decreased all at once.The second rea- son applies in the scenario of an individual who requires steroids on a more long-term basis. Our bodies allproduce aformof steroidsthat is requiredfor health.The right and theleft adrenal glands located above each kidney are responsible for meeting the\n\nbody's steroid requirements. The steroids produced by the adrenal glands are referred to as the body's “endoge nous steroids.\" When the adrenal glands detect “extra steroid medication in the bloodstream over time, they reduce their own endogenous steroid production.If the adrenalglands are exposed toa significant amount of steroid medication, they will fairly quickly respond by completely shutting down the body's own vital manu- facture of steroids. As long as a person continues to take his or her prescribed steroid medication, the adrenals remain “lazy” and cease the production of endogenous steroids.When steroid medication is grad- ually reduced, the adrenal glands have time to “wake up,” and will eventually resume producing endogenous steroids for the body's needs.If, on the other hand long-term steroid pills are not tapered and are stopped abruptly, the adrenal glands will not have sufficient time torecover andtorestartthe manufacture of endogenous steroids. The body will be left without any steroids at all, and an “adrenal crisis\"——a true medical emergencymay ensue.The treatment of adrenal crisis includessteroid administration.\n\nSteroids are considered safe when taken exactly as pre- scribed, for bona fide medical indications. Let's say that your asthma has become more active. Despite the fact that you are using inhaled, long-acting β2 agonists, along with an inhaled, high-dose corticosteroid, you are also requiring a short-acting rescue inhaled β2 agonist every 4 to 6 hours for relief of breathlessness. Your peak flow values have decreased. You are experiencing noc- turnal awakenings because of respiratory difficulty. You feel rotten. Your physician will undoubtedly prescribe a “steroid burst” for you. A “steroid burst\" is a prescription\n\nfor corticosteroid pills that you will take daily for a lim- ited period of time (usually 6 to 21 days, depending on your asthma). You will begin with higher doses, in order to get your asthma under control, followed by gradually decreasing doses, before finally tapering off the medi- cine. You can expect to begin to feel an improvement in your asthma exacerbation, with lessening of symptoms in as little as 6 to 12 hours after the first dose of steroid pills. When used properly, steroids are truly miraculous in their effectiveness. Prednisone and medrol are two different steroids in pill (or oral) form that are fre quently prescribed in the treatment of asthmatic exacer- bations and of severe allergic reactions. They are also sometimes given as controller therapy in very small daily doses in the treatment of severe persistent asthma. A 5 mg dose of prednisone is equivalent to a 4 mg dose of medrol. I usually advise my patients who require steroids to “start them early and get off them quickly, so they can take advantage of the beneficial qualities when treating an exacerbation and minimize potential sideeffects.\n\n72.What are possible steroid side effects\n\nThe potential side effects of steroids are well described in the medical literature and are related to:(1) the daily dose of steroid taken,(2） the total duration of steroid therapy, and (3) individual characteristics. A person who requires 60 mg of prednisone daily for 6 weeks, for example (an admittedly unusually high and prolonged dose in asthma treatment), can expect to develop differ- ent side effects as compared to a person taking 40 mg of prednisone for one day, 35 mg the next day, then 30 mg the day after, and so forth, tapering down by 5 mg each\n\nday for a total of 8 days of therapy altogether. Note too that oral (pill form) steroids affect different people in different ways. Steroids can cause mood elevation and increased energy. Some people may experience insomnia Steroids stimulate appetite; food “tastes better.\" Because steroidscanleadtowater retentionalong withan increase in appetite, weight gain often occurs, particu- larly with longer duration of use. Steroids can cause blood pressure to rise and can cause “glucose intoler ance,” which makes diabetes harder to control. With long-term use, steroids can lead to acne and cause the skin to bruise easily. Some people develop a rounded facial appearance that, like most other steroid side effects, is not permanent and will disappear after the steroid medication has been tapered and discontinued Long-term steroid treatment can lead to “\"thinning” and weakening of bone, and cause a type of osteoporosis called glucocorticoid-induced osteoporosis (GIO).\n\nGIO is being increasingly recognized in respiratory patients. There is some uncertainty and controversy regarding what a “minimum” safe, daily steroid dose is from the perspective of bone health. Clearly, steroids in pill form are of far greater concern than inhaled steroids when it comes to glucocorticoid-induced osteoporosis Not all persons on glucocorticoids develop bone loss or GIO. Some experts quote a dose of 5 mg of prednisone by mouth daily for 3 to 6 months or more as placing a patient at risk for the development of GIO.Others quote a dose of 7.5 mg in pill form daily. One prelimi- nary study examined bone density in asthmatics taking inhaled steroids for 6 years and detected reduced bone density in several parts of their bony skeleton. GIO can be prevented or reversed with early and timely treat- ment. Ways to prevent and treat GIO include: (1) pre-\n\nscription of the smallest effective dose of steroids, (2) favoring inhaled steroids for asthma treatment rather than oral (pill form） steroids,(3) adding calcium (1500 mg/day) and Vitamin D (800 IU/day) supple- ments daily, (4) performing regular weight-bearing exercises, (5) speaking to your physician about the pos- sible need for bone density measurement tests, and (6) taking a class of medicines called biophosphonates for the prevention and/or treatment of GIO, if medically appropriate. The FDA has approved risedronate for the prevention and treatment of GIO,and the medicine alendronate for the treatment of GIO.\n\nAsthma:\n\nMy asthma worsens each month near my period. Is\n\nShould I take extra vitamins or mineral supplements\n\nWhat sports are especially beneficial for asthma?\n\nOmazilumab is:\n\n1OOQUESTIONS&ANSWERSABOUTASTHMA\n\n73.What'snewinasthmatreatment\n\nAsthma is a condition that is of great interest tophysi cians, researchers, epidemiologists, and public health experts. In terms of treatment in general, the modern approach to asthma includes an accurate classification scheme, stepwise therapy with emphasis on trigger identification and avoidance, and the all-important role of anti-inflammatory medicines. Development of dry powder inhalers (DPIs) is a recent phenomenon. So, too, is the design of novel medication based on the basic science of asthma. The leukotriene antagonist medications, for example, were designed based on the specific study of leukotrienes, which are produced in greater numbers in allergic and asthmatic persons. The most recent result of our better understanding of asthma and allergy at the molecular level is a new class of medicine referred to as “IgE Blockers (Table 28).\"\n\nTable28TheFirstinaNewClassofAsthmaTreatments:lgEBlockers\n\nXolair? (Omalizumab), a medication that binds immunoglobulin E, is the prototype of a new and unique class of asthma treatment, the IgE blockers.\n\nImmunoglobulin E, abbreviated IgE, is a protein pro- duced by the body and was first identified in the mid- 1960s. IgE is an antibody. IgE is produced by the body in minute quantities and normally circulates in the bloodstream in very small amounts. Under certain conditions however, the body's (and blood or serum) level of IgE can rise significantly. High serum IgE lev els have, for example, been associated with persistent wheezing, allergy, and bronchial hyperresponsiveness. IgE plays a pivotal role in allergy, in asthma, and in the other “atopic diseases,” such as eczema, seasonal aller- gic rhinitis, peanut allergy, anaphylaxis, and hives. To better understand the central role of IgE, it is impor- tant tofirst review our understanding of the body's allergicresponse.\n\nWhen a person has an allergy to a specific allergen, the allergy has developed over time. In order for an allergy to emerge, a person must first be exposed to an aller- gen. With continued exposure, “sensitization” to the allergen takes place, and only then, with continued exposure to the allergen, will an allergic response develop. The genesis of a specific allergy in an individ. ual with certain innate genetic characteristics requires at least two successive steps: a preliminary exposure to an allergen, followed by sensitization to that same allergen. Many individuals are not “allergy prone, meaning that even thoughthey mayhave repeated frequent allergen exposure, their immune system does notbecome sensitized,and allergic symptoms never develop. Consider, for example, two siblings who live in a home with a cat. One child has no allergic symp- toms. The other child experiences itchy eyes, runny nose, chest tightness, and wheezing upon any exposure\n\nto the family cat. The second child's immune system has reacted to the continued exposure and sensitization to cat allergen by making antibodies against cat pro teins. The antibodies made in the course of the allergic response are IgE antibodies. The IgE directed against cat protein is the “culprit\" in the allergic response. The child'selevatedIgElevelscontributesignificantlyto the child's asthma symptoms. The increase in an aller- gic individual's IgE levels and IgE antibodies are easy for doctors to measure and assess.A simple blood test will yield values for total IgE. There are two tests for specific IgE: one is a skin “prick\" test, the other is an IgE-specific blood test measurement against the aller- gen, called a RAST test. To continue with our prior example, the cat-allergic child will demonstrate an ele vated total IgE blood measurement, a positive skin test to cat allergen, and a high level of cat-directed IgE (anti-cat IgE) in the blood on RAST testing\n\nScientists have been able to very precisely study and analyze effects of IgE inhumans at the cellular level Researchers have been able to map out how exactly the IgE in concert with “effector” cells in our bodies, such as macrophages, T cells, B cells, and activated mast cells,interact and release substances that create the symptoms of an allergic response. The sophisticated research has not only advanced our understanding of how allergy and asthma “develop,”\" but has also sug gested pathways for new asthma and allergy medica tions. In particular, a novel medication, Xolair? (omalizumab), was developed specifically for patients with IgE-mediated asthma. The FDA granted Xolair@ its approval in June of 2003. Xolair? treats asthma by a unique and completely different mechanism from other existing asthma medicines. Xolair@actually\n\nbinds the IgE circulating in the body. The IgE is blocked by the medication and does not interact with cells, meaning that IgE cannot exert its asthma-caus- ing effects. Xolair@ became available in the U.S. by prescription in July of 2003. It is approved by the FDA for treatment of moderate persistent or severe persist- entasthmainadolescentsandadultswhomeettwo additional specific criteria. One is the presence of a positive skin test, or RAST blood test for a year-round allergen, such as dust mite or mold, for example. The second criterion requires that inhaled corticosteroid treatment be ineffective in adequately controlling the patient's asthmatic symptomatology.\n\n74\\. My asthma worsens each month near my period. Is that possible?\n\n74\\. My asthma worsens each month\n\nThirty to forty percent of women with asthma who menstruateexperienceexacerbationoftheirasthma symptoms in relation to the menstrual cycle. They consistently note increased asthma symptoms just before and during their period. The term “premen- strual asthma\" has been applied to this phenomenon. Hormonal changes, possibly 1relatedtorisesin leukotriene levels, have been studied as a possible explanation for the increase in asthma symptoms. The first step in treating premenstrual asthma is to identify whether it is in fact present. A symptom diary togethen with daily peak-flow recordings can be helpful. If con firmed, premenstrual asthma can be treated with one or more of the following, depending on symptom severity and individual characteristics: (1) stepped-up controller medicine, (2) a trial of oral leukotriene mod- ifiers, and (3) in severe cases, hormone therapy or oral contraceptive medication to suppress ovulation.\n\n75.SbouldItake extra vitamins or\n\nA healthy adult who carries a diagnosis of asthma does not ordinarily or routinely require nutritional supple mentation simply because of the asthma (Table 29) Asthma is a respiratory condition and does not affect your body's ability to absorb nutrients from foods. It is important to take your asthma treatment as prescribed by your physician, to exercise, and strive for your ideal body weight by eating a well-balanced and nutritious diet. All the vitamins required for health are found in the foods we eat. The vitamin tablets you purchase in\n\nTable29VitaminandMineralSupplementsforAsthma\n\nTable29VitaminandMineralSupplementsforAsthma\n\nA healthy adult with asthma who eats a balanced, healthful diet will derive no additional benefit from taking supplements. There are, how ever, specific clinical circumstances that mandate consideration of either vitamin or mineral supplements (or both) to the diet.Your doc tor is a good source of advice in this regard. Consultation with a regis tereddieticianmay alsobebeneficial.\n\nSome situations thatmayrequiredietarysupplementationinclude: Food allergies that require elimination of a food group from the did Pregnancy Vegetariandiet Childhood ：Age 65years or older ·Persons with restricted calorie intake (for example<1200 cal/day) Recoveryfrom majorsurgery Remember that as a general rule: ·More vitamins and supplements are not necessarily better. Excess intake of fat-soluble vitamins can cause toxic effects. ·Before taking any supplements or minerals, check to make sure tha they in no way interact adversely with your“regular”maintenance medicines or any other prescription medicine you are taking.\n\nthe store are synthesized in a pharmaceuticallaboratory, copied\" in a sense from the vitamins extracted from food and found in nature. Supplements should never replace good eating habits and healthful food selections. Many foods in the American diet are, in fact, further fortified with vitamins and nutrients.Vitamin deficien cies in our society areusually due to anillness(often of the intestinal tract)that interferes with the body's abil- ity to absorb the vitamins present in food, rather than a vitamin deficiency in the diet or food itself.\n\nAcloserreviewofvitaminsrevealsthatthere aretwo categories of vitamins: fat-soluble vitamins and water- soluble vitamins. Fat-soluble vitamins include Vitamins A, D, E, and K. If taken in amounts exceeding the body's immediate requirements, the“extra” fat-soluble vitamins are stored in the body's fatty tissues. If still more fat-solu- ble vitamins are ingested, vitamin toxicity can develop. Water-soluble vitamins, on the other hand, are not stored by the human body. The B vitamins and Vitamin C are examples of water-soluble vitamins. If you take a tablet ofVitamin C, for example, most ofit is eliminated in your urine. Your body absorbs what is requires and the kidneys excrete the rest. Since the majority of the dose of the water-soluble vitamins people add to their diet in pill form ends up in their urine, many nutritionists joke that Americans have the “healthiest\" and most expensive toi- let water in the world!\n\nTheU.S.NationalAcademyof Science'sNational Research Council has established guidelines on the amount of various nutrients men and women should eat at different ages. The guidelines constitute the \"Recommended Dietary Allowances,” or RDAs- oftenreferredtoas RecommendedDaily\\[sic\\]\n\nAllowances.In 1997,the National Academy of Sci- ence's Institute of Medicine published an updated report that modified recommendations for calcium, Vitamin D, fluoride, magnesium, and phosphorus, and that eliminated the name RDA in favor of DRIs, on \"Dietary Reference Intakes.\" Most healthy persons withgoodeating habitseasily meettheDRIs.Note that adequate calcium intake is especially important in growing girls and teenagers. Many young girls drink soda daily or with meals. The large amounts of soft drinks consumed by adolescents may be responsible fon their increasingly inadequate calcium intake. The Institute of Medicine has also added a new category tolerable upper intake levels (ULs), to caution against excess intake of nutrients like Vitamin D that can be harmful in large amounts. What if you don't quite fit into the “healthy adult with asthma eating a balanced diet” category described above? There are, of course, specific circumstances that may lead your physician to advise you to regularly sup- plement your diet with a multivitamin tablet or miner- als. Those situations are not just asthma related. Fon example, all pregnant women should take a folic acid supplement to help prevent neural tube defects in the developing fetus. So, it goes without saying that the recommendation for folic acid supplementation also applies to pregnant women with asthma. Of particulan importance for the reader is the person with severe food allergy who requires the elimination of an entire food group. A child with a peanut allergy does not need to compensate for the lack of peanuts in his diet, for example, but another child unable to drink milk on eat cheese certainly should be placed on calcium sup- plementstoensureanadequateintakeofcalcium\n\nAllowances.In 1997,the National Academy of Sci- ence's Institute of Medicine published an updated report that modified recommendations for calcium, Vitamin D, fluoride, magnesium, and phosphorus, and that eliminated the name RDA in favor of DRIs, or “Dietary Reference Intakes.\" Most healthy persons with goodeating habitseasilymeet theDRIs.Note that adequate calcium intake is especially important in growing girls and teenagers. Many young girls drink soda daily or with meals. The large amounts of soft drinks consumed by adolescents may be responsible for their increasingly inadequate calcium intake. The Institute of Medicine has also added a new category, tolerable upper intake levels (ULs), to caution against excess intake of nutrients like Vitamin D that can be harmful in large amounts.\n\nWhat if you don't quite fit into the“healthy adult with asthma eating a balanced diet” category described above? There are, of course, specific circumstances that may lead your physician to advise you to regularly sup- plement your diet with a multivitamin tablet or miner- als. Those situations are not just asthma related. For example, all pregnant women should take a folic acid supplement to help prevent neural tube defects in the developing fetus. So, it goes without saying that the recommendation for folic acid supplementation also applies to pregnant women with asthma. Of particular importance for the reader is the person with severe food allergy who requires the elimination of an entire food group. A child with a peanut allergy does not need to compensate for the lack of peanuts in his diet, for example, but another child unable to drink milk on eat cheese certainly should be placed on calcium sup- plements to ensure an adequate intake of calcium.\n\nFinally, if your calorie intake is reduced or limited (by dieting or loss of appetite) below 1,200 calories (as a general cut off), you should most likely take a multivi- tamin and mineral supplement on a regular basis. Be sure to check with your doctor if you think you may require vitamin or mineral supplements.\n\n76.Is obesity related to asthma?\n\n76.Isobesityrelatedtoasthma?\n\nA suspected relationship between obesity and asthma continues to stimulate medical interest.Physicians as well as the general public have long postulated a link between obesity and asthma. The prevalence of both obesity and asthma are rising in parallel in Western societies. Several human population studies have demonstrated an association between being over- weight and the likelihood of carrying an asthma diag nosis. Yet, the precise relationship between the two conditions remains controversial\n\nDoesasthmacauseobesity?Doesobesitycause asthma? Or, is there a common underlying factor that causes both asthma and obesity? The scientific pul- monary community has started to tackle these ques- tions.Onetraditionaltheorymaintainsthat asthma. particularly less than optimally managed asthma, leads to a more sedentary lifestyle. According to the theory, certain asthmatics do not exercise, either because of a mistaken belief that exercise is “bad\" for asthma or because their asthma is not well controlled and flares with exercise. Because of lack of exercise, the asthmatic becomes more out of shape, more sedentary, gains more weight, and ultimately joins the ranks of the obese. An alternative theory suggests that obesity is the primary event, and that the obese state leads to\n\nchanges in the lungs and airways, and ultimately asthma. Both theories have their merits, but neither one satisfactorily explains why asthma does not affect males and females equally. A third, more contempo rary approach, with intriguing supportive data in labo- ratory animals, attempts to sort out the influence of chromosomal changes and hormonal factors that might confer predispositions to both asthma and over- weight status. In 1994, a protein molecule called leptin was identified in humans. Leptin is primarily pro duced by fatty tissues.Leptin and a second protein called ghrelin are both suspected of playing important roles in the regulation of food intake, energy balance, and dultimately of weight.Of interest to lung researchers, lung and airway cells have receptors fon leptin on their surfaces, and leptin furthermore stimu lates the proliferation of the lung and airway cells, act- ing as a kind of stimulatory lung growth factor. Some preliminary studies in humans have documented ele vated blood leptin levels in certain types of marked obesity. The finding raises the tantalizing possibility that there could be an association between obesity and asthma on one hand, and abnormal blood levels of lep tinandevenghrelinontheother.\n\nA key to better understanding the obesity-asthma link may come from the study of girls and boys in puberty and adolescence. More than 1,000 babies born between May 1980 and January of 1984 were entered at birth in the ambitious and ongoing Tucson Children's Respira- tory Study. Nearly 1,300 subjects were enrolled in the study, and have been followed and reassessed at regular intervals for over 20 years by Dr. Fernando Martinez and his team. The study was designed to study respiratory health and illness over time, in a prospective fashion. In\n\nparticular, the development of asthma was carefully eval- uated. In 2001, Dr. Martinez and his co-workers reported that females who became overweight or obese betweentheages of 6and 11 yearsof age had an increased risk for developing new asthma symptoms dur- ing early adolescence. They found that girls—but not boys—who became overweight between 6 and 11 years of age were 5 to 7 times more likely to develop new asthma symptoms at ages 11 and 13, compared to girls who did not become overweight or obese at ages 6 and 11 years. Boys who became significantly overweight between 6 and 11 years of age did not exhibit an increased risk for the development of asthma or asthma- like symptoms. The strongest association between over- weight status and asthma risk was seen in females who underwent puberty before the age of 11 years. Being overweight is associated with earlier onset of puberty. Could therebe a commonfactor that leadsto overweight status in girls, followed by early puberty and then the development of asthma? The findings are especially interesting because it has long been observed that new cases of asthma in females are especially common in the adolescent years. Further, the male (2:1) preponderance of asthma seen in young, school-age children changes over to a female preponderance by adulthood. A role for female hormones has long been suspected, and the data from the Tucson Children's Respiratory Study supports this theory and suggests avenues for further research.\n\nApartfrom consideration of thelinksbetween obesity and asthma risk, being overweight is medically unde- sirable. Even my patients with very well-controlled asthma symptoms report that their breathing is “so much easier” when they maintain a “comfortable' weight. They feel more limber, less achy, and describe greater endurance. It makes sense that if you carry\n\nexcess weight on your frame, it literally “feels\" as if you are transporting additional pounds as you walk around. How can you tell whether you or your child are obese? An obese adult is, by definition, a person who weighs 30%ormoreabovetheirpredictedoridealbody weight. One useful and handy formula for calculating\\] an adult's ideal body weight requires knowledge of your height. Females are allowed 100 pounds for the first 5 feet of height, and 5 more pounds for each addi- tional inch above 5 feet. A few additional pounds are added or subtracted for persons with large or small frames. So, a 5'3” woman should ideally weigh about 115 pounds. The formula for men is similar: A man is allowed 106 pounds for“the first\" 5 feet of height, and 6 additional pounds are added for every additional inch over 5 fet. A 6-foot tall man of average build would thus be expected to weigh 178 pounds. As for women, there is a correction for individuals with small and largeframes.\n\nIdeal body weight for children is best determined by computation of the body mass index (BMI). BMI is a measure that can also be used in adults.Assessment of BMI requires accurate measurement of height and weight, ideally in meters and kilograms. The BMI is the weight (in kilograms) divided by the square of the height (in meters). You will need to obtain a table of predicted BMI for any age to compare your child's BMI to the standard.A child with a BMI greater or equal to the 95th percentile for his or her age is considered obese. If you prefer not to do the math, there are several clever Web sites that ask you toenter data such asyour weight height, and age, and then calculate your ideal body weight and BMI for you. Simply go to your preferred search engine, and type a phrase such as: “ideal body weight cal-\n\nculator,” or “BMI computation\" to navigate among the different sites, and learn how you compare!\n\n77\\. Is caffeine good for people with\n\n77\\. Is caffeine good for people with asthma?\n\nCaffeine is a naturally occurring compound. The Ger- man analytical chemist Friedrich Ferdinand Runge (1795-1867) discovered caffeine in 1819,apparently at the urging of Goethe, who had encouraged Runge to study and analyze coffee.We now know that caffeine is naturally present in foods such as coffee beans, tea leaves, cacao beans (used to make chocolate),kola nuts, guarana, and maté. Caffeine is also frequently added to beverage products, such as carbonated soft drinks and drinks marketed as “energy drinks.\" It is also available in pill form,either alone (NoDoze? Vivarin@), or as an additive, to aspirin for example, as in Anacin? and Excedrin?\n\nResearch studies of the effect of caffeine in humans confirm that caffeine is a bronchodilator. It improves pulmonary function, and although it is a weak bron chodilator, it clearly has beneficial effects on direct measurements of lung function, such as the vital capac ity, the FEV1, and expiratory flows (discussed in Ques- tion 28).Studies of thehuman metabolism of caffeine reveal that ingested caffeine is metabolized by the body and transformed into three separate compounds. Caf- feine metabolites are paraxanthine, theobromine, and theophylline. Theophylline is a well-known bron- chodilator, used in pill form for decades in the treat- ment of several lung ailments, including asthma, chronic obstructive bronchitis, and emphysema. The effects of orally administeredcaffeinearemaximal at\n\nabout 2 hours after ingestion and wear off after approx- imately 6 hours. Incidentally, if you are undergoing pul- monary function testing as part of an evaluation of possible asthma, you should avoid caffeine for at least 4 hours prior to lung testing. So, to get back to the ques- tion about caffeine being “good\" for people with asthma—if you enjoy caffeinated beverages, know that the caffeine they contain will, if taken in high enough doses, provide bronchodilatation, and improve your lung function modestly. Sounds good to me!\n\n78\\. What sports can asthmatics participate in?Is it better to use my inbaledastbma medicationbeforeor after I work out? What sports are especially beneficial for astbma?\n\nGemma'scomment:\n\nI walk several mornings aweek witha friend my own age Althoughthisexerciseisparticularlystrenuous,Ialwaystake myinbaledmedicationbeforeIleavehome,becausewewalk inthemorning,whenthestreets arelikelytobedusty,sweep ersandgarbagetrucksareout,and,inthespringandfall pollen and leaf particles are in theair.I'm alsoa regular par ticipant in aerobic class at a neigbborbood gym.Ifind that a routinethatincludes warm-upstretches,aboutbalfanbour ofmorerapidmovement,someweightliftingandsomemat work is goodfor overall toning,as well as mood and relax- ation.Although the indoor air of the gym is rather stuffy,I don't needinbaled medicationwbenIworkout there.Infact, ifI'mgettingoveracold andfeel sometightness inthechest,I find“cruncbes\"especially belpful.The curled-uppositiongives justenougbcompressiontoloosensomeobstructioninthe\n\nlungs andmakebreathingeasier.Mydaughterrecommends Pranayama yoga(breathing exercises)toeaseastbma symp- toms.We both recognize that swimming and other aquatic routines protect joints andmayofferagoodaerobic workout, but we also agree that we bave never used a pool that does not,soonerorlater,causeitcbyskin,reddenedeyes,andtrou bledbreathing.\n\nExercise is a symptom “trigger\" for the majority of people with asthma, be they adults or children, weekendwarriorsor eliteathletes.Studies estimate that nearly 80% of asthmatics develop one or more symptoms of cough, breathlessness, or wheezing from exercising. Those individuals have, by definition, incompletely treated asthma.If your asthma interferes with your ability to exercise, then your asthma requires better control.Clinicians tend to differentiate between a person with asthma in whom exercise is one of sev- eral triggers, and a person who only experiences asthma symptoms in the setting of exercise.The latter individualprobablycarriesadiagnosisof exercise induced asthma,or EIA(discussed in Question 38) Remember that well-controlled asthma is compatible with a full and active lifestyle(discussed in Question 44). If you do experience exercise-related symptom flares of asthma, your asthma treatment needs improvement and fine-tuning. An “improved\" treat- ment regimen does not automatically mean that you require additional medicine. You may require a change as simple as taking your medicine sooner in the day before you exercise, for example. Just as importantly, an improved\" treatment regimen does not mean that you should no longer exercise or participate in sports that youenjoy.Aninterestingfact about asthma andexer\n\nExerciseitself isabroncho- dilator!\n\ncise is that exercise itself is a bronchodilator!With exercise, the lungs' passages actually dilate and open up more. Exercise is good for the lungs! You have a responsibility to report any exercise-related symptoms to your physician or asthma specialist. Your treating doctor has a responsibility, in turn, to address the emergence of exercise-related symptoms and advise you on appropriate measures and treatment.\n\nscription for aerobic exercise. A balanced exercise program, tailored to a person's specific interests and abilities, is ideal and inherent to good health. Exer- cise can be separated into aerobic, flexibility, and anaerobic activities. The first achieves cardio-pul monary fitness, the second targets the range of mus cle and joint motion, and the third focuses on muscle build-up and strength. Pedaling a bicycle is an exam ple of aerobic exercise. As you pedal faster, your heart and lungs work in tandem to provide oxygen to exer cising muscles while excreting acids from the accu mulating effort.Yoga is an example of a flexibility exercise. Weightlifting is an anaerobic exercise. A good exercise regimen can incorporate a balance of all three types of exercise, with particular emphasis on aerobic activities.\n\nStudies have identified factors that tend to trigger asth- matic symptoms during exercise. A leading hypothesis implicates the rapid inhalation of dry, cold air as the major contributor to exercise-induced asthma. Mouth breathing, in particular, bypasses the nasal passages, which serve to warm and moisten inhaled air before it enters the lungs. Another contributor to exercise symp- toms is obvious, but all too common: poor adherence to\n\ntreatment.In other words,if you are not taking your pre- scribed asthma medicine and you are experiencing flares in your asthma symptoms, then going outdoors to snow- shoe through the woods on your winter vacation, for example, will undoubtedly provoke additional symp- toms!Make sure that your asthma is under satisfactory control before exercising. Apart from taking your medi- cines, you may find it useful to measure your peak flow, and use the PEF value to make an objective decision about participation in sports that day.\n\nThe third factor in exercise-induced asthma relates to the type of exercise itself. Some types of exercise are especially advisable in the setting of asthma, while oth- ers are viewed as more likely to trigger asthma. In the latter category, distance running or cross-country ski ing, for example, can cause symptoms of cough breathlessness, or wheezing. Distance running, cycling: and skiing involve very good aerobic conditioning, but the activity is steady, without breaks or interruption, and includes exposure to the outdoors, with extremes of temperature, aeroallergens, and sometimes atmos- pheric pollutants as well. Athletic activity that incor- porates breaks in the intensity of exertion is less likely tocause asthma symptoms by,in a very real sense allowing time for you to “catch your breath.\" Examples include competitive sports such as tennis, soccer, field hockey, basketball, baseball, and lacrosse, among oth- ers. I encourage exercise and sports for all of my patients. The fact that distance activities have been shown in research studies to be more likely to provoke exercise-induced asthma symptoms in no way leads me to discourage my patients with asthma from cycling, running in a marathon, or cross-country sking, if they so desire. My patients tell me what athletics they want\n\nto participate in. My job is to help control their asthma and allow them full and satisfying participation in their chosen exercise routine.\n\nParentssometimeswanttoknowwhatsportto encourage for their child with asthma. Swimming is an excellent form of exercise for asthmatics of any age. The warm and humid air in indoor swimming is espe cially gentle for asthmatic lungs and unlikely to trigger symptoms. Swimming is also outstanding aerobic exercise. It develops muscle groups symmetrically, and helps develop a healthy awareness ofbreathing while increasing a person's overall fitness and well-being Since swimming is not a contact sport, musculoskeletal injuries are rare. Note, too, that swimming is a form of exercise that you never grow out of. It is truly a “for ever sport!\" Be aware that swimming in a cold atmos- phere,in water that is too cold,or in a heavily chlorinated pool can trigger asthma. Ozone treatment and disinfection of swimming pools has been com- monly practiced in Europe for over 50 years, and is slowly being introduced and accepted in the United States. Swimming pools disinfected primarily with ozone have enhanced water clarity, along with greatly reduced chemical odors. The pool water is purer and far less irritating to skin, eyes, and lungs. If you live in an area with a choice of pools, you may want to research whether any of the pools are primarily disin fected with ozone. The first commercial indoor pool in of the state of New York to be primarily disinfected by Ozone, for instance, is located in New York City, at the 92\"dStreetYMHAinManhattan\n\nTo successfully incorporate exercise and sports in your asthma treatment, keep your asthma well controlled,\n\nconsult with your physician regarding any special exer- cise or sport-specific required measures, and build up to your desired level of activity gradually and steadily Additional, more specific recommendations focus on preventive measures before each exercise session. Sev- eral inhaled asthma medications are especially useful when administered preventatively, shortly before exer- cise. The medicines include the inhaled, short-acting β2 agonists, as well as inhaled cromolyn and nedocro mil. Depending on the degree of your asthma and what your maintenance treatment is, your asthma could greatly benefit from a dose of inhaled medicine before exercise. It is far better, and medically more desirable,to take an inhaled medicine for your asthma before exercise than it is to attempt exercise and develop any combination of breathlessness, cough chest tightness, uncomfortable breathing, or wheezing. If symptoms occur, chances are that you will not achieve a satisfying workout and may even have to stop prematurely. You will then be in the position to “play catch-up\" in your attempt to treat the emerging symp toms. If your doctor instructs you to administer two puffs of an inhaler in the setting of exercise, take the inhalations before your workout to protect your lungs, and to prevent exercise-induced symptoms.\n\nLet's say for example that you have mild intermittent asthma and are treated with “as-needed\" inhaled, short- acting β2 agonist medication. Your asthma symptoms have been extremely well controlled. You now notice that you are developing asthma symptoms on the days that you participate in an aerobic dance class. You are then instructed to inhale two puffs of the inhaled medicine 30 minutes before your dance class to “protect\" your lungs. The results are striking. Not only does your asthma\n\nbecome controlled as before,but now you are able to keep up with the instructor and her demanding moves.\n\nAnother clinical scenario takes advantage of the fact that theleukotriene modifier class of asthma treatment isalso very helpfulin the treatment of exercise- induced asthma (EIA). A fit, healthy young man recently consulted me because of cough. On his first office visit, he explained that he had set his sights on running a marathon. He was very knowledgeable about running techniques and had embarked on a well-planned training regimen, after work and on weekends.Ashe continued to train,he developed an episodic cough. It turned out that my future marathoner had two diagnoses: seasonal allergic rhini tis (\"hay fever\")and exercise-induced asthma (EIA) He was determined to achieve his goal of becoming a distance runner and competing in“a few big marathon races.\" I was determined to treat his symptoms and control the EIA. I am happy to report that we both achieved our goals! I treated him with a once daily tablet of montelukast (Singulair?),one of the leuko triene modifier medicines. On cold winter days, wher he insisted on running outdoors despite the inauspi cious weather,he premedicated with two puffs of ar inhaled, short-acting β2 agonist before his warmup He was happy, and not coughing; I was happy with his lung function, and he was able to compete in and fin ish both the NewYork City and Boston marathons. In addition to inhaling any preventative and protective asthma medicine, always perform a warm up before exercising, and a cool-down afterwards. The warm-up activity takes advantage of the fact that exercise is a\n\nbronchodilator. When you warm up, your goal is to perform enough activity to allow the bronchial tubes to “open up\" a bit more. Depending on your sport, you shouldperform about 10minutesof lightexertion, enough to break a sweat. You could, for instance, do repeated, brief (10 to 30 second) sprints. Stop exercis- ing immediately after you complete your warm-up, and then wait for at least 30 minutes before getting down to your “real\" exercise. Avoid cold air as much as possible. Cover your nose and mouth during outdoor sports in cool air to help warm the air you inhale Some people like to wear a scarf or pull a neck gaiter over their mouth to keep warm. If you are a runner, switch to an indoor treadmill in a heated gym on very cold days. Similarly, if you live in an area with signifi cant air pollution at certain times of the year, consider moving your workout indoors on polluted days. Most daily newspapers publish measures of air quality on the weather page. If your area is subject to a day or more of atmospheric“ozone alerts\" during hot, muggy summer days, for example, pay attention, protect your lungs, and move the exercise indoors. Similar advice applies if you have allergic asthma triggers such as tree or grass pollens. If you are planning to exercise outdoors, and the atmosphere has high air concentration of specific allergens that you know trigger your asthma, use your common sense. Try to prevent an allergic flare and consider moving the activity to an indoor, air-condi- tionedvenue.\n\nIn conclusion, well-controlled asthma is no barrier to fitness and sport. If you require inhaled medicine, make certain you take it before exercise, even if your PEF is normal and you feel fine. Remember to warm\n\nup and cool down. View your physician as your ally, and report any concerns you may have about exercis- ingwith asthma.\n\n79\\. How should I pack my astbma medicinein anticipationofairtravel?\n\nAlways, always, always place your medicine in your carry-on bag when you travel by air. One obvious rea- son is that you may need to use your inhaled asthma medicine during the flight, or at the airport, and you will want to have it handy. You should not pack medi cine in your checked luggage. Checked suitcases are stored in the hold of the aircraft. The hold is neither heated nor pressurized the way the passenger cabin is. Most medicine needs to be kept at room temperature Also, checked suitcases are not infrequently waylaid or lost, unlike a bag you keep in your possession. Imagine what a vacation would be like if your medicine arrived threedays afteryou did!\n\nBefore you travel, make sure that you have enough of your prescription asthma and allergy medicines to last for the duration of your trip. You should bring all your usual maintenance asthma drugs with you, as well as any rescue inhalers that you use on an as needed basis. You should also travel with epinephrine auto-injectors if you have experienced anaphylaxis from severe allergy. If you are traveling outside of the United States, it is a good idea to check in with your physician ahead of time to see if there are any additional medicines you should bring along, such as corticosteroids, antibiotics, or epinephrine. Even though communication by phone anywhere in the world is now easily achieved, obtaining a prescription medication on a moment's notice in a country far away from your doctor can become very complicated.\n\n80.I'mtravelingto theCaribbean plan to go scuba diving, but my busband saysit's not safeifIhave asthma. What should I do?\n\n80.I'm traveling to the Caribbean and\n\nIn the past, asthma of any type and of any severity was viewed as an absolute contraindication to scuba diving. Scuba diving requires inhalation of dry compressed air though a mouthpiece, which many people find uncom- fortable. Scuba diving can, on a more serious note, lead to the development of a condition known as fatal arterial gas embolism and barotrauma. Asthma classically places an individual at increased risk of diving complications because of air trapping, bronchospasm, and mucus plug- ging in asthmatic airways. Asthma patients were advised that scuba diving was “off limits,”\" although snorkeling on the surface was acceptable. Today, with careful medical screening and medical preparation, some individuals with mild, well-controlled asthma can go scuba diving, after detailed medical evaluation and “clearance\" by a physician familiar with diving and asthma. Studies performed by physicians with a specialty in diving medicine in the United States and abroad have yielded specific recom- mendations and guidelines. For example, people with exercise-induced asthma (EIA) should not dive.Simi- larly, any asthmatic who requires inhalation of an inhaled β2 agonist “rescue quick-relief\" inhaler should be prohib- ited from diving for at least 48 hours following the last doseofbronchodilator.\n\nBefore answering your question, I would need to know more about your asthma, your overall level of fitness, as well as your swimming and diving skills. Common sense suggests that if you have never had scuba diving instruction, vacation is not a good time to start diving with asthma.An alternative approach would be to\n\nfirst consult with your physician,and undergo any appropriate testing and evaluation. Then, with your physician's approval, you could enroll in scuba classes taught by certified professionals. The YMCA's special YSCUBATM program,for example, s specifically addresses the needs of asthmatic divers. Physicians such as myself take the approach that safety comes first. At the risk of appearing to side with your spouse. if pressed for an answer, I would advise you not to scuba dive on your Caribbean trip and enjoy another sportinstead.\n\n81\\. What is influenza? Wby should I get a flu shot (influenza vaccination)? Will the flu shot makeme ill?\n\n81\\. What is influenza? Wby should I get\n\nInfluenza is a serious respiratory disease caused by the influenza virus. Influenza viruses are classified as types A, B, or C. Influenza A is further classified into vari- ous subtypes. Influenza viruses of the A and B type are responsible for classic influenza illness. The disease is completely different from the common cold or the stomach flu. Influenza is a specific illness, but many people say that they “have the flu\" to indicate that they are under the weather or ill in a general sort of way Influenza produces widespread, sporadic respiratory illness each year during fall and winter in the Northern hemisphere. It has also been known to occur in epi- demic or pandemic forms. The symptoms of influenza include the sudden, abrupt onset of chills and high fever in the range of 102°F to 103°F. Severe general- ized aches and pains,often most intense in the back and the legs, accompany the fever. Exhaustion is com- mon, as is headache and loss of appetite. Pain felt \"behind\" the eyeballs is often reported. Respiratory symptoms are initially mild; a scratchy or sore throat\n\ncan accompany a slight dry cough. The lung symptoms develop later and come to dominate the picture with persistent and productive cough as an unmistakable feature. Fever can last up to 5 days in uncomplicated cases. After other symptoms subside, weakness and fatigue may linger for aslong asseveral weeks.\n\ncases. After other symptoms subside, weakness and fatigue may linger for as long as several weeks. Unfortunately, not all persons who become ill with influenza have an uncomplicated course as described above.Severe,fulminant,or fatal pneumonia can com plicate influenza.Influenza is responsible for more than 35,000deaths and 110,000hospitalizations each year in the U.S. alone. Many of the deaths and hospi- talizations occur among persons with underlying health conditions that place them at increased risk fon complications. Increasing age (age 50 years or older), as well as very young age (age 2 years or younger) also place individuals at increased risk of influenza compli cations. Pregnancy is a common risk for influenza complications. Asthma is also considered a risk. Influenza can now be diagnosed in a few minutes in a doctor's office. If you have symptoms of influenza, your doctor may advise you to have a nasal wash per- formed tobe tested for theinfluenza virus.If you test positive for influenza, you might then be a candidate for immediate treatment withthe antiviral medicines oseltamivir (Tamiflu?), which is FDA approved for treatment ofinfluenza for those aged 1 year and older or zanamivir (Relenza?), which is approved for older childrenandadults.Zanamivir is administered by inhalation and may be less desirable in asthmatic indi- viduals.Both medicines shorten the time period dur ing whichyou cantransmit influenza to others and helptoreducetheseverity anddurationofyourillness. provided they are taken very early in the course of influenza. Oseltamivir, for example, is effective only if\n\nstartedwithin48hoursoftheonsetofinfluenza symptoms. Taking either medicine later in the course of an established influenza infection does not provide benefit. Oseltamivir is also approved for the prevention (prophylaxis）of influenza in exposed and at-risk adults,as well as adolescents aged 13 years and older. Neither oseltamivir nor zanamivir are considered a substituteforinfluenzavaccination.\n\nIhe single best way to prevent influenza is vaccination (Table 30). Vaccination against influenza virus causes the body's immune system to manufacture protective antibodies. The antibodies produced in response to suc cessful vaccination will help fight off influenza when and if a person becomes exposed to the virus. Detailed studiesofthestructureoftheinfluenzavirusrevealthat the virus wraps itself in a protective envelope or coat. Different strains of influenza virus carry (or “express\") different proteins on the surface of the viral envelope on coat.Influenza is considered a tricky and clever virus because of its ability to change the proteins on its coat. Even subtle changes increase influenza's ability to invadethehumanbodyandtocauseillness.Antibodies directed against one specific strain of influenza are actually specific against that particular strain's envelope proteins. So, the body needs to produce specific yet dif- ferent antibodies against different influenza virus enve- lope proteins in order to effectively protect against different strains of virus. Antibodies against one strain are unlikely to offer protection against a different strain with a different coat or envelope. Different strains of influenza circulate each“flu season\" which is why you can “get the flu\" for two or more years in succession. It is also the reason that each year, governmental health agencies advise vaccine manufacturers on what strains\n\n\\*Aperson wbobasexperiencedasignificanteggallergy,anallergicreaction toapriorinfluenzavaccineortoanyinfluenzavaccineconstituent,should notreceivetheinfluenzavaccine.\n\nto include in that particular year's influenza vaccine. A different influenza vaccine is thus developed and pro- duced each year. The influenza vaccine available each fall in the United States is directed against three (3) specific influenza strains that health authorities believe will cause most of the serious illness for that year's fall and winter influenza season. The vaccine you receive in the fall of 2005, for example, can be expected to protect you from the common disease-causing strains of influenza circulating in the United States during the winterof2005 and2006\n\nTwo different types of influenza vaccines are available for prevention of influenza in the United States: the inactivated influenza vaccine, and the live, attenuated influenza vaccine (LAIV)(Table 31). The first is an\n\n| . The vaccine is a “shot,\" given byinjection into muscle.  | . The vaccine is sprayed into the nostrils.  |\n| --- | --- |\n| . The vaccine has been used for manyyears.  | . The vaccine was licensed in the U.S.in 2003 for use in healthy children and  |\n| . The vaccine contains an inactivated(“killed\") form of influenza virus.  | adults from 5 to 49 years of age..The vaccine contains a live, attenuated  |\n| . The vaccine is updated every year.  | (\"weakened\") form of influenza virus.  |\n| . The vaccine is best taken in Octoberor November each fall. Vaccination isrequired yearly.  | . The vaccine is not presently recommended for pregnant women, and forpeople with underlying medical diseases. It is not presently recommended  |\n| . Protection begins about 14 days aftervaccination.  | for persons with asthma.  |\n| . Protection lasts about 1 year.  | . The vaccine is updated each year.  |\n| . Side effects, if any, are usually mild:  | . October or November is the best timefor vaccination. It should be repeated  |\n| stores at the injection site is themost common. Fever and aches canoccur. Call your doctor if you thinkyou are experienceing a more seriousside effect.  | yearly..Side effects, if any, are usually mildand may include: runny nose, congestion, cough, mild fever, aches, fatigue,throat soreness, and in children,abdominal pain, vomiting or diarrhea.  |\n\ninactivatedvaccine.\"Inactivated\"meansthatthevaccine contains a “killed\" strain or form of influenza. It is given by injection into a muscle. The inactivated vaccine is the familiar“flu shot\" that has been in clinical use for many years. The LAIV, or live, attenuated influenza vaccine, contains a weakened strain of influenza. The LAIV is administered intranasally, by spraying into the nostrils. The LAIV was first licensed in the United States in 2003. It is manufactured by Wyeth and is named Flu- Mist?. Like the inactivated influenza vaccine, LAIV stimulates the body's production of protective antibodies directed against three strains of influenza currently in circulation. Both vaccines are administered each year, ideally in October or November. LAIV, as of this writ ing, is only approved for administration to healthy per- sons between ages 5 and 49 years. It is not approved for use in pregnancy, nor is it approved in the setting of asthma at the present time. Because influenza can be a fatal anddevastating ill- ness, especially in certain groups of individuals, vacci- nationis recommended for those at high risk of developing medical complications from infection with influenza.“Medical complications\"is a term that encompasses hospitalization, severe illness manifesta tions, respiratory failure, and death. All persons with asthma, including children as well as adults, are candi- dates for yearlyinfluenza vaccination.Unvaccinated healthy persons can get sick with influenza, and in turn pass the infection along to others. Only in a few, very specific circumstances is vaccination absolutely contraindicated. A person who has experienced a sig- nificant egg allergy, or an allergic reaction to a prior influenza vaccine or to any constituent of the vaccine, should not receive the influenza vaccine. Anyone who hasbeendiagnosedwithaneurologicalcondition\n\ninactivatedvaccine.“Inactivated\"meansthatthevaccine contains a “killed\" strain or form of influenza. It is given by injection into a muscle. The inactivated vaccine is the familiar“flu shot\" that has been in clinical use for many years. The LAIV, or live, attenuated influenza vaccine, contains a weakened strain of influenza. The LAIV is administered intranasally, by spraying into the nostrils. The LAIV was first licensed in the United States in 2003.ItismanufacturedbyWyethandisnamedFlu- Mist?. Like the inactivated influenza vaccine, LAIV stimulates thebody's production of protective antibodies directed against three strains of influenza currently in circulation. Both vaccines are administered each year, deally in October or November. LAIV, as of this writ- ing, is only approved for administration to healthy per- sons between ages 5 and 49 years. It is not approved for use in pregnancy, nor is it approved in the setting of asthma atthepresenttime.\n\nBecause influenza can be a fatal and devastating ill- ness, especially in certain groups of individuals, vacci- nationis recommended for those at high risk of developing medical complications from infection with influenza.“Medical complications\"is a term that encompasses hospitalization, severe illness manifesta- tions, respiratory failure, and death. All persons with asthma, including children as well as adults, are candi- dates for yearly influenza vaccination.Unvaccinated healthy persons can get sick with influenza, and in turn pass the infection along to others. Only in a few, very specific circumstances is vaccination absolutely contraindicated. A person who has experienced a sig- nificant egg allergy, or an allergic reaction to a prior influenza vaccine or to any constituent of the vaccine, should not receive the influenza vaccine. Anyone who has been diagnosed with a neurological condition\n\ncalled Guillain-Barré Syndrome should consult closely with a physician knowledgeable about the risks of vac- cination. In general, influenza vaccination is very safe and effective. You cannot get “the flu\" from influenza vaccination, nor can the vaccination cause an infection. It is possible, however, to become ill with influenza even if you received the vaccine, as the vaccine does not protect against all strains of influenza. I remind my patients that the goal of influenza vaccination is to protectthemfrombecoming gseverelyillfrom influenza.I still consider vaccination a success if they come down with a milder form of illness that slows them for a few days, but does not lead to an exacerba- tionoftheir asthma ortohospitalization.\n\n82.I am a meticulous housekeeper, so wby does my bouse barbor dust mites? Shouldpeoplewithastbma encasetheir bedding? Is it a good idea to invest in an \"air purifier\"? Gemma's comment:\n\nUnfortunately,many standardleases requiretbat three- quartersofthefloorineveryroombecarpetedtoreduce soundinadjacent apartments,anddailyvacuumingis a bigtaskfor thebousewifewith small cbildren.Whichis onlytosaythattakingchargeofone'sasthmaisnotaneasy matter.\n\nDust mite is a common indoor year-round allergen; allergy to dust mite has been associated with allergic rhinitis and asthma in children, as well as in adults. If you or your child are diagnosed with an allergy to dust mite, your physician will likely advise you on measures you can take to reduce your exposure to dust mite.\n\nDust mites are eight-legged arachnids related to the spider family. Their cast skin and fecal matter are two constituents of house dust that many people are aller- gic to. Dust mites live indoors and are present in nearly all homes in areas where the relative humidity is 50% or greater for much of the year.Dust mites are microscopic; you cannot see them without a magnify ing microscope. They thrive in warm, dark, humid environments, and live off flecks of human skin. They do not drink free water, but absorb moisture from the surrounding environment. They are often found in bedding, in upholstered furniture, and in carpeting and draperies. They are fairly ubiquitous in the United States, and their presence in a home in no way implies poor housekeeping. That said, we know of several ways to reduce a person's exposure to dust mites. First, dust mites cannot survive at a high altitude or in very dry environments. Could that be why, several generations ago, asthmatics were often sent “to the desert” or “to the mountains\" to gain a respite from their symptoms? Was the relocation no more than a move to an area free of dust mite allergen? On a more practical note, ways to reduce your home's dust mite burden includes removing carpeting and heavy cloth draperies. Con- sider washable curtains or blinds. Avoid overstuffed furniture made offuzzyfabric.Analternativeto removing carpeting involves thorough, daily carpet vacuuming with a high-quality vacuum cleaner, possi- bly one fitted with a HEPA filter. Steam clean on shampoocarpets andrugs at least once a year\n\nThe bedroom merits special attention. Most of us spend at least 7 hours out of 24 sleeping in bed, with our head on a pillow or two, wrapped up in sheets, blankets and comforters. Bedding is a favorite location of dust mites. So, while we blissfully slumber away, we\n\nare in close contact with dust mite antigen, inhaling allergic material all night long. The solution? To inter- rupt the replication of dust mites, while reducing the amount of allergen that reaches us. The first goal is easy to achieve: since the dust mites have a life cycle of 2weeksandcannotsurviveelevatedtemperatures, simply launder sheets, mattress pads, and washable blankets in hot water at least once every two weeks Hot water is water heated to a temperature of at least 130°F. The hotter, the better! Items that cannot be washed frequently, such as pillows, comforters, and mattresses and box springs, are best encased in spe cially designed covers. The allergen impermeable cov ers are available from retailers specializing in allergy products. If your physician advises you to encase youn bedding, make certain the covers you purchase are rated for dust mite protection. Most covers are of high quality and are unobtrusive; you won't even know you're sleeping on one. They usually require washing once a year, and carry a warranty for up to 20years of use. Stuffed animals are dust mite magnets, and many children love to collect and sleep with them. Encour- age your child to keep the collection in a location other than the bedroom and consider identifying one “spe cial\" stuffed toy to sleep with.Then,if possible,laun der the favorite in your washing machine in hot water every two weeks, just as you would bedding. Unfortu- nately, not all stuffed animals are machine washable Despair not! Plan “B\" involves placing the furry toy in a sealed plastic bag, and placing the stuffed animal in your freezerfor 24 to48hours once ortwice aweek Should someone with dust mite allergy invest in an air purifier?Be suretoask yourphysicianor allergist\n\nShould someone with dust mite allergy invest in an air purifier? Be sure to ask your physician or allergist before buying one. Among the options currently avail-\n\nable, only a few have been studied in the medical (as opposed to the industrial) literature. Machines that are designed to filter the air in an enclosed space through a fine, high-efficiency particulate air (HEPA) filter are, if used correctly, very efficient in trapping particles of a defined size (usually as small as O.3 microns). HEPA filtersthusreducetheairborneconcentrationoff microscopically small airborne particles, including many aeroallergens, like pollens and dust mites. HEPA-filtering machines must be selected based on the square footage of the enclosed space they will filter. The machines usually contain both a carbon pre-filter and a true HEPA filter. The pre-filter should be changed every 3 to6 months,and theHEPA filter should be replaced every year. HEPA filters are expen- sive but effective. HEPA filter units do not require much maintenance, apart from filter changes and are engineered to run 24 hours a day. They have the disad- vantage of being rather noisy, and they do tend to dry the ambient air. The correct way to run a HEPA unit is to close the room's windows and doors, and set the unit's fan on “high\" when you are not home. When you are in the room, at night, for example, set the unit's fan on the highest level you can tolerate from the perspective of noise.\n\n83\\. Is astbma mostly a psychological\n\nGemma's comment:\n\nIvealreadyindicatedthat,inmyexperience,withmyown asthma and my daugbter's,doctors are slow topick up on astbmasymptomsif thepatientdoesnotreallycomplain about them.Butdon't let anyonetalkyou outofyoursymp- toms or suggest thatthey are“allin your bead\"!Even an\n\neducatedadultcanhaveaconfusedreactiontothesenseof suffocation”that comes withbreathlessness，as did one youngfriendofminewbomistakenlyattributedberfeeling efpanicinthedirty,particle-laden air ofaNewYorkCity subway to psychological causes.Sbe was starting a new job and,understandably,feltsomewbattenseandnervous,but ber breathing problems seemed“out-of-line”to ber,incon- sistent withberusual sensible self.After monthsof worry andseeingseveraldoctors,the diagnosis of astbma really came as a relief,andbelpedber dismiss berfearof amore amorphous,lessexplicableproblem\n\nAsthma is definitely not a psychological disease; it is a physical condition of the respiratory system. It is a myth and a great disservice to all persons diagnosed with asthma to view asthma as a disease of the mind,or of a somehow disturbed frame of mind. Asthma trig- gers are exposures that precipitate or worsen a person's asthma (discussed in Question 43). In some people with asthma, strong emotions can function as a trigger Conversely, flares of asthma symptomatology, espe cially if severe, can lead to strong emotional responses. During an exacerbation of asthma, breathing is com- promised and extremely uncomfortable. It is very frightening not to be able to breathe normally and effortlessly, and instead experience a sensation of suf- focation. Let's say that a young child, for example develops an exacerbation and becomes increasingly symptomatic in the middle of the night. As symptoms of wheezing and breathlessness progress, the child's parents become more and more worried, and start to panic a little; they yell at the child to “relax and take it easy.\" They argue about whether to proceed to the emergency room, or to call the pediatrician after hours.\n\n1OOQUESTIONS&ANSWERSABOUTASTHMA You can certainly imagine that the child is likely to become upset, too, and may start crying and acting \"emotionally.\" The child's asthma is not a “psychologi- cal disease,” but his response to the exacerbation, as well as to the reaction of the adults around him, might bewronglyattributedtoanemotionalproblem\n\nSpecial\n\nAre asthma medicines harmful to my unborn child?\n\nWill pregnancy make my asthma worse?\n\nWill I be able to breast-feed my baby if I'm taking medicine for my asthma?\n\n84\\. Will pregnancy make my asthma worse? How will pregnancy modify or affect my asthma?\n\nPregnancy will not necessarily make your asthma worse or more symptomatic. Studies of asthma in pregnancy reveal that about one third of pregnant women with asthma will have no change in the degree of their asthma; one third will experience a lessening of their asthma symptoms and a decreased need for medication; and one third of will have worsening of the asthma in pregnancy. Approximately 1 of every 3 pregnant women with asthma will thus experience more asthma sympto matology and require an increase in asthma medication. After the baby's delivery and the postpartum period, you can expect your asthma to gradually return to usual—whatever the usualwasforyou!\n\n85.DoIneed toseemy asthmaspecialist morefrequently now thatI'mpregnant? Yes, while you are pregnant, you should see your asthma specialist more frequently than before. In my practice, for example, I ask my pregnant patients with asthma to see me on a monthly basis, with about the same fre- quency that they visit the obstetrician. Some women may require more frequent appointments, and some less. Now that you are pregnant, you and your asthma doc tor have an“extra\"to think about and to take into con- sideration. The special “extra\" is, of course, the developing fetus. One of the goals of prenatal care for mother and child is the maintenance of a healthy preg- nancy to “term.\" Term refers to the time at which the\n\npregnancy is sufficiently advanced to permit the birth of a healthy, fully developed infant, and is defined as anytime after 37weeks of gestation.A baby's“due date\"is calculated so that it falls exactly 40 weeks after the first day of the mother's last menstrual period. The developing infant is carried in the mother's uterus (or womb). The intrauterine environment is an ideal envi- ronment for the fetus, with controlled temperature, oxygen, nutrients, and stimuli. The fetus’ oxygen is supplied via the mother's bloodstream through the pla- centa. The mother's blood oxygen, in turn, reflects her lung function. The overriding principle of asthma treatment in pregnancy is the provision of adequate oxygen to the developing fetus by careful and aggres- sive treatment of maternal asthma. The risks of uncon trolled asthma to the mother and infant are far greater than the possible or potential risks of medication (Table32)\n\nThe outcome of pregnancy for a woman who has well- controlled asthma can be expected to be no different fromthe outcome of awomanwithoutasthma.The emphasis is on the concept of well-controlled asthma. The goals of asthma treatment in pregnancy parallel those of asthma treatmentin general.Compliance with prescribed medication is emphasized along with peak flow (PEF) monitoring. Avoidance of known asthma triggers is encouraged as much as possible. Influenza vaccination is recommended for women who have no contraindication to the vaccine, and who will be in their third trimester of pregnancy during the fall and winter influenza season. Influenza vaccination is safe in preg- nancy. The vaccine should not be administered if the patient is allergic to eggs or is allergic to any of the con- stituentsofthevaccine.\n\n1OOQUESTIONS&ANSWERSABOUTASTHM\n\nTable32Asthma and Pregnancy:Key Poin\n\nIn pregnancy, about one third of asthmatic women experience a worsening of their asthma and an increased medication requirement, another third have no significant change in their asthma, and one third have asthma that is less symptomatic or improved. Most asthma exacerbations in pregnancy tend to occur between the 24th and the 36th weeks of pregnancy.Flares are rare during the last 4 weeks of pregnancy, or during labor and delivery\n\nPoorly controlled asthma in pregnancy is associated with potentially serious complications,including: ·Dangerous maternal blood pressure changes (pre-eclampsia) ·Prematurebirth ·Intrauterine growth retardation ·Lowbirthweight\n\nUncontrolled asthma in pregnancy poses a greater risk to mother and fetus than any medicineindicatedin asthma treatment.\n\nWell-controlled asthma in pregnancy does not place the mother or infant atincreasedrisk.\n\nAsthma treatment goals in pregnancy include: Avoidance of asthma triggers (allergic and non-allergic) Absence of asthma symptoms,without restricted activity ·Restful sleep,uninterrupted by any asthma symptoms Optimized peakflow(PEF)measurements Compliance with prescribed asthma medicines Avoidance of cigarette smoke (both maternal smoking and“passive\") Influenza vaccination for women who have no contraindication to the vaccine, and who will be in the third trimester of pregnancy dur- ing the winter influenza season.\n\nMaternal smoking cessation is crucial. If you do smoke, pregnancy is an ideal time to quit, for the health of the developing baby, for your health, and for your child's future well-being. Smoking can precipitate an asth- matic exacerbation in the mother, and smokers' babies tend to be small, with low birth weights.Infants are\n\nthree times more likely to die of Sudden Infant Death Syndrome (SIDS) if their mother smoked during on after pregnancy. There is strong evidence that the chil- dren of women who smoked during pregnancy face increased risk for poor lung health as they grow up. Children raised in homes with smokers experience more childhoodrespiratoryi illnesses,andare at increased risk for the development of asthma. As adults, they even carry an increased risk of certain types of lung cancer—as do the parents who are the“active”smokers. A child raised in a home with smoking parents is much more likely to become a smoker,as compared to chil- dren raised in homes where adults do not smoke\n\n86\\. Can I do anything special during my pregnancy to belp protect my unborn child from developing astbma in the\n\nThe fact that you have asthma does not necessarily mean that your child will develop asthma too. Your asthma diagnosis does, however, place your son or daughter at higher statistical risk of inheriting asthma as compared to a child born to parents with no per- sonal history of asthma. There are no specific measures you can undertake while pregnant to guarantee that your baby will never develop asthma. The most impor- tant steps for you to take while pregnant involve taking excellent care of yourself and making sure that your asthma is well controlled, and, hopefully, completely asymptomatic. Studies have shown a link between a mother's lung function and healthier babies at birth Better maternal lung functionleads toimproved fetal\n\noutcomes, with fewer premature births and fewer com- plicationsfor the infant.\n\n87.Are asthma medications barmful to\n\nMany studies have been carried out all over the world to help doctors decide which asthma medicines are “safest' in pregnancy. The single biggest risk to an asthmatic woman's pregnancy is poor asthma control in the mother Uncontrolled asthma is very harmful to the developing baby and can result in devastating complications for both mother and child. Complications of poor asthma control include pregnancy-induced hypertension, pre-eclampsia and eclampsia in the mother, preterm labor and prema ture birth, intrauterine growth retardation, and low birth weight babies, along with increased perinatal morbidity and mortality. Inadequate control of the mother's asthma leads to a reduced oxygen supply to the developing baby (\"maternal hypoxia\"), as well as a decreased blood supply to the womb. All pulmonary specialists agree that they should treat their pregnant asthma patients with asthma medicines that are not only highly effective, but also as safeaspossibleforbothmother andbaby.\n\nThe FDA classifies all medicines approved since 1980 into one of five different categories. The FDA classifi cation is based on studies of safety in pregnancy. The five categories are referred to as category A, B, C, D and X (Table 33). Category A is considered the very safest, while category X drugs are absolutely con- traindicated under any circumstances. There are no asthma medicines classified as category A. Most medi- cines used in asthma treatment fall into category C\n\n| Category B  | Animal studies have revealed no evidence of harmto the fetus, but there are no adequate and well-controlled studies in pregnant women.Or..  |\n| --- | --- |\n|  | Studies in animals have shown an adverse effect onthe animal fetus but adequate and well-controlledstudies in pregnant women have failed to demonstratea risk to the human fetus.  |\n| Category C  | \\=> No evidence of risk in humans.Studies in animals have shown an adverse effect onthe animal fetus and there are no adequate and well-controlled studies in pregnant women to assess risk tothe human fetus.Or..  |\n|  | No animal studies of the medicine have been performed and there are no adequate and well-controlledstudies in pregnant women to assess risk to thehuman fetus.  |\n| Category D  | \\=> Risk cannot be ruled out.Studies, adequate and well-controlled, or observ-tional, have demonstrated a risk to the fetus. Benefitsof therapy with this category of medicine in pregnancymay outweigh the potential risk to the fetus.  |\n| Category X  | \\=> Positive evidence of risk.Studies, adequate and well-controlled, or observ-tional, in animals or humans have demonstrated positive evidence of fetal abnormalities. The use of themedicine is contraindicated in women who are pregnant or who may become pregnant.=> Contraindicated in pregnantv.  |\n\nCategoryB Animal studies have revealed no evidence of harm to the fetus, but there are no adequate and well- controlled studies in pregnant women. Or... Studies in animals have shown an adverse effect o1 the animal fetus but adequate and well-controlled studies in pregnant women have failed to demonst a risk to the human fetus. i lCilil\n\nCategoryC Studies in animals have shown an adverse effect on the animal fetus and there are no adequate and well- controlled studies in pregnant women to assess risk to thehuman fetus. Or... No animal studies of the medicine have been per- formed and there are no adequate and well-controlled studies in pregnant women to assess risk to the humanfetus.\n\nand several are classified in category B.All short- acting β2 agonist “rescue” inhaled bronchodilator med- ications, for example, are classified as category C, even though they have been in use for over two decades, and are widely viewed as very safe by the medical pro- fession. They have not been shown to have adverse effects on the course of the pregnancy, and have not been shown to be harmful to the human fetus. All long acting β2 agonist inhaled bronchodilators are also cate- gory C medicines. The “C\" classification for the β2 agonist group of inhalers reflects the absence of studies in pregnant women. One inhaled corticosteroid prepa- ration, Pulmicort? (budesonide), is category B; all other inhaled steroids are, as of this writing, labeled category C. The long-term inhaled “controller” medi- cines Intal?(cromolyn) and Tilade? (nedocromil) are category B, as are the leukotriene modifier tablets Sin- gulair (montelukast sodium）and Acolade?(zafir lukast). The new IgE blocker Xolair? (omalizumab) carries a category B rating. The theophylline medi- cines are all category C drugs.\n\nBecause both uncontrolledasthma and poorly con- trolled asthma in the mother have such serious conse- quences for her and her unborn child, the guiding principle for the treatment of asthma in pregnancy is to achieve optimal asthma control even if daily med- ication is required. It is crucial to normalize maternal lung function and ensure that the mother is not expe- riencing any symptoms of asthma. Pulmonologists take the point of view that any medicine that is required Hforoptimalasthmatreatmentshould be administered to a pregnant woman. For example, steroid bursts are used in the setting of pregnancy just as they are when a woman is not pregnant. As a rule of thumb, we would use category B medicines first,\n\nadding any required medicines that may fall into the C category (or even D), if needed to achieve good asthma control. If you are pregnant and have any ques- tions or any concerns about the safety of the medicines you have been prescribed, you should consult with your treating physicians. Both your obstetrician and your asthma doctor have the expertise to counsel you and give advice that is best for you. Under no circum- stances should you stop your prescribed asthma regi- men or not follow the treatment plans recommended byyourdoctor.\n\n88.Will I be able to breast-feed my baby if I'm taking medicine for my asthma?\n\nYes, you will certainly be able to breast-feed if you so wish. Asthma medicine, especially that administered in inhaled form, is not a contraindication to nursing your infant. Breast-feeding has many widely known advan tages for both mother and child, and may even have beneficial effects in delaying or altogether avoiding the development of asthma in young children. In fact, a recent study in Australia involving over 2,000 children found that infants who were “exclusively breast-fed, thatis,whoreceivedonly mother's milkfor atleast the first 4 months of life, had a significantly reduced risk of developing asthma by the age of 6. Breast-feeding also appears to delay the development of allergy in children.Studiesindicate thatbreast-fedchildren known to be at increased risk for the development of allergy (because of a family history) develop allergies at an older age as compared to children with similar risk factors who are not exclusivelybreast-fed.Of course, you should seek guidance from your baby's pediatrician if you are taking any over-the-counter or prescription medicines while you are breast-feeding.\n\nSpecial Topic:\n\nWill my child outgrow his or her asthma?\n\nShould I take my young child to a physician who specializes in asthma?\n\nHow can I make sure that my child's school staff can deal with his or her asthma? What about summer camp staff?\n\nHow can I make sure that my child's school staff\n\n89\\. Can I catch asthma from my cbild?\n\nAsthma is not an infectious condition. It cannot be transmitted from person to person, nor can it spread between people. That said, it has been noted for many years that the tendency to develop asthma tends to run in families. There is an inherited com- ponent to the development of asthma and allergy. If one parent has asthma or certain allergies, a child has a greater chance of developing asthma and/or allergies than does a child of unaffected parents. The chance of a child developing asthma increases fur- ther whenbothparentshave asthma.Theinheri tance of asthma is poorly understood and is far from \"the whole story.\" Current thinking also attributes a large role to environmental factors in the develop ment of asthma.\n\n90\\. Do more boys than girls bave astbma?\n\nYes, but only as children. In young children, boys are almost twice as likely as girls to develop asthma. Inter estingly, the pattern is reversed when looking at asthma in older age groups. An article published in the medical journal Chestin October 2003found that 62%of chil- drenwithasthma(asthmapatients younger than18 years of age) were male, while 68% of the adult patients with asthma were female. In studies of severe asthma the preponderance of boys is notable as well: 2 of 3 chil- dren with severe asthma are boys.But, among adults with severe asthma, women account for two thirds of those affected. The gender-based differences are not understood. Theories suggest the influence of female hormones, as well as the difference in size between male and female lungs as they grow into adulthood.\n\nIOOQUESTIONS&ANSWERSABOUTASTHMA\n\n91\\. If my 7-year-old daugbter wbeezes, does it mean that she bas asthma?\n\nMaybe not, but asthma is very likely. Repeated bouts of cough and wheezing in school-age children—boys as well as girls—are almost always due to asthma. Chil- dren may catch many colds each year, especially when school is in session. Asthma is often underdiagnosed, especially in children, so it is important to distinguish between repeated infections such as bronchitis or pneumonia, and asthma. Don't assume that your child is experiencing a “bad winter” if she seems to suffer from multiple chest colds.It may be that she has asthma. If so, make sure you get appropriate medical care, establish the correct diagnosis, and allow your daughter to receive asthma treatment if required.\n\n92.Domilkproductscauseincreased mucusinasthmatics,especiallyinchildren? Milk is not a cause of increased mucus production, nor is it considered to be an asthma trigger (Table 34). Consumption of milk has no effect on lung capacity, either deleterious or beneficial. It is a myth that milk is somehow harmful to children with asthma. Milk can, however, be an allergen in sensitized children. Cow's milk allergy is a true food allergy and is due to an allergy to the protein constituents of the milk. Like many food allergies, milk allergy usually manifests as gastrointestinal symptoms, or as a skin reaction such as hives or eczema, but not as increased mucus. If you suspect that milk does not agree with your child, bring it to your physician's attention. Do not automatically eliminate milk and milk products from the child's diet without medical consultation and advice. I clearly\n\nTable34AsthmaMythsandFalsehoods\n\nAsthma is a purely psychological disease. Mothers with asthma should never breastfeed. ·An asthmatic who never wheezes doesn't have asthma. People with asthma should never exercise. ·Children and young people with asthma should be exempted from gym class, and should not be required to fulfill a physical education requirementin school. · Milk and dairy products cause exces mucus and worsen asthma. ·Asthmatics will become“addicted\" or dependent on their asthma medications. ·All children will eventually outgrow their asthma and will be“cured withtime.\n\nremember a very charming and delightful 3-year-old girl who refused to drink milk, and told her mother repeatedly, “milk makes me sick.\" The parents were convinced that the girl was allergic to milk; after all, allergies ran in the family, and an older sibling had multiple food allergies. Luckily, rather than blindly eliminate milk and dairy products from the toddler's diet, the parents sought a professional opinion. The child saw a pediatric allergist and repeated her story. The doctor casually asked if chocolate milk tasted good. The child insisted that chocolate milk was \"good\" but that the white milk made her “sick.\" Need- less to say, allergy testing was performed. The results showed that the child was not allergic to milk, nor was she allergic to chocolate. She was, in her own special way, trying to convince her mother to substitute chocolate milk for “the usual.\" Lacking the sophistica tion to explain herself, she instead tried to convince her parents in her own way that milk was “no good!\" Growing children need calcium in their diets to pro- mote bone health and proper development. In addition\n\ntocalcium,dairyproducts are a significant dietary source of protein, riboflavin, and Vitamins A and B12 You should consider having your child evaluated for possible milk allergy if you have any concerns about milk and dairy products affecting their asthma. If your child is allergic to milk, treatment will include elimi- nation of dairy products. Your physician will assist you in modifying your child's diet without compromising his or her nutritional status.\n\n93\\. Ifthe pediatrician says that my toddler bas“a wbeezy chest,\"does she baveasthma?\n\n93\\. Ifthe pediatrician says that my\n\nNot necessarily. Some pediatricians will not even use the term “asthma\" until a child is 2 years of age or older. Wheezing in infancy is never normal. It can, however, be divided into two general patterns: non- allergic wheezing and allergic wheezing (Table 35). In the first instance, wheezing occurs when the infant\n\nTable35PatternsofWheezinginInfants\n\nNon-Allergic Wheezing\n\nWheezing when sick with viral upper respiratory tract infection Allergiesnotpresent Wheezing disappears as the baby grows in the pre-school years The wheezing seen in infancy is not a harbinger of asthma\n\nWheezing when sick with viral upper respiratory tract infection Allergies such as eczema, food allergy, or rhinitis are also present Wheezing with viral upper respiratory infections persists as the child grows The wheezing in infancy is a form of asthmatic response\n\nbecomes ill with an acute upper respiratory viral infec- tion. The infant's airways grow larger in the preschool years, and the wheezing disappears as the toddler grows. In non-allergic wheezing, symptoms seen in infancy do not recur with subsequent upper respiratory viral infections. The “wheezy chest\" is not an early manifestation of asthma.\n\nInfants who exhibit the second, allergic, pattern also wheeze when infected with an acute upper respiratory virus. But because they fall into the allergic wheezing category, they are more likely to have “real” asthma that continues throughout childhood. They are also more likely to have diagnosed allergies such as rhinitis, eczema, or food allergies. Their airways will also grow larger as they become toddlers, but the wheezing per- sists. They have asthma, not a narrowed, “immature' airway as a cause of wheezing in infancy during upper respiratoryviralinfections.\n\n94\\. Should I take my young child to a physician wbo specializes in asthma? Gemma'scomment:\n\n94\\. Should I take my young child to a\n\nYes!Tbefocusedattentionofbotbpbysicianandpatientis all-important.During ber early years,my daugbter's aller gies and astbmasymptomswererepeatedlyoverlookedby the busy pediatricians wbo saw ber only for a few over bookedminutesinacrowdedofficefullof cryingbabies and frazzledmoms.\n\nYou should take your child to an asthma specialist if your child's asthma is active for most days, if there are frequent night-time asthma symptoms that interfere\n\nwith sleep and rest, if your child is absent from school because of asthma symptoms, or if your child requires hospital emergency room visits for asthma. You should also consider seeking a consultation with an asthma expert if you or your child believe that asthma symp- toms are not controllable, or if you do not understand how to take care of those symptoms. You might seek consultation from a pediatric pulmonologist or from a pediatric allergist. After your child has undergone the appropriate evaluation, you and the specialist can decide whether the child requires continuing ongoing care from an asthma specialist or if your pediatrician can resume caring for your child's asthma.\n\nThe most recent 2002 update of the NAEPP's Expert Panel Report addresses the question of when infants and children 5 years of age or younger should be referred to an asthma specialist. Consultation with an asthma specialist is recommended for all young children with moderate or severe persistent asthma. Similarly, referral to an asthma specialist should be considered for infants and young children with mild persistent asthma.\n\n95\\. Will my cbild outgrow bis or ber\n\nYes, and no. Yes—because symptoms and the require- ment for medication seem to disappear during adoles cenceinsomechildrenwhohavemildasthma No—-because research indicates that asthma is lifelong and is never truly outgrown. A child with physician- diagnosed asthma is viewed as having a lifelong condi tion. The state of baseline hyperreactivity (discussed in Question12)thatdefinesasthmaneverdisappears\n\nThat said, it has long been observed that many chil- dren appear to“grow out\" of their asthma. Contempo- rary medical thinking views the phenomenon of disappearing” asthma as a state of prolonged asthma remission. Typically, adults in their late 20s or 30s who develops asthmatic symptoms will recall having had mild asthma as a child and are surprised that they con- tinue to have asthma in adulthood.\n\n96\\. Sbould my child be excused from pbysicaleducationclassessincebe'sbeen diagnosedwithasthma?\n\nNo, absolutely not. Your child's asthma should be brought under good control, and then he should be encouraged to participate fully in all aspects of school life, including fitness and sports. A diagnosis of asthmashouldnever automaticallyleadtocurtailed physical activity. Participation in physical education and in team sports is an important component of the healthy lifestyle advocated for all persons with asthma Having your child excused from physical education class not only robs him of the benefits associated with exercise, but also stigmatizes him, and sends the mes- sage that asthma is a physical impairment rather than a lungdisease\n\n97\\. Should my child use a peak-flow meter?\n\nA peak-flow meter is a tool that you and your child can use to help assess the degree of asthma control at any given time. Even though some might erroneously view self-monitoring as a “bother” or a “nuisance,” it should be neither. Regular home peak-flow monitoring has\n\nbeen shown to improve a child's asthma control, reduce exacerbations, and decrease school absences. Using a peak-flow monitor may also increase your child's confi- dence as it will help him or her learn how to optimize asthma control and achieve greater mastery over his or her asthma.Most children can accurately measure thein peak flow under adult guidance starting at about 6 years of age. Measurement of peak flow is an assessment of lung function, more precisely, of airflow through larger airways (discussed in Question 28).Peak-flow monitor- ing also allows for objective decisions about modifying your child's asthma regimen if appropriate, based on information contained in the written asthma action plan yourphysicianhasprovided.\n\nWhen your child is given a prescription for home peak- flow monitoring, you will be asked to determine his on her “personal best” value based on measurements obtained when your child feels well and is symptom- free. An asthma action plan provides instructions on what asthma medication to take as the peak-flow value falls into one of three zones labeled “green,”“yellow,”\" on “red.\" The green zone includes peak-flow measure- ments in the range of 80% to 100% of a child's personal best. Yellow corresponds to peak-flow measurements in the range of 60% to 80% of the personal best value. The red zone includes all peak flow values below 60% of a child's personal best. Peak-flow measurements in the red zone indicate that the child's asthma is poorly con- trolled, and that you will need to either contact youn physician, proceed to the emergency room, or both. So, if your 10-year-old child with asthma is scheduled to play in a soccer match on Saturday morning and he wakes up feeling apprehensive about the important game, how will a peak-flow measurement be of help?\n\nSuppose you obtain three peak-flow measurements and see that all three values are well into the green zone. These, in fact, approximate the “personal best.\" You know that your child's asthma continues to be well- controlled, and that your young athlete can continue his or her asthma regimen without modification. Pre- game jitters are one thing, and loss of asthma control is another. The reassuring peak-flow values let you address the former without raising your concern about asthma.\n\n98\\. My cbild with astbma is also allergic to our family pet. How important is it for us to find a new bome for our pet?\n\n98\\. My cbild with astbma is also allergic\n\nGemma's comment:\n\nObviously,it'sbesttorelocate yourpet orneverget one in thefirstplace.But your cbildmay feelvery strongly about baving a pet, especially in the early school years wben show andtell'sessionsoftenturnonstoriesaboutbousebold members, including pets, family trips, etc. I've known nursery scbool teachers wboinsist that every child should baveapet(turtlesorfishwon'tdo!)\n\nIt is crucially important that you relocate your pet to a new home. If your child is allergic to the family pet, and especially if the pet allergy is a trigger for your child's asthma, it is in your child's medical best interest for you to relocate the animal. A fundamental princi ple of allergy control is known as allergen avoidance After an individual has been diagnosed with a clinical allergy to a specific allergen, the goal of allergen avoid- ance is the elimination of any and all exposures to that specific allergen. Allergen avoidance, if successful, is a\n\nhighly effective measure in allergy treatment. Some allergens, such as dust mites or molds, are so ubiqui- tous that it can be nearly impossible to completely remove them from the home environment. Others, such as pet dander, are far easier to address. If you remove the family pet from your home, and you are then able to rid your home of any pet allergen left behind, your child will likely have a significant lessen ing in allergy and asthma symptoms, as well as decreasedmedicationrequirements.\n\nIf you are not willing to relocate your pet for the health benefits it will provide your child, then you should at minimum reduce the child's exposure to pet allergen. You shouldmake sure that the allergic child'sbedroom remains off limits to the pet and that the bedroom is kept as allergen-free as possible. An allergist can provide you with specific recommendations depending on what type of pet you have and the layout of your home.\n\n99.How canImake sure that my child's schoolstaffcancopewithbisorber asthma?What about summer camp staff? Thebestway tomake sure thatyour child's school on camp is in a position to cope with your child's asthma is toteach your child about asthma and toestablish good communication with the school and camp administration. Even though asthma is a very common condition throughout childhood and adolescence, it is still a good idea to make sure that school and camp staff know that your child carries a diagnosis of asthma.Several measures are helpful to ensure that yourchild'sasthmaremainswell-controlled atschool or camp. Familiarize yourself with the school or camp\n\npolicy (if any) regarding asthma in general, and inhaler use in particular. For example, some schools allow a student to carry a “rescue\" inhaler at all times; others require that it be left in the school nurse's office. Dis- cuss any concerns you may have with your child's doc- tor in advance of the start of camp or school. A good time might be when the physician fills out the required pre-enrollment health forms. Make sure your child knows how to measure peak flow and is aware of his or her asthma action plan. The school and camp should be given a written copy of the plan, as well as a copy off your child's medication list. Make sure that your child learns when to use the“rescue” inhaler and how to use the MDI with a spacer. Finally, there are a number of useful, patient-centered asthma Web sites that you can reviewfor additional pointers.\n\n100\\. Will my smoking cigarettes affect\n\n100\\. Will my smoking cigarettes affect my child wbo bas just been diagnosed withasthma?\n\nYes, your smoking will affect your child with newly diagnosed asthma. Your child will be affected in many different ways.Every child today knows that “smoking is bad for you.\" Some are aware of the links between cig- arette smoking and lung diseases such as emphysema. Others know about smoking and lung cancer, as well as the fact that cigarette smoking causes heart disease and stroke. Your smoking adversely affects your health and decreases your life expectancy; both factors certainly impact your children. Children of parents who smoke are more likely to become smokers in adolescence and beyond. Your smoking provides a bad model for your childwhoismuchmorelikelytodoasyoudorather\n\nthan do as you say. Children raised in a home with smokers have an increased risk of developing asthma.\n\nYour child has just been diagnosed with asthma. Look at it from your son or daughter's perspective. Until the diagnosis was made and medicine prescribed, he or she was experiencing asthma symptoms. To get an idea of what that might be like, try a simple experiment. Get a very narrow straw or plastic coffee stirrer and place it in your mouth. Breathe through the narrow straw (or plas tic coffee stirrer) by pinching your nostrils together Then, march briskly in place. You will become aware of a very uncomfortable sensation of breathing, and it wil take a great deal of effort to keep marching in place. The breathing experiment you have just performed approxi- mates how it might feel to breathe through constricted breathing passages. Your child has been feeling poorly, has undergone a medical evaluation, and now has to take medicine and adapt tohis or her new diagnosis. Depending on the child and his or her age, as well as the severity of the asthma, the entire family is entering a period of change and adaptation. As a parent, you may be experiencing increased stress. If you are a smoker, you may crave cigarettes more intensely than usual. Ciga- rette smoking is a universal asthma trigger. Your contin- ued smoking will contribute to increased symptoms in your child, along with an increased medication require ment. My advice: Seriously consider smoking cessation, bothforyourhealthandthatofyourchildren\n\nAsthmaResources\n\nAsthma resources include books,pamphlets,and educational materials as well as web sites and, of course, your physician.Remember that if you have a specific clinical question or concern about your asthma or how to specifically treat it, you shouldseekpersonalized advicefromyour physician.\n\nBooks\n\nParent'sGuidetoAsthma:HowYouCanHelpYourChildControlAsthmaatHome, SchoolandPlaybyNancySaunder.Plume,1994.ISBN 0-4522-7216-5\n\nOrganizations\n\nAAAAIAmericanAcademyofAllergy,Ast Immunology 611EastWellsStreet,Milwaukee,WI53202 1-800-822-2762 www.aaaai.org\n\nThe AAAAI is the largest professional medical specialty organi- zation in the United States representing professionals in the fields of allergy, asthma and immunology.\n\nThe AAFA is a private, non-profit organization dedicated to finding a cure for and educating the public about asthma and allergies.AAFA offers community workshops, newsletters for adultsandteenswithasthma.\n\nACAAI—American College ofAllergy,Asthma and\n\n85West Algonquin Road,Suite 550,Arlington Heights,IL 60005 1-800-842-7777 www.allergy.mcg.edu/home.btml\n\nALA—AmericanLungAssociation\n\nLocal ALA chapters sponsor the“Open Airways for Schools\" elementary school based asthma education program. The ALA provides information on asthma camps as well as educational materials, speakers, and resources on asthma for all age groups.\n\nAllergy and Asthma Network—Mothers of\n\n2751 Prosperity Avenue, Suite 150,Fairfax, VA 22031 1-800-878-4403 Newsletter:TheMAReport\n\n2751 Prosperity Avenue,S 1-800-878-4403 Newsletter:TheMAReport\n\nThe Allergy and Asthma Network—Mothers of Asthmatics is a non-profit community based organization founded by a parent of a child with asthma.The organization publishes several practical booklets on asthma and allergy management. It main- tains aweb site,www.aanma.org/breatberville.htm,with interest ing links for younger asthmatics. Membership in the network includes a newsletter and discounts on products.\n\nFAAN—Food,Allergy, and Anaphylaxis Network 11781LeeJacksonHighway,Suite 160,Fairfax,VA 22033-3309 1-800-929-4040 www.foodallergy.org The Food, Allergy, and Anaphylaxis Network is dedicated to raising public awareness of food allergies and anaphylaxis along withpromotingeducationandresearch.\n\nNational Heart, Lung, and Blood Institute (NHLBI)\n\nPOBox30105,Bethesda,MD20824-0105 1-301-251-1222 www.nhlbi.nih.gov The NHLBI is the primary NIH organization for research on asthma and is the sponsor of the NAEPP (National Asthma EducationandPreventionProgram)discussedinthetext\n\nionalJewishMedicalandResearchCe\n\n1-303-388-4461 Lung Line allows you to speak to a nurse and request that printed information and pamphlets on asthma and allergy be mailed to you:1-800-222-LUNG www.asthma.nationaljewish.org www.library.nationaljewish.org/pathfinders/\n\nMoreUsefulWebInformation\n\nMoreUseful WebInformation\n\nCDC. The Centers for Disease Control and Prevention has a very informative site on asthma. It includes a map of the United States that allows you to“click” on your state to find out what current asthma research programs are being carried out. www.cdc.gov/asthma/default/html\n\nChestNet.The American College of ChestPhysicians'website, ChestNet has educational materials on many aspects of asthma, including on how to use inhalers correctly. The ACCP's educa- tional guide for elementary school students will be interesting to teachers and parents alike, and is presented in both English andSpanish. www.chestnet.org/education/patient/guides\n\nClinical studies of asthma lists ongoinginvestigational studies of asthma and how to participate if you are interested. www.clinicaltrials.gov/ct/gui/cation/FindCondition?ui=D001249 recruiting=true\n\nConsortium on Asthma Camps is a helpful site for campers and theirparents. www.asthma.camps.org\n\nEPA.The Environmental Protection Agency has a bilingual and userfriendly website on asthma with special attention toindoon and outdoor air quality.TheEPAsite alsohas a section on \"Managing Asthma in the School Environment.\" www.epa.gov/asthma.index.html www.epa.gov/iaq/schools/asthma\n\nHospital web sites include the Mayo Clinic's Foundation for MedicalEducation andResearch,theNationalJewishMedical andResearchCenter. www.mayoclinic.com www.nationaljewish.org\n\nwww.mayoclinic.com www.nationaljewish.org\n\nMedlinePlus?offers links to reliable health information on asthma from the U.S. National Library of Medicine. The up- to-date information is organized in categories such as: “Latest News,”“Disease Management,”“Women”to name a few. www.nlm.nib.gov/medlineplus/asthma.btml\n\nPharmaceutical company sponsored web sites have become a popular source of information. They are not truly“independent as they are funded by companies that sell asthma and allergy medicines.Examples follow. www.ScboolAstbmaAllergy.com—sponsored by Schering-Plough www.respiratoryinstitute.com—sponsored by GlaxoSmithKline www.PregancyandAsthma.com—sponsored by AstraZeneca\n\nSearch engines allow you to“surf the web”on a topic of your choosing. To get information on an asthma action plan for exam- ple, you might search under “asthma action plan.\" AltaVistawww.altavista.com\n\nDogpilewww.dogpile.com Excitewww.excite.com Fast www.alltheweb.com Google www.google.com HotBot www.botbot.com Lycos www.lycos.com MetaCrawler www.metacrawler.com NorthernLight www.northernlight.com Yahoowww.yaboo.com\n\nABG: An acronym for Arterial Blood Gas. The body's arteries carry (O2) oxygen-rich and carbon dioxide (CO2)-poor blood to our organs and tissues.AnABGtestsasample of blood taken directly from an artery. The measured values of O2 and CO2 intheABGsampleletadoctorknow how well the lungs are functioning in getting the O2 into the body, and the CO2 out. The ABG assesses how much O2 and CO2 are in the arterial system, a reflection of the efficiency and function of the respiratory system. Acute: Short-lived, brief, sudden, not drawn out. Chronic is the oppo- siteofacute.Avirussuchas influenza will cause an acute illness that may last a few weeks.Asthma is an example of a non-acute or chronic condition. Although its symptoms may recede,asthma lasts indefinitely. Agonist: A medicine or drug that exerts its actions by combining with specific sites (called receptors)in the\n\nGlossary\n\nbody.Albuterol,for example,attaches to the lungs' β2 receptors. By attaching to the β2 receptors, albuterol exerts its bronchodilatory effects, and causes narrowed bronchial passages to dilate or “open up.” Stimulation of the lung β2 receptors leads to rapid relief of wheezing, tightness, and bronchocon- striction.Medicines such as albuterol are called β (beta) agonists since they \"fit\" the β2 receptor, and exert thein effects through activation of the recep- torsites. Allergen: An agent that is able to produceanabnormal(allergic) response in a susceptible individual when that person becomes exposed to the agent. An allergen is usually a protein, and can be of various origins. Foods, drugs, and chemicals, fon example, can act as allergens in cer- tain persons. So can substances of plant or animal origin. Examples of allergens include peanut, penicillin, ragweed, and cat dander. The key\n\nconcept is that allergens are not uni- versal. In other words, an allergen leads to an allergic response only in susceptible persons. Allergens are also asthma triggers for persons with asthma and allergy. Allergenic: Capable of causing an abnormal (allergic) response in a sus- ceptible (\"allergic\") individual. Some substancesareconsideredtobemore allergenic than others, meaning that thosesubstancesareknowtomore frequently lead to allergy symptoms in general. Pediatricians, for example, knowwhichfoodsaremoreinherently allergenic that others, and so generally advise introducing them later in a child's diet, and only very gradually at first. Tree nuts, fish, and eggs are more allergenic in very young children than other foods such as rice, banana, beef, or green beans, and are added to the“menu\"only as a child grows older. Allergic rhinitis: A manifestation of allergy expressed as nasal symptoms with itching, runny nose and conges- tion.When due to seasonal airborne allergens, allergic rhinitis is some- times referred to as “hay fever” or “rose fever.\" See also the glossary entry for“Rhinitis.\" Allergist: A physician specialized in the diagnosis and treatment of per- sons with allergies. Many practicing allergists in the U.S. have special training first in pediatrics, followed by additional qualifications in allergy. Although they treat patients in all age groups, pediatric allergists have a\n\nparticularinterestandexpertisei in allergies in children. Since many (if not most) allergies are first diagnosed in childhood, it makes sense to have the “extra” dual medical background. Allergy: The body's physical reaction to certain external substances known as allergens. Allergens are harmless to other non-allergic persons. Allergy involves the body's production of a specific antibody in direct response to a specific allergen. The result of the allergy-antibody interaction includes inflammatory and immune changes Those changes, in turn, lead to symp- toms that may affect the eyes (\"aller- gic conjunctivitis\"), nose (\"allergic rhinitis\"), sinuses (\"allergic sinusitis\"), skin (“eczema, hives, atopic dermati- tis\"), and lungs (\"asthma triggers\" or \"allergic asthma\"). Allopath: The term, as used cur- rently, refers to a physician graduate of an allopathic medical school. The majority of medical schools in the U.S. are allopathic, and confer the M.D. degree. The original meaning of allopath is that of a physician trained in (or who practices) allopa- thy.Allopathy historically involved treating diseases with remedies that produced effects different from those produced by the disease itself. Alveolar-capillary membrane: The alveolar-capillary membrane is the interface between the alveolar wall and the blood circulation. It permits rapid, nearly instantaneous exchange of oxygen, carbon dioxide, and other\n\n00 QUESTIONS&ANSWERSABOUTASTHMA\n\ngases between the air-filled alveoli, and the body's blood circulation run- ning through the capillary blood vessels. The alveolar-capillary mem- brane is destroyed in diseases such as emphysema, but is unaffected by well-controlled asthma. Alveolus (pl. alveoli): An alveolus is) a lung's air sac. Oxygen is exchanged forcarbondioxideinthelungalveoli. A dense network of capillary vessels surrounds each alveolus. The close arrangement allows for very rapid exchange (or “diffusion\"） of oxygen from alveolus to capillary, and of car- bon dioxide from capillary to alveolus. A healthy adult human lung contains approximately 300 million alveoli. The average diameter of a human alveolus is one quarter of a millimeter. Thetotal alveolarsurface availablefor gas exchange in a healthy adult approximates 100 meters,which is about the size of a tennis court. Anaphylaxis: The most severe form of an allergic reaction or response. If untreated, anaphylaxis can be fatal. The term “anaphylactic shock\"is sometimes used to describe the most dramatic and serious form of anaphy- laxis. Anaphylaxis usually involves sev- eral organ systems, including the cardiovascular system, the skin, the respiratory system, and the gastroin- testinal tract. Symptoms include a dangerous drop in blood pressure (hypotension), hives (urticaria) with itching and rash, respiratory distress and wheezing, throat tightness,nau-\n\nlossary\n\nsea, vomiting, and abdominal pain. Immediate emergencytreatmentis imperative. Persons at risk for the development of anaphylaxis, such as persons known to have had a prior sig- nificant allergic reaction to peanut on bee stings for example, should always have injectable epinephrine on hand If an anaphylactic reaction were to occur,prompt injection ofepinephrine under the skin is literally life saving. Antibody:A protein molecule pro duced in blood or in tissues in direct response to a foreign substance on antigen. A specific antigen leads to the production of a corresponding specific antibody. The production of antibody can be beneficial or deleteri- ous, depending on the circumstances Antibody made in response to an infectious agent, measles, for exam- ple,will protect against a second measles infection or a recurrence. Antibody made in response to com- mon environmental agents such as pollens, grasses, mold, and animal dander may lead to the development of allergy. Only susceptible persons (allergic or atopic individuals) will actuallyproduce antibodyagainst common allergens. The presence of antibody in response to a particular antigen is referred to as “sensitiza- tion\" to that particular antigen. When such a person goes on to develop an allergy to that allergen, the antibody is usually of the IgE class. Arterial:Related to one or more arteries.Thebody'sarterialcircula-\n\ntionleavestheheartviaamajor artery named the aorta.The arterial circulation provides the body,its organs, and tissues with (O2) oxygen- richblood.The arterial system com plements thevenous circulation.\n\nAspirin: Originally,Bayer's trademark for acetylsalicylic acid, a medicine with anti-inflammatory properties. Rather than refer to the Bayer brand, aspirin now refers to any preparation of acetylsalicylic acid. Aspirin has anal- gesic and antipyretic properties; it is prescribed to relieve pain and fever. Because of its anti-inflammatory actions, it is also used in the treatment of rheumatoid arthritis and juvenile rheumatoid arthritis, as well as in the treatment of many forms of heart dis- ease. Its use is contraindicated in any person with aspirin-sensitive asthma. Asthma:Originally derived from the phrase:“difficult breathing.”Asthma is a chronic respiratory condition characterized by breathing symptoms of varying intensity and frequency. Asthma has a strong genetic (inher- ited) basis, although environmental influences play an important role as well. Asthma frequently goes hand- in-hand with allergy, especially in younger age groups. Asymptomatic: Without any mani- festations or symptoms of disease or illness. The major goal of asthma treatment is to achieve an asympto- matic state so that the person with asthmaexperiencesnosymptoms whatsoever, and is able to lead a full and nroductive life\n\nAsymptomatic: Without any mani- festations or symptoms of disease or illness. The major goal of asthma treatment is to achieve an asympto- matic state so that the person with asthma experiences no symptoms whatsoever, and is able to lead a full andproductivelife.\n\nAtopy: An inherited predisposition to the development of allergic condi- tions such as hay fever, eczema, aller- gic rhinitis, and even certain forms off asthma.A person with evidence of atopy is said to be“atopic.\" Auscultation: The process of listen- ing to the chest through a stethoscope. Baseline hyper-reactivity:Baseline hyper-reactivity (BHR) is a key char- acteristic of asthma.BHR refers to asthmaticlungs’innate tendency to react to certain stimuli with an inflammatory response, that in turn leads to typical asthma symptoms including: breathlessness, chest tight- ness, breathing discomfort, cough and wheezing. Asthma and a state of increased baseline hyper-reactivity go hand-in-hand. BHR can be concep- tualized as the asthmatic lungs greater “sensitivity” to inhaled sub- stances thatwouldproducenoeffect in a healthy person without asthma. A person with asthma, for example. might start to experience uncomfort- able breathing when entering a room where people are smoking cigarettes or when running outdoors to catch a bus in subzero temperatures. Thein friends, who are accompanying them to the party, or sprinting alongside to catch the bus, have no respiratory discomfort in the same situations Physicians can assess BHR, in part, with a special pulmonary function test: the methacholine challenge (on \"bronchoprovocation\")test.Scientists and physicians hope that future research into BHR might yield treat- mentsthatwouldmodifyorlessen\n\n00 QUESTIONS&ANSWERSABOUTASTHMA\n\ntheincreasedBHR that is character- istic of asthma. BMI:An abbreviation for:“body mass index.”The BMIis amathe- matical formula based on height and weight. BMI is a tool used in population studiesof obesity because of its ease of measurement. The BMI in most individuals corre- lates to measures of body fat. To calculate your BMI, you can use either metric or conventional Amer- ican units. You need to know your weight measured in kilograms or in pounds,and your height measured in meters or inches. Then use one of the formulae below: \\*\\*BMI = weight in kilograms÷ (height in meters X height in meters) \\*BMI = (weight in pounds ÷ height in inches ÷ height in inches)× 703. Obesity can be defined based on a person's BMI. An adult with a BMI ofbetween25-30isconsideredover- weight, and an adult with a BMI of 30 or greater meets criteria for a diagnosis of obesity.Note that BMI isuseddifferentlyinchildrenand adolescents. The interpretation of BMI values in children and adoles- cents requires an adjustment for age. Bronchiectasis: A lung disease that causes abnormal, permanent dilata- tion of thesmallbronchiolar air tubes and passages that lead to the lung alveoli.Bronchiectasis causes a wide spectrum of disease. In its mildest form,bronchiectasis can be inappar- ent,asymptomatic,and silent.When more extensive, bronchiectasis can\n\nlossary\n\nleadtorecurrentlunginfection along with symptoms of breathless- ness, cough,mucus production, and wheezing. Bronchiole: The fine, tapered, thin walled breathing passages that branch and extend from the bronchus, and end in the alveolar air sacs. Bronchiolitis:Aninflammationof the tiniest bronchial tubes. Bronchi- olitiscanbesecondary toaninfection (“infectious bronchiolitis\"),or from a non-infectious cause such as cigarette smoking (\"smoker's bronchiolitis\"). Bronchitis: An inflammation of the lining of the larger bronchial tubes. Bronchitis can be acute, as from infection, or chronic, as in the case of tobacco abuse.Chronic obstruc tive bronchitis is the correct Ameri can term for the cigarette-related type of COPD that demonstrates obstructive dysfunctiononPFTs and that causes symptoms of cough mucus production, breathlessness, and episodes of wheezing. Bronchoconstriction: An abnormal narrowing of the air passages. Bronchoconstrictionis a prominent characteristic of asthma, and is due to an increased inflammatory response in the lung. Bronchodilatation: A widening on “opening up” of the lung air passages; the reverse of bronchoconstriction. Bronchodilator medicines improve breathing and relieve asthma symp- toms by“opening” and restoring the caliber of abnormally narrowed(con stricted)bronchi\n\nBroncoprovocation test: A special- ized pulmonary function test that correlates with baseline hyper-reac- tivity (BHR) and that can be helpful in the diagnostic evaluation of sus- pected asthma.Both methacholine challenge testing and cold-air exer- cise challenge are examples of bron- choprovocation tests. Bronchoscopy: A procedure that allows a lung specialist to visually inspect the lungs’ breathing passages (bronchi), and to obtain specimens or biopsies of any abnormalities. Bron choscopy can also be used for thera- peutic purposes, to remove mucus accumulation or inhaled foreign bod- ies, or to place stents in the airways in the case of abnormal narrowing. Bronchus (pl. bronchi): A breathing passage or tube. The trachea splits at the level of the carina into the right and left mainstem bronchi. The right mainstem bronchus leads air to and from the entire right lung. The left mainstem bronchus leads air to and from the entire left lung. The main- stembronchifurther subdivideinto bronchialtubes thatleadtothesub- divisions of each lung. Those bronchial tubes eventually branch out into smaller and narrower air pas- sages called bronchioles before end- ing in alveoli. Caffeine:Anaturally yoccurring compound found in coffee and tea, and added to other beverages such as soda or “energy” drinks. It is also added some medications, such as those used for treatment of pain or headache.Caffeine hasseveral\n\neffects in the body.It is a weaklung bronchodilator. It is a central nerv- ous system stimulant, and increases mental alertness and wakefulness. Caffeine acts as a mild kidney diuretic,leading to an increase in urine excretion. Capillary:Acapillaryis a tiny,thin walled blood vessel. The word is derived from capillus,the Latin word for hair. The lungs’ capillaries play a crucial role in health as part of the alveolar-capillary membrane,ab- sorbing O2 into the body and get- ting rid of CO2. Carbondioxide:Carbondioxide (CO2) is an odorless, colorless gas produced as a waste by-product by the body's metabolism. Carbon diox- ide is normally excreted by the lungs. andshouldnotbeconfusedwith car- bon monoxide (symbol:CO),which is a poisonous, odorless gas that, wheninhaled,canleadtocarbon monoxidepoisoning. Cardiac asthma: Refers to the symp- toms produced by dysfunction of the left ventricle, the heart's main pump- ing chamber in a condition known as CHF, or congestive heart failure. The symptoms of “cardiac asthma are reminiscent of those experienced by persons during an asthma exacer- bation, but the symptoms are not due to asthma. In cardiac asthma, breath- lessness, cough, and wheezing occur because of heart disease combined with a state of fluid retention, not because of a lung condition. As such, the term“cardiac asthma\"is a mis- nomer of sorts.\n\n100 QUESTIONS&ANSWERSABOUTASTHMA\n\nCarina:The“split”where thelungs tracheadividesintotwobranches: the right mainstem bronchus and the left mainstem bronchus.Each bronchus leads air to the right and left lung respectively. Chlorofluorocarbons: Chlorofluoro- carbons (CFCs) are chemical propel- lants previously used 1inthe manufacture of metered dose inhalers. The manufacture and use of CFCs are now banned.A time-lim- ited exception has been granted for certain inhalers until an equivalent replacement formulation is in pro- duction and available to patients. Chromosome: Cellular microscopic structures that contain groupings of DNA. Chromosomes carry genetic information, or genes, in their DNA. All human cells (except for a female's mature ova and a male's sperm cells) contain in their center,or nucleus,a total of 46 chromosomes,divided in 23 pairs. An individual's 46 chromo- somes constitute their genome. Half of the chromosomes are inherited from the father (via the sperm cells) 23 chromosomes),and half from the mother (via the mature ovum's 23 chromosomes). Chronic: Longstanding, lingering, or expected to last indefinitely; as opposed to acute. Asthma and hyper tension are considered to be chronic illnesses,forexample.Althoughboth respond very well to treatment, and can be readily brought under control, they still last indefinitely from a medical perspective.\n\nlossary\n\nChronicobstructivebronchitis: Chronicobstructivebronchitisis thetechnicallycorrectmedicalterm for the cigarette-related type C of COPD that demonstrates obstruc tivedysfunction on PFTs,andthat causes symptoms of cough,mucus production, breathlessness, and episodes of wheezing. Constriction: Narrowing, the oppo- site of dilatation.See also the defini tion for bronchoconstriction. COPD: An acronym for:“Chronic Obstructive Pulmonary Disease. COPDrefers to severaldifferent lung diseases that share similar symp- toms, and that demonstrate a similar patternof（ dysfunction on the spirometrypartofPFTs. The COPD group of lung conditions includes the cigarette-related lung diseases, emphysema, and chronic obstructive bronchitis. Consequently many persons will use the term COPDtorefertoeither emphysema or chronic obstructive bronchitis,or both.Some even employ the term as akind of shorthand for tobacco related lung disease. Corticosteroids: Corticosteroids are hormones that are normally produced in very small quantities in health by the body's adrenal glands. Corticos- teroids play a role in the regulation off blood pressure, as well as in the body's salt and water balance. Corti- costeroids have been synthesized in the laboratory. They are useful medi- cines when prescribed in the treat- ment of inflammatory conditions. Corticosteroidsininhaled form are a\n\nkey medication used in the treatment of asthma in all age groups. Diffusion: The process in which gases and liquids intermingle until a state of balance or equilibrium is obtained. During respiration,O2 (a gas) in the alveolus diffuses into cap- illary blood (a liquid) in the lung, while CO2 (another gas) diffuses out of the capillary blood into the alveo lus.Diffusion of O2 and of CO2 occurs extremely rapidly across the alveolar-capillary membrane in healthy lungs. Several disease states can interfere with the diffusing capacity of the lung.Emphysema,for example, destroys normal lung. As diffusion becomes more and more impaired,emphysematous lungs can no longer supply enough O2 for the body's needs. Supplemental (extra) oxygen is sometimes required in the treatment of advanced emphysema and is administered continuously via tubing and nasal prongs. Pulmonary function testing (PFT) includes an assessmentofthelung'sdiffusion capacity in a test called, appropri- ately,“diffusion.”Although diffusion can be impaired during a significant exacerbation of asthma, diffusion measured on PFTs is generally within normal or predicted values in asthma. Dilatation: An opening or widening; the opposite of constriction. See also the definition for bronchoconstriction. DPI: Stands for dry powder inhaler, a newer method of delivering med- ication directly to the lungs and res- piratory passages. DPIs are supplanting traditional MDIs partly\n\nbecause of their ease of use,conven ience and good patient acceptance. They are breath-activated,and do not contain any propellant so their manufacture does require chlorofluo- rocarbons (CFCs). Several different classes of respiratory medicines are available in DPI form, including inhaled corticosteroids,long-acting β2 2agonists, and anticholinergic bronchodilators. Dust mites: Dust mites are common household allergens. They are micro scopic living organisms found indoors in tempered climates, espe cially in mattresses, bedding, and upholstered furniture.Dust mites live off scales of human skin. Although they are a common cause of allergy and consequently of asthma exacer- bation, their numbers can be greatly reduced in the home (and perhaps nearlyeliminated)bystraightforward control measures. Such measures might include adjustment of the home's humidity level, encasement of all bedding in special covers, launder- ing bedding in hot water on a regular basis, and eliminating stuffed animals along with certain types of furniture and draperies. Dyspnea:An abnormal awareness of breathing; a kind of breathless ness. The act of breathing should be automatic and comfortable. Dys- pnea is a classic symptom of asthma, and should lessen once treatment is prescribed. Eczema: Eczema is an allergic skin condition and is also knownas \"atopic dermatitis.\" In babies,\n\neczemaofteninvolvesthecheeks and diaper area, whereas in older children a distribution behind the elbow creases and the area behind the knees is classic. Eczema can be very itchy and drying. Emphysema:OneoftheCOPD group of lung diseases. Cigarette smoking is a significant risk factor for the development of emphysema. Endogenous steroids: Steroids nor- mally produced in health by the body's adrenal glands. See Corticosteroids. Endotracheal intubation:Refers to the procedure in which a specialized breathing tube is placed into the tra- chea through the mouth or the nasal passages to allow airway support and the administration of extra oxygen. Endotrachealintubationcanbelife saving in cases of respiratory failure. It is also performed for major surgery, typically in the operating room when a person is to receive general anesthesia. Eosiniphilic pneumonia: a rare type of lung disease characterized by breathlessness, and elevated eosinophil counts like asthma, but with abnormal X-ray studies, unlike asthma. Epidemiological: Based on the study of populations or of large groups of people. Exacerbation:Aflareofdisease activ- ity or of disease symptoms. An exacer- bation of asthma can be caused by a viral infection, for example, and would lead to increased symptoms of cough, mucus, chest tightness and wheezing. Expiration: The action of breathing air out of your lungs, called exhaling.\n\nlossary\n\nhealth.HEPA filters are used in industrial settings, as well as in hos- pitals. In hospitals, HEPA filters are incorporated in the ventilation and exhaust systems of operating suites and “isolation” rooms, for example HEPA filters are occasionally recom- mended in the home in the setting of allergy. Some vacuum cleaners incor- porate HEPA filtration, and room- sizefansareavailablethatfilter the room's air through theHEPA device. Hormone: A chemical substance produced in the body by specialized endocrine glands. Once synthesized, hormones circulate inthe blood- stream and regulate different body functions. Insulin is a hormone, for example. It is produced in the pan- creas gland, and enters the blood cir- culation where it exerts profound effects on glucose (sugar) and carbo- hydrate metabolism. Hydrofluroalkanes:Hydrofluroalka- nes, abbreviated HFA, are medically inert substances that are used as pro- pellants in metered dose inhalers, and meet CFC-free criteria. Immunoglobulin E: IgE is a type of immunoglobulin that rises and is pro- duced in increased quantity in the set- ting of atopy, allergic asthma, and in the setting of a typical allergic reaction. Immunoglobulin: A protein pro- duced by the body's immune system as part of an immune response to an anti- gen. Antigens can be infectious agents such as viruses, bacteria and parasites,\n\nor otherproteins.Whenimmunoglob- ulins are synthesized in response to an infection, they play a defensive and protective role. Immunoglobulins are sometimes called “gamma globulins” an older terminology. Immunoglobu- lins are of five classes:IgA,IgD,IgE IgG, and IgM. Immunotherapy:Thetechnical term for allergy shots, used in the treat- ment of specific allergies that do not respond satisfactorily to allergen avoidance ormedicaltreatmentsuch as antihistamines. Incidence: In medicine, refers to the number ofnewcases ofadisease at any point in time. To say, for exam- ple,that the incidence of peanut allergy increased in a certain commu- nity in the year 2004, as compared to the prior year, you would need to count the number of new cases of peanut allergy in the community that were diagnosed in 2003, and compare thatstatistictothenumberofnew cases found in 2004. Influenza:Refers interchangeably to the influenza virus and to the infec- tious illness caused by that virus Influenza begins abruptlyand is characterized by high fever, chills, aches, and exhaustion. The illness is preventable via vaccination. Inspiration: The action of taking a breath of air into your lungs. The res- piratory cycle has two parts: inspira tion and expiration. Inspiratory: Breathing in.\n\nInternist:Aphysician specializedin the non-surgical medical care of adults. Larynx:Thevoicebox.Twovocal cords allow for speech as inhaled air passes between them, and sets up vibrations within the larynx located in the mid-neck. Leptin: Leptin is a human protein identified in 1994,and named after leptos the Greek word for “thin.\" Leptin seems to play a role in the regulation of fat accumulation.In humans, increasing body fat appears to correlate with increased leptinlevels. Leukotriene: Leukotrienes are inflammatory molecules. There are twofamilies of leukotrienes.One in particular, called the cysteinyl-leuko- triene,is important in asthma and allergy. Cysteinyl-leukotrienes are released in increased number during asthma exacerbations. Drugs,known as“leukotriene modifiers,”have been developed based on current knowl- edge of leukotrienes. The leukotriene modifiers include: (1) receptor antag- onists or blockers,and (2) synthesis inhibitors. The first class blocks the effects of leukotrienes (blockers), while the secondinterfereswith their formation(synthesis inhibitors). Medicines in the first category are very safe and widely used in the maintenance treatment of allergic rhinitis and asthma. MDI:Standsformetereddose inhaler.MDIs are devices that allow\n\nthe delivery of a precise and accurate dose of medicine to the lungs by inhalation. MDIs arereliable, portable,and very convenient.Many different types of respiratory medi- cines come in MDI form, including short-acting “rescue”bronchodila- tors, inhaled steroids, and anti- inflammatory medicines, as well as inhaled anticholinergics.Medicines inMDIform are used in the treat mentof asthmaandCOPD.The newer MDIs use a CFC-free propel- lant, usually HFA. Methacholine challenge test: The methacholine challenge test is a type of bronchoprovocation test. It is a specialized PFT used in the evalua- tion of suspected asthma, when the diagnosis is otherwise uncertain. Morbidity: A measure of illness in a given population.The yearly morbid ity rate from a disease is defined as the proportion of people affected by that disease per year, per given unit of population. Mortality:Ameasureofillness;the rate of death from a disease in a given community or population at a precise point in time.The yearly mortality rate from a disease is defined as the ratio of deaths due to that disease,to the total number of persons in that community or population. Mucus:Mucus is a mixture com posed of water, salt,and proteins pro duced by specialized cells in the nose sinuses, and lung passages. Mucus\n\nplays a defensive role and helps to protect from infection. Mucus can also be produced in increased quanti- ties as a consequence of irritation of the mucus-producing glands, as often occurstransientlyinasthmaexacerba tions, and on a more long-term basis in chronic smokers.Doctors often use the phrase “mucus hypersecretion” when extra mucus develops. NAEPP:The National Asthma Education and Prevention Program, abbreviated NAEPP, was founded in 1989 under the auspices of the National InstituteofHealth's National Heart Lung and Blood Institute.The NAEPP aims to improve asthma care in the U.S. by teaching health professionals, asthma patients, and the general public about asthma. The NEAPP's panel of experts has published several expert panel reports\" with guide- lines for the diagnosis and manage- ment of asthma. Nebulizer:Anebulizerisadevice that transforms a respiratory drug in liquidformintoafinemistofmedi- cine particles that are easily inhaled into the respiratory passages. It is powered by a machine or compressor thatruns offelectricalcurrent orbat teries. Nebulizers are used in babies and very young children with asthma who cannot use an MDI or DPI They are also often used in an emer- gency setting.Severaldifferent classes of asthma medicines are avail- able for nebulization,including β2 agonists and inhaled corticosteroid preparations.\n\nNocturnal:Taking place or occur- ring during the night. Asthmatic exacerbations, for example, usually include nocturnal symptoms. NSAIDs: Non-steroidal anti- inflammatory drugs are often referred to as NSAIDs. The different types of NSAIDs are all potent anti-inflam matory drugs,widely prescribed for the treatment of pain, fever, and con- ditions such as arthritis.Some NSAIDs are available over the counter; others require a physician's prescription. As a rule, NSAIDs “cross react\" with aspirin, and are contraindicated in persons with aspirin-sensitive asthma. Obesity: Obesity refers to the condi tion of being significantly over- weight, or obese. A person is obese is they weight more than 30% above their ideal body weight for thein given age, height, and gender Another definition ofobesity involves computation of the BMI An overweight adult has a BMI of between 25 and 30,while an obese adult has a BMI of 30 or greater. Obstructive dysfunction:Apattern ofabnormalitydetected by pul- monary function testing. Several dif- ferent lung conditions leadto obstructive dysfunction on spirome try, one of the PFTs.Asthma is one of the conditions that, on testing, demonstrates obstructive dysfunc tion.A key element of the obstruc- tive dysfunction uniquely seenin asthma is that,by definition,the obstruction(or abnormality)is com- pletelyreversible.\n\n100 QUESTIONS&ANSWERSABOUTASTHMA\n\nOral:By mouth.Oralmedications are taken by mouth and swallowed. Onceswallowed,theydissolvein the digestive tract, and become absorbed into the bloodstream.From there, they enter the organs and tissues to exert their pharmacological effects. Oral medicines come in tablet, cap- sules,chewable, and liquid forms.\n\nOsteopath:A practitioner of\n\nosteopathy, a school of medicine orig- inally based upon the concept that the body in“correct alignment”becomes efficient at making its own remedies against illness. Osteopaths today are physiciangraduatesofosteopathic medical schools. They use the desig- nation D.O. after their names to indi- cate that they are aDoctor off Osteopathy. D.O.'s are trained to use the diagnostic and therapeutic modal- ities of“regular” medicine, in addition to manipulative methods. Osteopathy:A system of medicine that uses conventional medical reme- dies,and is based on the theory that disturbances in the musculoskeletal system affect other body parts and lead 1todisease.Consequently, manipulation of the body and muscu- loskeletal system restores health. Oxygen: Symbol O2, an odorless, col- orless gas necessary for life. The air we breathe is comprised of 21% oxygen. Peak Expiratory Flow (PEF): The PEF is part of the several different measurements obtained during the spirometry portion of PFTs.Since exacerbationsof asthma lead to decreasing values of PEF,home self-\n\nmonitoring of PEF in asthma is part of contemporary asthma manage- ment. Measuring PEF helps guide therapy. If the PEF begins to drop, anasthmaticmayneedtorestart their “rescue” inhaler, and increase their dose of inhaled corticosteroid, for example. Lightweight, home peak flow monitors are convenient and easy-to-use, even by children. Pediatrician:A physician specialized in the care of children and adolescents younger than 18 to 21 years of age. Percussion: The physical examina- tion of the lungs includes a technique called percussion that requires gently tapping on the chest wall and listen- ing to the quality of the sound pro- duced. Healthy air-filled lungs are “resonant”to percussion.Pneumonia or a fluid collection around the lungs on the other hand give rise to “dull- ness\"to percussion. PIE: A vary rare lung disease, Pul- monary Infiltrates with Eosinophilia or, PIE can have symptoms that mimic those of asthma.The chest X- rays and chest CT scans are abnormal in PIE which is one differentiating featurefrom asthma. Postnatally: After birth. Human lungs continue to grow and develop postna- tally, after birth and into infancy. Prevalence:In medicine,the total number of cases of a disease diag- nosed at a given point in time. Includes all “cases,” whether the diagnosis is new or more longstand- ing. To assess the prevalence of asthmain acommunity as ofJanuary\n\n1,for example, you would count all persons on that date who were ever told by a medical professional that they had a diagnosis of asthma. Puberty: The time at which sexual maturation begins is the start of puberty. Also refers to the time when reproductive organs develop to allow reproduction. Pulmonary Function Tests (PFTs): Include the measurement of lung vol- umes, spirometry, diffusion, and sometimesABGs Pulmonary embolus: A clot, usually originating in the leg veins that becomes lodged in the lung circula- tion. The diagnosis of pulmonary embolus can be very difficult. Pul- monary embolus leads to a variety of symptoms which can include breath- lessness and wheezing. A large or massive pulmonary embolus can be a cause of sudden death. Pulmonary symptomatology: Symp- toms experienced by an individual and related to the lungs and to the act of breathing.Wheezing, cough, breathlessness, mucus production are examples of pulmonary sympto- matology. Pulmonologist: A physician specialist with extra training and qualifications in the diagnosis and treatment of the different lung diseases. Some pulmo- nologists are pediatric specialists, as well; such specialists are known as ‘pediatric pulmonologists,” Pediatric pulmonologists treat babies, children, and adolescents with lung diseases. The other“type”of pulmonologist is\n\nan internist, who limits their practice to adults with respiratory conditions. RAST: RAST is a laboratory allergy testthatdetectsandmeasuresthe levelofIgEantibodiesdirected against specific antigens in a blood sample. Measuring blood RAST is one way of assessing the possible presence of an allergy. If a person is suspected of being allergic to grass, for example,their doctor mightsend a blood sample for RAST testing. The doctor would request a test that would detect significant levels ofl IgE directed against grasses. The absenceofanydetectableIgEto grasses would argue against a grass allergy. RAST is an abbreviation for RadioAllergoSorbentTest,”a trade mark of Pharmacia Diagnostics that originated and developed the first RAST test. RDA: Refer to the Recommended Dietary Allowance, guidelines estab- lished by the United States National AcademyofSciences’ National Research Council. The RDAs advise whatnutrientsmalesandfemales should eat at different ages. In 1997, TheNationalAcademy of Science Institute of Medicine report intro- duced the concept of Dietary Refer- ence Intakes (DRI）which have supplanted theRDAs. Remission:When used in a medical context, a remission refers to the sub- siding of disease symptoms. A person with asthma who enters a period in which they experience no asthma symptoms has entered a period ofl asthma\\_remission. The disease is still\n\npresent,but it is undetectable to the patient; it has no symptoms. Respiration:Refers to the act of breathing in (inspiration), and then out (expiration). Also refers to the process whereby the lungs exchange gases, more specifically, oxygen (O2) and carbon dioxide (CO2) at the level of the alveolus and the alveolar-capil- lary membrane. Respiratory failure: A state or illness in which the lungs become incapable of respiration.They become unable to provide the body with needed oxygen, and cannot rid the body of accumu- lated carbon dioxide and metabolic waste products. Respiratory failure can be acute, as after a car accident for example, or chronic, as in the case of emphysema. Uncontrolled asthma can result in progressive respiratory failure, a true medical emergency. Left untreated, respiratory failure is fatal. Rhinitis: Refers to an inflammation of the nasal lining. Symptoms include: an irritated,“runny” nose and itching. Rhinitis can be due to different causes including allergy. Allergic rhinitis is seen in “hay fever,” pet allergies, and ragweed allergy, for example. Rigid bronchoscopy: A type C of bronchoscopy (see Bronchoscopy) performed with a specialized surgicall instrument called a rigid broncho- scope. Rigid bronchoscopy requires general anesthesia and is indicated under differentcircumstances than flexiblebronchoscopy. Sinus: The sinuses are air-filled cavi tieswithinthehumanskull.Adults\n\nlossary\n\nhave several sinuses,named by loca tion: the frontal, ethmoid, sphenoid and maxillary sinuses. The sinuses con- tinue to form after birth; consequently, the frontal and sphenoid sinuses are not well developed in children. Sinusitis:Aninflammationofthe lining of sinuses, due most commonly toeither infection(viralor bacteriall sinusitis), or allergy (allergic sinusitis). Spacer: The name for a device that facilitates the inhalation of medicine from a metered dose inhaler (MDI) There are different brands and designs of spacers on the market. Spacers allow you to“space\" the two required steps for correct MDI use over time. Correct MDI technique requires simultaneously activating the MDI canister, releasing medicine, and inhaling as deeply as you can. Adding a spacer permits you to first activate the medicine, and then inhale deeply Spacer use makes it easier to use the MDImedicine,enhances medication delivery to the lungs, and reduces dep- osition of medicine on the voice box The last fact is important as deposi tionofinhalermedicineinthethroat and on the vocal cords not only wastes medicine, but can also lead to throat irritationandhoarseness.Holding chambers are similar to spacer devices. Some use the terms interchangeably. Spirometry: Spirometry is one of the PFTs, and is the most important PFT in the setting of asthma diagno- sis and treatment. Spirometry meas- ures the flow of air from the lungs as a person forcefully and fully exhales from a deep inspiration. During the\n\nperformance of spirometry, a subject is first asked to take a very deep breath in, and then to blow it out, as hard and as quickly as possible. Spirometry is used to detect the pres- ence of “obstructive dysfunction.”If obstructive dysfunction” is in fact present, spirometry also measures the extent of the dysfunction.An indi- vidual with well-controlled and asymptomatic asthma usually has normal values on spirometry. An exacerbation of asthma will cause the emergence of an “obstructive dys- function” pattern on spirometry. Stent:adeviceusedtomaintainthe patency of a body orifice or structure. Stethoscope: A medical instrument used to amplify and listen to sounds produced by internal organs, such as the lungs, heart, or bowels during a physicalexamination.Theprocess of listening through the stethoscope is called 1auscultation. TheFrench physicianH RenéLaennec(1781- 1826) is credited with the invention of the stethoscope. Symptoms: ：Whatt the patient notices, experiences, and reports to their treating physician as abnormal or different from usual. Symptoms can relate to changes in body appear- ance, function, or sensation. Symp- toms are always, and by definition, completely subjective. Examples of symptoms include cough, pain, breathlessness, chest tightness, and fatigue. Trachea:Thescientificnamefor the windpipe.The uppermost por-\n\ntionofthetracheacanbefeltin the front of the neck.The trachealeads air from the back of the nose and mouth into the lungs. Trigger: In the context of asthma, a trigger is a stimulus to asthma or to allergy. For example, asthma symp- toms may worsen when an asthmatic is ill with a viral respiratory infection Inthat situation,theinfection is con sidered a “trigger” for worsening asthma. Similarly, a person who is allergic to cats will notice itchy eyes and a runny nose triggered by entering a room with a resident cat. Part of allergy and asthma treatment involves correct identification of symptom \"triggers,” with the goal of avoiding them as much as possible in the future. Urticaria:Urticaria is the scientific name for hives, a type of skin rash. Hives, or urticaria, are raised, welt- like,reddened,and intensely itchy The most common cause of urticaria is an allergic reaction. Sometimes urticaria are idiopathic, meaning that no cause can be identified.Urticaria are treated with anti-inflammatory medicine,or anti-histamines,orboth. Vaccine: A vaccine is a specialized preparation designed to stimulate the body's immune system to make pro- tective antibodies directed against a specific infectious agent. Some vac- cines areinjectedintomuscle or skin; othersareinhaledorswallowed. Some vaccines protect against spe- cific viruses, such as influenza on polio; others protect against bacteria, such as haemophilus (HiB) or pneu- mococcus.Some vaccines containa\n\n00 QUESTIONS&ANSWERSABOUTASTHMA\n\nlive,weakened strain; others contain only a portion of the infectious agent. VCD:Vocal Cord DysfunctionSyn- drome,or VCD, is a condition that can be confused with asthma. VCD's primary disturbance involves the vocal cords and their abnormal ten- dency to move toward each other (rather than move apart) during inspiration, or breathing in. It is important to diagnose VCD if it is present, since asthma treatments will not beeffectiveforVCD Venous:Related to the veins.Veins are blood vessels that carry oxygen- poor and carbon dioxide-rich blood away from our organs, toward the heart and lungs, where respiration and gas exchange will take place. Ventilator:A machine that provides respiratory support to failing lungs. Respirators can provide breaths and oxygen to patients who are critically ill. They can also be used to support breathing in a non-hospital setting. Respirator machines, or “respira- tors,”\" are similar, and the terms are interchangeable. Viral: Caused by or related to a virus. Virus: A type of infectious agent. Viruses contain a single strand of\n\neither DNA or RNA,surrounded by a protein coat. Since they only contain one strand of genetic information viruses cannot replicate on their own, and require a “host\" cell for replica tion. Different viruses have different degrees of infectivity, and also infect different species. Some viruses infect plants, for example.Viruses that infect humans can cause disease. Depending on the particular virus and on the underlying health of the human, viral infections can run the gamut from mild to life-threatening. Influenza virus, for example, can be fatal. Vitamin:A substance required in minute quantities for health.Vita- mins occur naturally in a wide range of foods.Vitamin deficiencies are unusual in Western society, and reflect either a disease of the absorp- tive capacity of the gastrointestinal system with consequent malabsorp- tion of nutrients, or a severely restricteddiet. Wheeze: The abnormal sound pro- duced when air travels in and out through a narrowed breathing pas- sage or breathing tube. The narrow- ing in asthma can be due toa constriction of the breathing tube or accumulated mucus,orboth.\n\nA Allergy, 204 Aleve (naprosyn), 6 ABAI (American Board of Allergy & Immunology),83 Allopath, 82-83,20 Alveolar-capillary m ABGs (arterial blood gases), 38, 40, 96, 203 sampling, 44-45, Alveoli, alveolus, 6 American Board of ABIM(American Board of Internal Medi- cine),83 Anacin, 65,149 Anaphylaxis, anaph ABPed (American Board of Pediatrics),83 88,139,20 Acolade (zafirlukast), 64, 102, 180 ACE inhibitors,29,32 medication for, 1 Acetylsalicylic acid (aspirin), 64, 65, 105, Antibody, 205 Antihypertensive m 206 ACLS (advanced cardiac life support), 97 Arterial,205-206 Action plans, 72-75 Aspergum, 65 online, 75 Aspiration,of foreig Aspirin, 64-67, 105 Acute,203 Advair Diskus (fluticasone propionate and Aspirin-induced ast Asthma specialist, salmeterol powder), 111, 114 Asthmatic triad,63 Advil (ibuprofen), 65 Asymptomatic,206 Aerobid (flunisolide), 104, 111 Aerolizer, 111,113,114,117 Atopic dermatitis, Atrovent (ipratropiu Agonist, 203. See also β2 agonists Auscultation,206 AIA (aspirin-induced asthma), 64-67 Aventis Pharmaceu Albuterol (Ventolin),101,102,104,105, Azapropazone (Apa 111, 112 Alendronate (Fosamax),135 Azmacort (triamcin 124125 Alka Seltzer Plus, 65 Allergenic, 204 Allergens, 11, 13,33,23 B Allergic rhinitis, 88, 103, 204 β2 agonists, 52-54, Allergies, 4, 9, 10, 1214, 79, 156 102, 111, 1 diagnosing,87-88 in pregnancy,18 dust mite, 141, 166-169 Babies. See Infants a and flu vaccine, 163,165,175 Baseline hyper-reac and IgE blockers, 138-139 206-207 milk, 185, 186187 Beclomethasone (B pet,192-193 Vanceril), 1 Allergists, 87, 204 Bellevue Hospital, I\n\nAllergy, 204 Aleve (naprosyn), 65 Allopath,82-83,204 Alveolar-capillary membrane, 204-205 Alveoli, alveolus, 6-8, 205 American Board of Medical Specialties, 83 Anacin, 65,149 Anaphylaxis,anaphylactic reaction,12,26, 88,139,205 medication for,158 Antibody, 205 Antihypertensive medications,32 Arterial,205-206 Aspergum,65 Aspiration, of foreign body, 26, 46-47 Aspirin, 6467, 105106, 206 Aspirin-induced asthma (AIA), 6467 Asthma specialist, 81-84, 85-86, 87, 91, 94 Asthmatic triad, 63-64 Asymptomatic,206 Atopic dermatitis,88 Atrovent (ipratropium), 104 Auscultation,206 Aventis Pharmaceuticals, 124-125 Azapropazone (Apazone), 66 Azmacort (triamcinolone acetonide), 111, 124125\n\nOOQUESTIONS&ANSWERSABOUTASTHMA\n\n1OOQUESTIONS&ANSWERSABOUTASTHMA\n\nOOQUESTIONS&ANSWERSABOUTASTHMA\n\nanatomy and function, 6-8 development of, 8-9 Ibuprofen (Advil, Motrin), 65 IgE blockers, 102, 138-141,180 Illnesses other than asthma, 33-35 M Immunoglobulin E,88,138-141,212 Martinez,Fernando,146-147 Immunotherapy, 87-88,212 Maxair inhaler (pirbuterol), 101, 102, 104, Infants and babies, 187-188 111, 118 medication administration,53,56,58, MDIs (metered dose inhalers), 110-112, 5960, 127,128,130 113 Infections, respiratory, 78, 93, 94 and CFCs, 110-111 Infections, viral, 33 common errors in use, 121 Inflammation, 16-18 effectiveness, vs nebulizer, 129-130 Influenza,160-166,212 empty,122-123 complications, 161 spacers for, 124-126 medications for, 161-162 storage,118,119 vaccination,162-166 use of, 117-121 contraindications, 165-166 Medical training, 81-83 Information resources,197-202 Medications,100-135 internet, 201202 and addiction,186 Inhalers, 31,63,81, 92,95,100,101,103 and breastfeeding, 181 CFC-free,110,112-113 bronchodilators,149-150,152 DPIs (dry powder inhalers). See DPIs compliance with, 94 (dry powder inhalers) controller,72,76,101-103,133 effectiveness, vs nebulizer, 129-130 daily. See Controller medications list, of commonly used, 104, 111 development of, 103106,133 MDIs (metered dose inhalers). See MDIs before exercise,155-157 (metered dose inhalers) generic vs. brand name, 103-104, mechanisms of action, 107-108 105-106 Inspiration, 212 in aspirin-induced asthma, 33, 6467 Inspiratory, 212 inhalers.SeeInhalers InspirEase spacer, 125 modes of administration,101 Intal(cromolyn),56,61,63,102,111 packing,for travel, 158159 Internist, 213 in pregnancy, 175, 178-179 Intubation, endotracheal, 96-97, 211 FDA classifications, 179-181 Ipratropium (Atrovent),104 quick-relief, 101, 102, 103 in step 1 treatment,53-54 1 in step 2 treatment, 55-56 Jet nebulizer, 121, 127 in step 3 treatment,58-59 steroid. See Steroids as symptom producers,29,32,79 Medrol (methylprednisolone), 102, 133 LAIV (live, attenuated influenza vaccine, Menstrual cycle, and exacerbations,141 164165 Merck, 104 Larynx, 213 Methacholine challenge test, 16, 43-44, 213 Leptin,146,213 Methylprednisolone,102,133 Leukotriene, 213 Mild intermittent asthma, 5154,64,100 antagonists,33 Mild persistent asthma, 52, 5557, 59, modifiers,55,56,59,61,63,66, 100101, 101, 102 102-103, 180 Milk allergy, 185, 186187 in pregnancy, 180 Moderate persistent asthma,52,57-59,64 Lung disease, 25-30, 31, 39 Montelukast (Singulair), 66, 102, 156, 180 Lungs Montreal Protocol, 108, 109-110\n\n1OOQUESTIONS&ANSWERSABOUTASTHMA\n\nlorbidity,213 Occupational asthma (OA), 67-70 Iortality, 213 Occupational exposures to toxins, 33 lotrin (ibuprofen),65 Omalizumab (Xolair), 138, 139-141,180 Iouth care, after inhalers,121122 Oral, 215 IRI (magnetic resonance imaging),39 Oral care, after inhalers, 121122 ucus,20,21,23,25,31,47,213214 Organizations,198-200 Iyths,about asthma,186 Oseltamivir (Tamiflu), 161-162 Osteopath,osteopathy,83,215 Osteoporosis,glucocorticoid-induced (GIO), 134-135 AEPP (National Asthma Education and Oxygen, 45-46, 215 Prevention Program), 40, 50-51, low levels,81,90,95,96 214 asthma classification,41,52,55,57,59 Ozone,108-109 Expert Panel Report: Guidelines for the Diagnosis and Management of P Asthma, 5051,55,57,59,183 Pamprin, 65 and medication recommendations, Paraxanthine,149 5051, 55,57, 59, 100 Pari Respiratory Equipment Company, aprosyn (Alleve),65 126 ational Academy of Science's National Peak expiratory flow (PEF), 40, 41-43,53, Research Council, RDAs, vita- 55,58,60,215 mins, 143144 monitoring,73,74 ational AsthmaEducation andPrevention for children, 190-192 Program (NAEPP), 40, 50-51, 72, during pregnancy, 175 75 Pediatrician,215 Expert Panel Report: Guidelines for the Pentazozine (Talwin),65 Diagnosis and Management of Pepto Bismol, 65 Asthma, 50-51,55,57,59,86 Percodan,62 ational Health Interview Survey (CDC), 4 Percussion, 215 ationalInstitutes of Health'sNational Pet allergies, 192-193 Heart, Lung and Blood Institute PET scan (positron emission tomography), (NHLBI), 50, 200 39 ebulizer,126129,214 Physical education, school, 190 care of, 128-129 Physical exam,22,28,36,37,38,43 effectiveness, vs. inhaler, 129-130 Physician,initial assessment by, 3637 use of, 127-128 Physicians, 202 edocromil (Tilade),56,61,102,111,180 allergists, 88 ighttime symptoms. See Nocturnal symp- asthma specialists, 82-83, 85-86 toms general practitioners, 85 octurnal, 214 medical training, 81-83 octurnal symptoms, 20,21, 34, 106-107 PIE (pulmonary infiltrates with oDoze,149 SAIDS (non-steroidal anti-inflammatory eosinophilia), 29, 31, 215 Pirbuterol (Maxair), 101,102,104,111, drugs), 64, 65, 66, 214 118 utrition,186-187 Pneumonia, 78 Postnatally, 215 Prednisolone,102 besity, 145-149, 214 Prednisone, 102, 133-134 and early puberty,147 Pregnancy, 174-181 and sedentary lifestyle, 145-146 and asthma, treatment goals,175 bliterative bronchitis,28 exacerbations in, 174-175 bstructive dysfunction, 214 and flu vaccine, 163, 175\n\nOOQUESTIONS＆ANSWERSABOUTASTHMA\n\nmedications in,178-181 School PEF monitoring, 175 physical education classes,190 smoking, risks, 175177 treatment at,193 uncontrolled asthma in, 175, 178 Scuba diving, 158 180-181 Search engines, internet, 202 Prevalence, 4, 14, 215216 Seasons, change of, 4, 17, 18 and gender,184 Self-management.See also Peak expiratory Prevention, of exacerbation,12-13,17,18, flow (PEF),monitoring 23 plan, 72-75 compliance with medications, 76-77 Serevent (salmeterol xinafoate powder),104, Propoxyphene (Darvon), 65 111, 114 Proventil (albuterol), 104, 105, 111 Severe persistent asthma,52,590 Psychological issues, 169-170, 186 Severity, classifications of, 5152 Puberty, 147,216 Singulair (montelukast), 104, 156,180 Pulmicort (budesonide), 111, 114,180 Sinus, 217 Pulmicort Respules, 111, 127 Sinusitis,32,33,217 Pulmonary embolus, 29, 31, 216 Sleep, interrupted. See Nocturnal symptoms Pulmonary function tests (PFTs), 38, Smoking,5,9-10,11,14,28,30,31,33,78 39-41, 216 during pregnancy, 175-177 Pulmonary sarcoidosis, 28 second-hand, 194195 Pulmonary symptomatology,216 Sodium salicylate,66 Pulmonologist, 216 Spacers, 124-126, 217 Specialist, consulting, 187-188 Q Spiriva (tiotropium),102 Spirometry, 29, 30, 38, 39-42, 43-44, Quick-relief medications,101,102,103 217-218 Quiescent vs.exacerbated asthma,16 Sports. See Exercise Qvar HFA (beclomethasone), 111, 112 Stent,218 Step 1 treatment, 53-54 R Step 2 treatment,55-56 RADS (reactive airways dysfunction syn- Step 3 treatment,58-59 drome), 69 for children, 58 Stepwise approach, to medications,100101 RAST (RadioAllergoSorbentTest), 216 RDA (recommended daily allowance), for Steroids,130-135,209-210 vitamins,143-144,216 corticosteroids vs.anabolic steroids, Relenza (zanamivir),161-162 131 Remission, 216-217 inhaled,56,57,101,102,111,127 Rescue inhalers, 101, 102, 103 oral, 57, 59 Research, on prevention, 1314 in pregnancy, 180 Resources, information, 197-202 “rescue”，53,54,55,57 Respiration, 217 safety of, 130-131 Respiratory failure, 93, 94-95, 217 side effects,133-135 Rhinitis,32,33,217 use of, 121122, 124125 Rigid bronchoscopy, 46-47, 217 using safely, 131134 Rotahaler,113,114,117 Stethoscope,22,23,38,218 Runge, Friedrich Ferdinand, 149 Strachan, David, 14 Stress, as trigger, 78 Sulfites,33,78 S Swimming,153-155 Salicylamide, 66 Symptoms,20-22,186,218 Salmeterol (Sevevent), 102, 114 nocturnal, 20 Samter, Max, 64 serious, 90 Samter's Syndrome, 64 wheezing. See Wheeze, wheezing\n\nVaccines,218-219 influenza, 162-166 contraindicatiosfor.165-166"}}